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1. PUBLIC HEALTH STATEMENT
This Statement was prepared to give you information about fluorine, hydrogen
fluoride, and fluorides, and to emphasize the human health effects that may result from
exposure to them. The Environmental Protection Agency (EPA) has identified 1,334 sites on
its National Priorities List (NPL) sites. Fluoride-containing compounds have been found
at 130 of these sites. Fluorine has been found at 28 of these sites, and hydrogen
fluoride or hydrofluoric acid have been found at 19 of the sites. However, we do not know
how many of the 1,334 NPL sites have been evaluated for fluorine, hydrogen fluoride, or
fluorides. As EPA evaluates more sites, the number of sites at which fluorine, hydrogen
fluoride, and fluorides are found may change. The information in this profile is
important for you because fluorine, hydrogen fluoride, and fluorides may cause harmful
health effects and because these sites are potential or actual sources of human exposure
to fluorine, hydrogen fluoride, or fluorides.
When a chemical is released from a large area such as an industrial plant, or from
a container such as a drum or bottle, it enters the environment as a chemical emission.
This emission, which is also called a release, does not always lead to exposure. You are
exposed only when you come into contact with the chemical. You can come into contact with
it in the environment through breathing, eating, or drinking substances containing the
chemical. Exposure may also result from skin contact with it.
If you are exposed to substances such as fluorine, hydrogen fluoride, or fluorides,
several factors determine whether harmful health effects will occur and what the type and
severity of those health effects will be. These factors include the dose (how much), the
duration (how long), the route or pathway by which you are exposed (breathing, eating,
drinking, or skin contact), the other chemicals to which you are exposed, and your
individual characteristics such as age, sex, nutritional status, family traits, life
style, and state of
health.
1.1 WHAT ARE FLUORINE, HYDROGEN FLUORIDE, AND FLUORIDES?
Fluorine is a pale, yellow-green, irritating gas that has a strong, sharp odor. It
is so chemically reactive that it is nearly always found combined with metals as a salt.
Fluorine is unlikely to be released from landfills as a gas because it rapidly combines
with many earth materials to form fluoride compounds in the soil.
Hydrogen fluoride is a colorless gas that is made up of a hydrogen ion and a fluoride
ion. It readily dissolves in water, where it is also colorless at room temperature. The
dissolved form is called hydrofluoric acid. Hydrogen fluoride may be found at hazardous
waste sites.
In this profile, the term fluorides will be used to refer to the common salts of
the element fluorine. Examples of fluorides include sodium fluoride
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and calcium fluoride. Sodium fluoride and calcium fluoride are white solids.
Sodium fluoride dissolves easily in water, but calcium fluoride does not.
Fluoride salts as a group are properly called fluorides. However,
because toxic effects are due to the fluoride ion, the word fluoride is used
in discussing health effects. Certain fluoride-containing compounds can
reasonably be expected to occur at hazardous waste sites. These may include
sodium fluoride and calcium fluoride. Cryolite is a mineral that contains
sodium, fluoride, and aluminum and is used in making aluminum metal. It may
also be found at hazardous waste sites.
Fluorides are found in many natural materials such as coal, clay, and
minerals. They also occur naturally in the earth's crust. Fluorides can be
released to the air from these substances when they are heated to high
temperatures, such as in aluminum smelters; glass, brick, and tile works; and
plastic factories. The biggest natural source of fluorides released to the
air is volcanic eruptions. Once released to the air, fluorides are carried by
wind and rain onto nearby water, soil, and food sources.
The biggest natural source of fluorides in soil and water is the
breakdown of rocks containing fluoride. Fluorides are removed from surface
water, such as lakes and streams, when they attach to particles in the water.
Some phosphorus fertilizers have fluorides in them. Use of these fertilizers
may also cause fluorides to enter food and water supplies. Some plants, such
as tea, accumulate fluorides and concentrate them in their leaves and stems.
Fluorine is used in rocket fuels, and in making glass, enamel, and
bricks. Hydrogen fluoride is used mainly in making aluminum and in making
chlorofluorocarbons (CFCs). Fluorides are used in making steel, chemicals,
ceramics, lubricants, dyes, and plastics. They are also used as pesticides,
mainly against ants and roaches. Fluorides are also added to some medicines
and household products such as toothpaste and mouth rinses. Substances
containing radioactive fluorine can be used to help visualize tumors in
medical tests. Fluorides are added to drinking water to prevent cavities in
many communities where the water supply is naturally low in fluoride.
For more information on the chemical properties of fluorine, hydrogen
fluoride, and fluorides, and their production, use, and fate in the
environment, see Chapters 3, 4, and 5.
1.2 HOW MIGHT I BE EXPOSED TO FLUORINE, HYDROGEN FLUORIDE, OR FLUORIDES?
Because fluorides are part of the earth, you are exposed to small
amounts of them in air, water, and soil. These amounts are called background
levels. Fluorides are found in your body fluids, bones, and tissues.
Fluorides are normally found in very small amounts in the air. Levels
measured in areas around cities are usually less than 1 microgram of fluoride
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per cubic meter (µg/m3) of air. Rural areas where few people live have even
lower levels. Air around hazardous waste sites or factories that use or
produce hydrogen fluoride or fluoride compounds may contain high levels of
these chemicals.
Levels of naturally occurring fluorides in surface water such as rivers,
streams, and lakes usually range from 0.01 to 0.3 parts of fluoride per
million parts of water (ppm). Levels of fluorides in underground water are
usually higher than those found in rivers, streams, and lakes (0.02-1.5 ppm).
Sea water generally has more fluoride than fresh water. Levels in sea water
range from 1.4 to 1.5 ppm. Surface and groundwater levels near industrial
sites using fluorides may be higher than normal if fluorides are released. In
areas near hazardous waste sites, you are most likely to be exposed to higher
than normal levels of fluorides by drinking contaminated groundwater.
Workers may be exposed to high levels of hydrogen fluoride or cryolite
in the air if their work involves certain machinery, air transportation,
medical and other health services, textile and metal manufacturing, or
petroleum and coal production. Workers in these jobs may breathe in levels as
high as 2.5 milligrams of fluoride per cubic meter (mg/m3) of air. Some
hazardous waste sites contain containers of hydrofluoric acid. If material
leaks from these containers, clean-up workers can be exposed to hydrofluoric
acid. In areas near hazardous waste sites, you are not likely to be exposed
to hydrofluoric acid because the acid will react with soil to form fluoride
salts before it reaches you. Some hazardous waste sites may contain fluorine
in pressurized containers. Fluorine reacts even faster than hydrofluoric
acid. It is very unlikely that people living near a hazardous waste site
would be exposed to fluorine.
The level of fluorides in soils is usually between 200 and 300 ppm.
However, soils with high amounts of minerals may have higher amounts of
fluorides. Some industrial processes, such as the removal of phosphorus from
rocks during fertilizer manufacture or the smelting of aluminum, can release
fluorides to the air. The released fluorides can then settle on the soil.
Higher than normal levels of fluorides in soil have also been found at
hazardous waste sites. You could be exposed to fluorides through contact with
these soils.
Food grown in areas where soils have high amounts of fluorides or where
fertilizers containing fluorides are used may have high levels of fluorides.
Tea and some seafoods have been found to have high levels of fluorides. Food
cooked in water with added fluorides may also have increased fluoride levels.
To prevent dental decay (caries), fluorides are sometimes added to
drinking water to achieve levels of about 1 ppm. You may also come in contact
with fluorides from using household items. Most of these are dental products,
such as toothpastes, fluoride gels, and fluoride rinses. If you swallow the treated
water, or these products, you will be exposed to fluoride. Swallowing
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toothpaste can account for a large percentage of the fluoride to which a small
child might be exposed. Certain medicines used to treat some skin diseases
and cancer contain fluorides, and using them also increases exposure. Skin
contact with products such as lubricants and oils containing fluorides or
hydrofluoric acid may also increase your exposure. The average daily fluoride
intake from food and water is estimated to be about 1 milligram (mg) if you
have water that is not artificially fluoridated, and about 2.7 mg if you have
fluoridated water.
For more information on how you can be exposed to fluorine, hydrogen
fluoride, or fluorides, see Chapter 5.
1.3 HOW CAN FLUORINE, HYDROGEN FLUORIDE, BODY, AND FLUORIDES ENTER AND
    LEAVE MY BODY?
When you breathe in air containing fluorine, fluoride can enter your bloodstream through
your lungs, but it is not known how quickly this happens.  Much of the fluoride leaves
your body in urine, but some is stored in your
bones and teeth.
When you breathe in air containing hydrogen fluoride or fluoride dusts,
it enters your bloodstream quickly through your lungs. When hydrofluoric acid
touches skin, most of it can quickly pass through the skin into the blood.
How much of it enters your blood stream depends on how concentrated the
hydrofluoric acid is and how long it stays on your skin. Almost all of the
fluoride that enters the body in these ways is quickly removed from the body
in the urine, but some is stored in your bones and teeth.
Generally, most of the fluoride in food or water that you swallow enters
your bloodstream quickly through the digestive tract. However, the amount
that enters your blood stream also depends on factors such as how much of the
fluoride you swallowed, how well the fluoride dissolves in water, whether you
ate or drank recently, and what you ate or drank. It is likely that you will
vomit if you drink water that contains high levels of fluoride, and the
vomiting will probably also reduce the amount of fluoride that enters your
bloodstream. Things such as age, sex, and health status affect what happens
to the fluoride ion once it is in your body. After entering your body, about
half of the fluoride leaves the body quickly in urine, usually within several
days. Most of the fluoride ion that stays in your body is stored in your
bones and teeth.
For more information on how fluorine, hydrogen fluoride, and fluorides
enter and leave your body, see Chapter 2.
1.4 HOW CAN FLUORINE, HYDROGEN FLUORIDE, AND FLUORIDES AFFECT MY HEALTH?
Fluorine. Fluorine gas is very irritating and very dangerous to the eyes, skin, and
lungs. Fluorine gas at low concentrations makes your eyes and
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nose hurt. At higher concentrations, it becomes hard to breathe. Exposure to
high concentrations of fluorine can do so much damage to your lungs that it
can kill you.
Hydrogen Fluoride. Hydrogen fluoride is also a very irritating gas.
Hydrogen fluoride is not as dangerous as fluorine, but large amounts of it can
also cause death. The actual amounts that cause death are not known because
these measurements are hard to make. Breathing in a large amount of hydrogen
fluoride with air can also harm the lungs and heart. The human health effects
of breathing moderate amounts of hydrogen fluoride for several months are not
well known, but rats that breathed hydrogen fluoride for several months had
kidney damage and nervous system changes, such as learning problems. If you
breathe hydrogen fluoride or fluoride-containing dust for several years,
changes in your bones, called skeletal fluorosis, can happen. Skeletal
fluorosis is further described below.
Hydrofluoric acid is dangerous to humans because it can burn the eyes
and skin. The initial exposure to hydrofluoric acid may not look like a
typical acid burn. Skin may only appear red and may not be painful at first.
Damage to skin may happen over several hours or days, and deep, painful wounds
may develop. When not treated properly, serious skin damage and tissue loss
can occur. In the worst cases, getting a large amount of hydrofluoric acid on
your skin can lead to death caused by the fluoride affecting your lungs or
heart. The major public health concern regarding hydrofluoric acid is related
to short-term exposure at work.
Fluoride. Several medicines that contain fluoride are used for treating
skin diseases and some cancers. In addition, small amounts of sodium fluoride
are added to toothpaste or drinking water to help prevent dental decay. In
1991, the Public Health Service (PHS) of the U.S. Department of Health and
Human Services completed a report on the risks and benefits of exposure to
fluorides in drinking water. The PHS report determined that 50 years of
experience shows that adding fluorides to drinking water supplies (water
fluoridation) has reduced tooth cavities. The PHS also noted that there are
health and economic benefits of water fluoridation for people of all ages and
social and economic groups, especially for children who do not get adequate
dental care.
However, exposure to certain levels of fluoride can harm your health.
The health effects depend on the type of fluoride you are exposed to, how long
you are exposed, and how much gets into your body. In general, the more
soluble the fluoride-containing substance is, the more toxic it is. Drinking
or eating fluoride during the time teeth are being formed can cause visible
changes in teeth. These changes increase in severity with increasing levels
of fluoride. The condition is called dental fluorosis. In the most mild
cases, there are a few almost invisible white spots on the teeth. In moderate
cases, there are large white spots on the teeth (mottled teeth), and some
brown spots. In severe cases, the teeth are pitted and have many brown
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stains. Symptoms are not identical for all children exposed to the same level
of fluoride. In general, some children who drink water with 1 ppm fluoride
may get a few small spots or slight discolorations on their teeth. Some
children who drink water with 4 ppm fluoride in it for long periods before
their permanent teeth are in place may get brown spots or pitting on their
teeth. At these higher levels of fluoride, the teeth can become more fragile
and sometimes develop a greater number of cavities.
Skeletal fluorosis can be caused by eating, drinking, or breathing large
amounts of fluorides. This disease only occurs after long-term exposures and
can cause denser bones, joint pain, and a limited range of joint movement. In
the most severe cases, the spine is completely rigid. Skeletal fluorosis that
severely limits movement is extremely rare in the United States. It is more
common in places where people do not get proper nutrition. Although fluoride
exposure results in denser bones, the bone appears to be weaker than normal
bone. Fluoride has been used to treat women with osteoporosis. However,
these women have a greater risk of breaking a bone if they take fluoride pills
containing over 30 mg fluoride per day. Fluorides in drinking water may
increase the risk of old women and men breaking a bone. If you eat relatively
large amounts of sodium fluoride, it can cause stomach aches, vomiting, and
diarrhea. Still larger amounts can cause death by damaging your stomach and
affecting your heart.
It is not known whether fluoride affects reproduction in people.
Certain animal species, such as cows and various birds, have reproductive
problems when they eat or drink large amounts of fluoride. Some experiments
have found reproductive effects of fluoride in laboratory animals, while
others have not. The significance of these results to human health is
unclear. It is also not known whether fluoride causes birth defects in people
or animals. Fluoride does cross the placenta from the mother's blood to the
developing fetus. However, no birth defects related to fluoride were seen in
newborn humans in one study. No experiments have studied developmental
effects of fluoride using standard testing methods. Some animal studies have
found developmental effects of fluoride, while others have not. As with
reproductive effects, cows may be more sensitive than laboratory animals.
Studies have been done to see if fluoride causes cancer in people who
live in areas with fluoridated water or naturally high levels of fluoride in
drinking water, or people who work in jobs where they may be exposed to
fluorides. The studies that were well-designed have generally not found any
association between fluoride and cancer in people. However, these studies may
not have been sensitive enough to have detected very low cancer rates. A
large study of fluoride conducted by the National Toxicology Program with both
rats and mice found that a small number of male rats developed bone cancer
after drinking water with high levels of fluoride in it throughout their
lives. This was considered equivocal evidence that fluoride causes cancer in
male rats. Fluoride did not cause cancer in mice or female rats. Another
study found no evidence that fluoride causes cancer in rats. Both animal
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studies had problems that limited their usefulness in showing whether or not
fluoride can cause cancer in humans. It is not known if the same effects
would be seen in people exposed the same way. The bone cancer seen in the rat
study is rare in humans, although its frequency has recently increased among
males in counties with fluoridated water. In spite of this geographical
association, a careful analysis by the National Cancer Institute indicates
that exposure to fluoride in drinking water was not the cause of this
increase.
For more information on the health effects of fluorine, hydrogen
fluoride, and fluorides, see Chapter 2.
1.5 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO
    FLUORINE, HYDROGEN FLUORIDE, OR FLUORIDES?
Urine samples can be analyzed to find out if you have been exposed to
fluorides. The fluoride level in the sample is compared to the level of
fluoride usually found in urine. This will show if a person has been exposed
recently to higher than normal levels of fluorides. However, this test cannot
be used to predict any specific health effects that may occur after fluoride
exposure. The urine test must be performed soon after exposure because
fluoride that is not stored in the bones leaves the body within a few days.
This test can be done at most laboratories that test for chemical exposure.
Blood sampling does not provide as good a measure of exposure to fluoride as
urine sampling. Bone sampling can be done in special cases to measure long-
term exposure to fluorides. Because fluorine, hydrogen fluoride, and fluorides all enter
the body as fluoride, these tests can not distinguish among exposure to these different
chemicals. However, the tests are not normally used to monitor fluorine exposure.
For more information on medical tests to determine exposure to fluorine,
hydrogen fluoride, and fluorides, see Chapters 2 and 6.
1.6 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT
    HUMAN HEALTH?
Fluorine, hydrogen fluoride and sodium fluoride have been named
hazardous substances by EPA. Spills of more than 10 pounds of fluorine,
100 pounds of hydrogen fluoride, or 1,000 pounds of sodium fluoride must be
reported to the National Response Center. The highest level allowed by the
Occupational Safety and Health Administration (OSHA) for fluorine in air for
an 8-hour work day, 40-hour work week is 0.2 milligrams of fluorine per cubic
meter of air (mg/m3); for hydrogen fluoride it is 2.5 mg/m3. The highest
level of fluoride allowed by OSHA for an 8-hour work day, 40-hour work week is
2.5 mg/m3. The maximum amount of fluoride allowed in drinking water by EPA is
4 mg/L. EPA recommends that states limit the amount of fluoride in drinking
water to 2 mg/L.
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Scientists within the PHS recently formed a committee to study the risks
and benefits of exposure to fluoride. The committee prepared a report that
states that fluoride in drinking water helps to prevent tooth decay. However,
the scientists also said that there is a need to study fluoride further to
find out more about other possible health effects in humans and animals
exposed to fluoride in drinking water.
For more information on recommendations regarding exposure to fluorine,
hydrogen fluoride, and fluorides, see Chapter 7.
1.7 WHERE CAN I GET MORE INFORMATION?
If you have any more questions or concerns not covered here, please
contact your state health or environmental department or:
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road, E-29
Atlanta, Georgia 30333
This agency can also provide you with information on the location of the
nearest occupational and environmental health clinic. Such clinics specialize





The primary purpose of this chapter is to provide public health
officials, physicians, toxicologists, and other interested individuals and
groups with an overall perspective of the toxicology of fluorine, hydrogen
fluoride, and fluorides, and a depiction of significant exposure levels
associated with various adverse health effects. It contains descriptions and
evaluations of studies and presents levels of significant exposure for
fluorine, hydrogen fluoride, and fluorides based on toxicological studies and
epidemiological investigations.
Fluorine is a gaseous element that occurs only in very low concentrations in the
environment in the absence of anthropogenic sources (see Chapter 5 for further
discussion). Because it is strongly electronegative, it is rarely found in the
environment in the elemental state, nor is it likely to be found in the environment near
toxic waste sites as molecular fluorine. Hydrogen fluoride is also a gas and it is very
water soluble. When hydrogen fluoride is dissolved in water it is called hydrofluoric
acid.
Hydrogen fluoride is very water-soluble and dissolves readily in any water present
in the air or other media. Although hydrofluoric acid is very corrosive and can etch
glass, it is a weak acid, meaning that it can be present in water as an undissociated
molecule. However, in dilute solutions it is almost completely ionized; salts are formed
if cautions are available. Due to formation of complexes, very concentrated solutions of
hydrofluoric acid are also largely ionic in nature. Therefore, a hydrogen fluoride or
hydrofluoric acid spill would result in contamination with fluoride ion, but hydrogen
fluoride or hydrofluoric acid would not be of concern outside the immediate vicinity of
the spill. However, while members of the public are only likely to come into contact with
fluoride contamination, clean-up workers could be exposed to hydrogen
fluoride/hydrofluoric acid. In this profile, hydrogen fluoride is used to refer to the
gas, while hydrofluoric acid is used to refer to the liquid form. When both forms are
included, the word hydrogen fluoride is used.
The term fluoride properly refers to numerous natural and synthesized
compounds that are derived from hydrofluoric acid. This class of chemicals is
commonly referred to as fluorides. Some of these compounds, such as oxygen
difluoride, are very reactive and highly toxic. Because of their reactivity,
these compounds would not migrate unchanged from a hazardous waste site.
Fluoride salts, such as sodium fluoride and calcium fluoride, are much less
reactive and much less toxic. Since the fluoride ion is the toxicologically
active agent, and discussion of water fluoridation uses the term fluoride, the
term fluoride is used generically in this profile to refer to toxicology of
fluoride salts. Because numerous different fluoride compounds exist naturally
in the environment and have varying chemical properties, the term fluorides is
used in the discussion of environmental media. Most of the available
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literature on fluoride toxicity concerns sodium fluoride. Additional toxicity
literature is available on some other forms of fluoride, such as stannous
fluoride. Other forms of fluoride are discussed only if exposure is likely to
occur at a hazardous waste site. (Such exposure to stannous fluoride is not
likely.) Wherever the form of fluoride exposure is known, that salt is
identified in the profile.
Limited information also exists concerning occupational exposure to the
mineral cryolite (Na3A1F6), sometimes with concomitant exposure to hydrogen
fluoride. Because these exposures usually involve exposure to both hydrogen
fluoride and cryolite, sometimes along with exposure to other fluoride dusts,
they are discussed separately in the profile.
This profile will discuss data, or the absence of data, concerning the
toxicity of inorganic compounds of fluorine which people could be exposed to
at a hazardous waste site. Exposure and toxicity are discussed separately for
fluorine, hydrogen fluoride/hydrofluoric acid, and fluoride. Toxic effects of
occupational exposure in aluminum reduction plants, where exposure to hydrogen
fluoride, fluoride dusts, and cryolite all occur, are also discussed
separately. Because the toxic effects of fluorine are largely due to the
action of the fluorine molecule on the respiratory tract or other exposed
surfaces, fluorine exposure is reported as exposure to a level of diatomic
fluorine. By contrast, systemic effects of hydrogen fluoride are due to the
fluoride ion, so concentrations of hydrogen fluoride are converted to fluoride
equivalents. All doses of fluoride are reported as amount of fluoride ion.
The primary routes and durations of concern vary with the different
fluorine compounds. In general, the more soluble the fluoride is, the more
that can be absorbed by oral ingestion, and the more toxic it is. The primary
exposure routes and duration for hydrofluoric acid are by the inhalation or
dermal routes, related to acute occupational exposure, while the primary
exposure route and duration for fluoride is chronic exposure to fluoride in
the drinking water (often as sodium fluoride) and in food. Therefore, most of
the information for the inhalation and dermal routes comes from studies of
acute exposure to fluorine or hydrofluoric acid, while most of the information
regarding the oral route is based on sodium fluoride. The toxicity following
inhalation or dermal exposure to other inorganic fluorine compounds differs
from that of hydrofluoric acid. Similarly, oral exposure to various fluorides
other than sodium fluoride may result in different toxic effects.
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
To help public health professionals address the needs of persons living
or working near hazardous waste sites, the information in this section is
organized first by route of exposure--inhalation, oral, and dermal--and then
by health effect--death, systemic, immunological, neurological, developmental,
reproductive, genotoxic, and carcinogenic effects. These data are discussed
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in terms of three exposure periods--acute (less than 15 days), intermediate
(15-364 days), and chronic (365 days or more).
Levels of significant exposure for each route and duration are presented
in tables and illustrated in figures. The points in the figures showing noobserved-
adverse-effect levels (NOAELs) or lowest-observed-adverse-effect
levels (LOAELs) reflect the actual doses (levels of exposure) used in the
studies. LOAELs have been classified into "less serious" or "serious"
effects. These distinctions are intended to help the users of the document
identify the levels of exposure at which adverse health effects start to
appear. They should also help to determine whether or not the effects vary
with dose and/or duration, and place into perspective the possible
significance of these effects to human health.
The significance of the exposure levels shown in the tables and figures
may differ depending on the user's perspective. For example, physicians
concerned with the interpretation of clinical findings in exposed persons may
be interested in levels of exposure associated with "serious" effects. Public
health officials and project managers concerned with appropriate actions to
take at hazardous waste sites may want information on levels of exposure
associated with more subtle effects in humans or animals (LOAEL) or exposure
levels below which no adverse effects (NOAEL) have been observed. Estimates
of levels posing minimal risk to humans (Minimal Risk Levels, MRLs) may be of
interest to health professionals and citizens alike.
Estimates of exposure levels posing minimal risk to humans (MRLs) have
been made, where data were believed reliable, for the most sensitive noncancer
effect for each exposure duration. MRLs include adjustments to reflect human
variability in the extrapolation of laboratory animal data to health effects
in humans.
Although methods have been established to derive these levels (Barnes et
al. 1988; EPA 1990), uncertainties are associated with these techniques.
Furthermore, ATSDR acknowledges additional uncertainties inherent in the
application of the procedures to derive less than lifetime MRLs. As an
example, acute inhalation MRLs may not be protective for health effects that
are delayed in development or are acquired following repeated acute insults,
such as hypersensitivity reactions, asthma, or chronic bronchitis. As these
kinds of health effects data become available and methods to assess levels of
significant human exposure improve, these MRLs will be revised.
2.2.1 Inhalation Exposure
Inhalation exposure most commonly occurs in an occupational setting. As
discussed above, most of the available information concerning toxic effects of
fluorine and its compounds following inhalation exposure comes from studies of
exposure to hydrogen fluoride or hydrofluoric acid. There are also a limited
number of useful studies concerning inhalation exposure to fluorine or
12
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particulates of inorganic fluoride compounds. However, no animal studies were
located regarding toxic effects of exposure to the particulate fluoride
compounds. Toxic effects of hydrogen fluoride are discussed in all of the
following sections. Where toxicity data exist for fluorine or fluoride, these
substances are also discussed.
Fluorine gas is extremely irritating. The primary health effects of
acute fluorine inhalation are nasal and eye irritation (at low levels), and
death due to pulmonary edema (at high levels). In animals, renal and hepatic
damage have also observed.
Acute inhalation of hydrogen fluoride following facial splashes with
hydrofluoric acid can cause bronchiolar ulceration, pulmonary hemorrhage and
edema, and death. In addition, renal and hepatic damage have been observed in
animal studies. Many of the human studies regarding inhalation of hydrogen
fluoride fumes also involved dermal exposure; in such cases, it is difficult
to determine which effects are specific to the inhalation route. However, the
respiratory effects of hydrogen fluoride appear to be inhalation-specific,
since they have not been reported in cases where there was clearly no
inhalation exposure. The effects of combined inhalation and dermal exposure
to hydrofluoric acid are also discussed in Section 2.2.3.
The major health effect of chronic inhalation exposure to fluoride is
skeletal fluorosis, which has been reported in cases of exposure to fluoride
dusts and hydrogen fluoride, either individually or in combination.
2.2.1.1 Death
Both fluorine and hydrogen fluoride can cause lethal pulmonary edema,
although cardiac effects also contribute to the toxicity of hydrogen fluoride.
The reported LC50 values for hydrogen fluoride (in mg/m3 as fluoride) in rats
for a given duration are generally at least 3.5-fold the value for fluorine
(as diatomic fluorine) in rats for the same duration. Although strain
differences could account for some of this difference, the LC50 of hydrogen
fluoride in Crl:CD®BR and Wistar-derived rats was very similar.
Fluorine. No information was located on death in humans caused by
fluorine. Fluorine toxicity has been investigated in Osborne-Mendel rats,
Swiss-Webster mice, New England guinea pigs, and New Zealand rabbits
(Keplinger and Suissa 1968). Similar values for the LC50, were calculated for
the different species. In the rats, the LC50 for exposures of 5, 15, 30, and
60 minutes were 1,088, 606, 420, and 287 mg/m3, respectively. At concentrations
near the LC50, few signs of intoxication were observed immediately
after exposure, except for irritation of the eyes and nose. Several hours
after exposure, the animals exhibited lethargy, dyspnea, and general weakness.
Except at concentrations above the LC90, death generally occurred 12-18 hours
after exposure. Animals that survived for 48 hours generally survived for the
duration of the observation period. Loss of body weight was also observed but
was considered nonspecific and was attributed to anorexia.
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Toxic effects of inhalation exposure to fluorine and hydrogen fluoride
were compared in rats, mice, rabbits, and guinea pigs (Stokinger 1949).
Lethal doses from fluorine exposure determined by this group are about
3-4 times those determined by Keplinger and Suissa (1968), but quantitative
exposure level data from these experiments are not reliable due to technical
problems in monitoring fluorine gas levels. However, qualitative results from
these experiments are useful. These experiments also found that fluorine was
more toxic than hydrogen fluoride.
There are some indications that pre-exposure to low levels of fluorine
may provide resistance to lethal effects of fluorine. Increased survival
times were seen in New Zealand rabbits when challenged 48 hours after a pre-exposure
regimen (Keplinger 1969). For example, 4 weeks of exposure to
78 mg/m3 for 30 minutes once/week increased the survival time following a 30-
minute challenge with 622 mg/m3 from a maximum of 18 hours to 48 hours. Small
increases in the LC50 were observed when mice were pre-exposed four times in 7
days to 39 mg/m3 for 15 minutes/exposure, followed by a challenge exposure
24-168 hours later. No mechanism for the possible tolerance was suggested.
Repeated exposures of rats, mice, guinea pigs, and rabbits to 0.8, 3, 8,
or 25 mg/m3 fluorine were conducted for up to 178 hours over 35 days
(Stokinger 1949). The exposure regimen was not stated, but appears to be
5-6 hours/day, 5 days/week. The exposure levels at these lower concentrations
were considered fairly reliable. Guinea pigs and rats were less sensitive to
lethal effects than were rabbits or dogs. All of the rabbits, mice, and dogs
exposed to 25 mg/m3 died, while only half of the rats and guinea pigs died.
The highest exposure level at which some rabbits survived was 3 mg/m3. Almost
all animals of all species survived exposure to 0.8 mg/m3.
Hydrogen Fluoride. Acute inhalation of hydrogen fluoride fumes in
combination with dermal exposure to hydrofluoric acid has been reported to
cause death in humans. Actual exposure concentrations are not known in any of
these cases. Death was generally due to pulmonary edema (resulting from
irritation and constriction of the airways), or cardiac arrhythmias with
pronounced hyperkalemia, hypocalcemia, and hypomagnesemia.
The death of a chemist who sustained first-and second-degree burns of
the face, hands, and arms when a vat containing hydrofluoric acid accidentally
ruptured has been described (Kleinfeld 1965). This 29-year-old male died
10 hours after admission to the hospital. Postmortem examination revealed
severe tracheobronchitis and hemorrhagic pulmonary edema. A petroleum
refinery worker was splashed in the face with 100% anhydrous hydrofluoric acid
(Tepperman 1980). The absorption of fluoride produced acute systemic fluoride
poisoning with profound hypocalcemia and hypomagnesemia and cardiac
arrhythmias. The patient died less than 24 hours after exposure; autopsy
revealed pulmonary edema. A young woman splashed in the face with
hydrofluoric acid died of respiratory insufficiency a few hours after exposure
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(Chela et al. 1989). The autopsy revealed severe burns of the skin and lungs,
with hemorrhagic pulmonary edema produced by hydrofluoric acid and its vapor.
The lethal concentration of hydrogen fluoride has been investigated in
rats, mice, and guinea pigs. It appears that mice are more sensitive to the
acute effects of hydrogen fluoride than are rats, and rats are more sensitive
than guinea pigs. The 15-minute LC50 values for hydrogen fluoride were
3,362 mg fluoride/m3 for guinea pigs and 2,090 mg fluoride/m3 for Wistar-derived
rats (Rosenholtz. et al. 1963). The 60-minute LC50 for hydrogen
fluoride in ICR-derived mice was 266 mg fluoride/m3 (Wohlslagel et al. 1976),
while in rats it has been reported as 1,084 mg fluoride/m3 for a Sprague-
Dawley-derived strain (Wohlslagel et al. 1976) and 1,016 mg fluoride/m3 for a
Wistar-derived strain (Rosenholtz et al. 1963).
The LC50 values reported by Haskell Laboratory (1988) for Crl:CDBR rats
were much higher than the values reported by the above investigators, although
the size of the discrepancy decreased with longer exposure durations. For
example, the 15-minute LC50, was reported as 5,144 mg/m3, while the 60-minute
LC50 was 1,251 mg/m3. Although the concentration of hydrogen fluoride that
produced death was reported to be lower when it was administered to rats in
humid air (Haskell Laboratory 1988), the method for measuring fluoride in
humid air may not have given accurate results. This limitation was recognized
by the authors, who stated that the collection efficiency of the sampling
train for aerosols was not evaluated.
Longer-term effects of hydrogen fluoride were investigated by exposing
various species to 7 or 24 mg/m3 hydrogen fluoride for 6 hours/day,
6 days/week, for 30 days (Stokinger 1949). Humidity was 47-97% at the lower
concentration, and 48-66% at the higher concentration. Marked species
differences were observed. All rats and mice exposed to 24 mg/m3 died, but no
guinea pigs, rabbits, or dogs exposed at this level died. No animal of any
species died following exposure to 7 mg/m3. In an experiment where five
rabbits, three guinea pigs, and two Rhesus monkeys were exposed to 14.4 mg/m3
for 6-7 hours/day, 5 days/week, for 50 days (309 hours total), the only deaths
observed were two guinea pigs (Machle and Kitzmiller 1935). Exposure of one
of these animals stopped after 134 hours' exposure, and exposure of the other
one stopped after 160 hours, when marked weight loss was observed. Nevertheless,
the animals died about 2 weeks later.
The LC50 values for each species and duration category of exposure to
fluorine are recorded in Table 2-l and plotted in Figure 2-l. The LC50 values
for each species and duration category of exposure to hydrogen fluoride are
recorded in Table 2-2 and plotted in Figure 2-2.
2.2.1.2 Systemic Effects
The predominant systemic effects of acute inhalation exposure to







Kidney and liver necrosis have also been observed in animals. No data were
located regarding chronic inhalation exposure to fluorine. Most of the data
that were located regarding systemic effects of chronic inhalation exposure
are from occupational exposure to fluoride dusts, sometimes in combination
with hydrogen fluoride. In these cases, the predominant systemic effect is
skeletal fluorosis. Pre-existing conditions were generally not determined in
the occupational or case studies, and levels of exposure and exposure
durations were often approximations.
The highest NOAEL values and all reliable LOAEL values for systemic
effects in each species and duration category of exposure to fluorine are
recorded in Table 2-1 and plotted in Figure 2-1. The highest NOAEL values and
all reliable LOAEL values for systemic effects in each species and duration
category of exposure to hydrogen fluoride are recorded in Table 2-2 and
plotted in Figure 2-2.
Respiratory Effects. Both fluorine and hydrogen fluoride irritate the
respiratory tract and can cause hemorrhaging in a duration-and concentration-dependent
manner. Nasal irritation is discussed under dermal exposure (Section 2.2.3) because it is
caused by direct contact with the gases.
Fluorine. Limited data are available regarding respiratory effects of
fluorine on humans. Five volunteers (gender not specified) (19-50 years of
age) were exposed to fluorine through a face mask that covered the eyes and
nose but not the mouth (Keplinger and Suissa 1968). A concentration of
16 mg/m3 was not irritating to the respiratory tract for at least 15 minutes.
Intermittent inhalation (not defined further) of 36 mg/m3 over a 5-minute
period did not cause respiratory difficulty. Higher levels were tested only
by exposure of the face and eyes. The study is limited by the small number of
subjects tested.
An occupational cohort study comparing the incidence of respiratory
complaints by 61 exposed workers with over 2,000 "unexposed" workers found no
increase in the exposed group (Lyon 1962). The average fluorine level was
1.4 mg/m3, and the maximum measured value was 38 mg/m3. The study author
concluded that the workers became "hardened" to the irritating effects of
fluorine. The study is limited in that both groups were also exposed to
uranium hexafluoride and hydrogen fluoride. The method of measuring
respiratory complaints (visits to the plant medical department) was also not
very sensitive. However, the observation of tolerance caused by repeated low
level exposures is supported by the results from animal studies discussed in
Section 2.2.1.1 and later in this section (Keplinger 1969).
Dyspnea and diffuse lung congestion were reported for Osborne Mendel
rats and Swiss-Webster mice exposed to concentrations greater than or equal to
∼25% of the LC50 (i.e., 263 mg/m3 for both species) for 5 minutes (Keplinger
and Suissa 1968). Similar effects were seen at levels greater than or equal
to ∼25% of the LC50 for longer exposure durations (15-60 minutes), although








severity of the lung congestion was concentration related. Rats and mice exposed
for 15-60 minutes, to ∼50% of the LC50 developed irritation of the nose.
In the single-exposure experiments of Stokinger (1949), rabbits that
died from fluorine exposure generally had severe edema of the alveoli, along
with necrosis of the bronchial epithelium in some animals. "Infectious
processes" were noted in some rabbits that survived exposure to the higher
levels, suggesting that bronchial defenses were damaged. Similar effects were
noted in rats, except pulmonary hemorrhage was noted in rabbits but rarely in
rats. Technical problems with monitoring the fluorine concentration made the
concentration data unreliable. Pulmonary irritation was also observed in
rabbits that died from the repeated exposures to fluorine and in rats at the
high-exposure level. Nasal irritation was observed in dogs and rats subjected
to repeated exposures to 25 or 8 mg/m3.
Swiss-Webster mice that were pre-exposed once to 47 mg/m3 fluorine for
60 minutes, and were then exposed to 183-637 mg/m3 fluorine for 15 minutes
after an interval of 4-96 hours showed markedly less lung pathology than
animals that were not pretreated (Keplinger 1969)., At the highest level (637
mg/m3)exposure, 4 hours prior to the challenge reduced the lung pathology from the most
severe rating to a rating of normal-mild. Pre-exposure also reduced the increased lung
weight otherwise seen following fluorine exposure. However, a similar pre-exposure
regimen only resulted in slight increases in the LC50, as discussed in Section 2.2.1.1.
Hydrogen Fluoride. Acute inhalation of 100 mg/m3 hydrogen fluoride by
two male volunteers produced marked respiratory irritation within 1 minute
(Machle et al. 1934). Pulmonary edema, pulmonary hemorrhagic edema, and
tracheobronchitis have been reported in cases of people being splashed in the
face with hydrofluoric acid, where concurrent inhalation and dermal exposure
are likely (Chan et al. 1987; Chela et al. 1989; Dieffenbacher and Thompson
1962; Kleinfeld 1965; Tepperman 1980). Exposure concentrations were not known
in these cases.
Lethality studies in animals have also reported respiratory effects in
rats, mice, and guinea pigs from acute inhalation exposure to hydrogen
fluoride. True respiratory effects, such as respiratory distress, pulmonary
congestion, and intraalveolar edema were generally observed at levels of at
least ~50% of the LC50 (Haskell Laboratory 1988; Rosenholtz et al. 1963;
Wohlslagel et al. 1976). These effects appear to be reversible within a week
upon cessation of exposure. Irritation of the conjunctivae and nasal tissues
is a result of direct contact with hydrogen fluoride, and is discussed under
dermal effects.
Pulmonary hemorrhage was noted in dogs,24 mg/m3 for 6 hours/day, rabbits and rats
exposed to 7 mg/m3, 6 days/week for 30 days (Stokinger 1949). At
no effect was seen in rats or rabbits, and localized hemorrhages were
seen in only l/5 dogs.
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Pulmonary hemorrhage, alveolar inflammation, and hyperplasia of the
bronchial epithelium were observed in guinea pigs that died due to exposure to
14.4 mg/m3 for 6-7 hours/day, 5 days/week, for about 35 days (Machle and
Kitzmiller 1935). This effect was not readily reversible. The one surviving
guinea pig had alveolar exudates, thickening of the alveolar walls, and
hemorrhages of the lungs when necropsied 9 months after the conclusion of the
full 50-day exposure period. Similarly, all four rabbits exposed under the
same conditions had lobular pneumonia and leucocytic infiltration of the
alveolar walls, sometimes with edema and thickening of the walls, when
necropsied 7-8 months after the last exposure. No clinical signs of toxicity
were reported in rabbits and weight gain was generally similar to the
controls. This study is limited by the small number of animals used and the
incomplete reporting of the data.
Hydrogen Fluoride and Fluoride Dusts. A study of an occupational cohort
exposed to hydrogen fluoride and fluoride dusts in the pot rooms of an
aluminum smelter reported a significantly lower forced expiratory volume and
increased cough and sputum production in the, highest exposure group, compared
with controls who worked in the office or casting department and were reported
to have no significant occupational exposure to air contaminants. Corrections
were made for age, height, and smoking habits. The ambient air fluoride
concentration in the high-exposure area was 0.2 mg fluoride/m3 as vapor
(presumably hydrogen fluoride) and 0.28 mg/m3 "particulate fluoride." It is
not clear whether the latter value represented the air concentration of
fluoride in particulates or the concentration of the particulates that contain
fluoride. Actual exposure was unknown because the workers wore respirators.
Although urinary fluoride levels increased over the course of one work shift
in the high-exposure group and not in the control group, the decrease in
respiratory volume in the same time period was about the same in both groups
(Chan-Yeung et al. 1983a). This effect was attributed to the fact that the
exposed workers wore respirators; historical use of respirators was not
reported. Since actual exposure was not known, no quantitative relationship
between clinical symptoms and environmental or urinary fluoride levels could
be established. There also may have been concomitant exposure to other
respiratory irritants.
No studies were located regarding respiratory effects in animals
following inhalation of fluoride dusts.
Cardiovascular Effects
Hydrogen Fluoride. Cardiac arrhythmias have been seen in humans
following hydrofluoric acid splashes in the face region, where both dermal and
inhalation exposure were involved (Chan et al. 1987; Tepperman 1980). It is
not known whether inhalation exposure alone would cause these effects.
However, myocardial necrosis and congestion were observed in three rabbits
following inhalation exposure of 22.8 mg/m3 anhydrous hydrogen fluoride for an
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unspecified period (Machle et al. 1934). The study was limited by the small
sample size and undetermined exposure period.
Gastrointestinal Effects
Hydrogen Fluoride. A population exposed to airborne hydrogen fluoride
near a smelter reported nausea (22.6%) and diarrhea (21.7%). The corresponding levels
reported by a control population were 6.9% and 12.1%, respectively. The total level of
gastrointestinal complaints was 70.5% and 36.2% in the subject and control populations,
respectively. The subject population appears to have been derived by self-selection and
random house-to house sampling, while the control population lived in a non industrial
area. Although atmospheric concentrations were not presented, concentrations of fluoride
in animals and plants in the area surrounding the smelter were substantially above
normal. The smelter was also reported to emit metallic oxide fumes (Waldbott 1979).
Hematological Effects
Fluorine. No studies were located on hematological effects of
inhalation exposure of humans to fluorine. No effect on complete blood count
parameters was observed following exposure of Osborne-Mendel rats to
concentrations up to 221 mg/m3 for 60 minutes, or at concentrations up to
511 mg/m3 for 15 minutes (Keplinger and Suissa 1968). These concentrations
were higher than the corresponding LC50 values. Blood counts were monitored
for 21 days post-exposure. Similarly, Stokinger (1949) saw no effect on
hematological parameters in dogs, rabbits, or rats following repeated
exposures at concentrations up to lethal levels (25 mg/m3 for 95 exposure
hours over 21 days). This study did not specify which parameters were
measured.
Hydrogen Fluoride. Hemograms of 20 variables (not specified) determined
in the rat (30/group), rabbit (10/group), and dog (4/group) following exposure to 24 mg/m3
for 6 hours/day, 6 days/week, and dog (4/group) following exposure for 30 days showed no
clear changes (Stokinger 1949).
Five rabbits and two rhesus monkeys were exposed to 14.4 mg/m3 hydrogen
fluoride via inhalation 6-7 hours a day, for 50 days (Machle and Kitzmiller
1935). Blood counts were done beginning 1 week prior to exposure and ending
3 months after the final exposure. There was a small but significant decrease
in erythrocyte levels in both species, but the study authors considered that
the result may have been due to biological variation. Significant increases
in hemoglobin levels were seen in monkeys. There was no effect on hemoglobin
levels in rabbits or leucocyte levels in either species. These experiments
used only a few animals from each species, and the exposure measurement
technology was not very precise.
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Hydrogen Fluoride and Fluoride Dusts. No signs of hematological
effects, as measured by routine blood counts, were seen in a large cohort of
aluminum workers exposed to total fluoride levels below 2.5 mg/m3 for
durations of up to at least 10 years (Chan-Yeung et al. 1983b). Similarly, no
increase in abnormal findings was seen in 74 workers exposed at a phosphate
fertilizer plant (Derryberry et al. 1963). The average urinary fluoride level
in the exposed group was 4.6 mg/L. Significantly reduced levels of hemoglobin
were reported in Slovak children aged 6-14 years living near an aluminum
smelter (Macuch et al. 1963), but no information was provided on any
statistical tests used. No information was provided on air fluoride
concentrations, but urinary fluoride levels were about 0.8 mg/L for 6-ll-year old
children, and about 0.4 mg/L for 12-14-year-old children. In an outdated
study of 78 workers exposed to cryolite, anemia was present in 11/30 subjects
with pathological bone changes (Moller and Gudjonsson 1932). Blood parameters
were not analyzed for the workers without bone changes.
Musculoskeletal Effects. Skeletal fluorosis is a clinical syndrome
sometimes seen following chronic exposure to fluoride. It is characterized by
increased x-ray bone opacity, exostoses, and calcification of ligaments.
Symptoms may include bone and joint pain, and limited range of movement.
Skeletal fluorosis has been reported following exposure to hydrogen fluoride,
cryolite, and sodium fluoride.
Fluorine. No data were located regarding musculoskeletal effects of
fluorine inhalation on humans.
Fluoride levels in the teeth of rats exposed to 25 mg/m3 for
approximately 5 hours/day, 5 days/week for 21 days were about 14 times the
levels in controls; fluoride levels in the femur were about 6 times that of
the controls (Stokinger 1949). The appearance of the teeth was characterized
as corresponding to that of very mild to mild dental fluorosis. The fluoride
levels in the teeth and bone at lower concentrations decreased in a
concentration-related manner. Pigment changes were reported as just
perceptible in animals exposed to 3 mg/m3.
Hydrogen Fluoride. A male exposed for 10 years to hydrogen fluoride at
an alkylation unit of an oil company complained of back pains, leg pains, and
loss of memory (Waldbott and Lee 1978). Initially, time away from work lessened
the symptoms, but as time on the job increased, the symptoms persisted
throughout periods away from work. During hospitalization following an
accident, advanced osteoarthritis of the spine was diagnosed. Based on bone
fluoride measurements of 1,100 ppm 10 years after exposure ceased, the study
authors concluded that the worker suffered from chronic intoxication resulting
from frequent, variable exposures to airborne hydrogen fluoride. However,
concomitant exposure to petroleum products, while not reported, cannot be
ruled out as a cause of the pains and memory loss.
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Duration- and concentration-related increases in tooth and bone fluoride
levels were reported in the rat following exposure to 7 or 24 mg/m3 for
6 hours/day, 6 days/week for up to 30 days (Stokinger 1949). The study author
did not report whether there were any visible or radiological signs of dental
or skeletal fluorosis.
Hydrogen Fluoride and Fluoride Dusts. Marked evidence of skeletal
fluorosis was reported in workers exposed to gaseous fluoride (largely
hydrogen fluoride) and fluoride dust in the pot rooms of the aluminum industry
(Kaltreider et al. 1972). Individual exposure concentrations and durations
were not presented. However, the estimated time-weighted average (TWA) 8-hour
exposure to total fluorides for one plant ranged from 2.4 to 6.0 mg/m3.
Average urinary fluoride levels were about 9 mg/L. Exposure at a second plant
was lower as a result of industrial hygiene measures; no TWA was available,
but urinary fluoride levels ranged from 1.4 to 4.6 mg/L. No skeletal changes
were observed at the second plant, and detailed physical examinations of the
workers at both plants revealed no general health impairment. No data were
presented that correlated urinary fluoride levels to the presence or absence
of fluorosis.
In a follow-up study of 59 of the potroom workers at the second plant,
the average preshift (after 48 hours away from work) urinary fluoride level
was 2.24 mg/L (range, 1.4-3.1). The average level after 3-5 working days
(postshift) was 5.68 mg/L (range, 2.7-10.4). In spite of this evidence of
fluoride exposure, there was no radiological evidence of any fluoride-related
bone abnormalities (Dinman et al. 1976c). Total occupational exposure ranged
from 10 to 43 years. This study may provide urinary fluoride levels that are
not associated with any bone effects in healthy adults. However, since only
workers who remained at the high-exposure tasks for the duration of the study
were examined, any sensitive population that may have found work elsewhere
because of adverse health effects might have been missed.
Clinical and radiological investigations were performed for
2,258 aluminum workers exposed to fluoride for an average of 17.6 years
(Czerwinski et al. 1988). The form of fluoride was not reported, but it was
probably hydrogen fluoride and fluoride dust. Possible fluorosis (multiple
joint pains, limited motion in at least two joints or in the spine, and
initial ossifications visible on x-ray films) was found in 14% of the workers.
The prevalence of definite fluorosis, with advanced limitation of movement in
at least two joints or the spine, marked ossifications, and osteosclerosis, or
more severe symptoms, was 6.2%. The study authors reported finding a close
positive correlation between the occurrence of fluorosis and the time and
level of fluoride exposure. Another health study of 2,066 workers in an
aluminum smelter reported early signs of skeletal fluorosis in pot room
workers employed for more than 10 years. No effects, however, were seen in
workers exposed for less than 10 years. Actual airborne fluoride levels
measured at the time of the health assessment were 0.2 mg/m3 hydrogen fluoride
and 0.28 mg/m3 fluoride dusts. Historical fluoride levels were not reported,
30
2. HEALTH EFFECTS
although the study authors implied that exposure levels had been below
2.5 mg/m3 for some period (Chan-Yeung et al. 1983b).
While the above studies generally found radiologically-apparent skeletal
fluorosis appearing prior to or concurrent with musculoskeletal symptoms,
Carnow and Conibear (1981) found musculoskeletal symptoms in aluminum workers
in the absence of radiological findings. Questionnaire answers suggested a
significant increase in incidence and severity of musculoskeletal disease and
fracture frequency with fluoride exposure. By contrast, there was no
exposure-related increase in evidence of skeletal fluorosis on chest and
spinal X-ray films that were analyzed blind. Neither radiologic data nor
actual exposure levels or durations were reported. As the authors recognized,
the exposure group was heterogeneous and were exposed to other chemicals, and
some of the musculoskeletal symptoms may have actually been due to heavy
physical labor.
Fluoride. A 58-year-old man was exposed to various fluoride compounds
(chiefly sodium fluoride) for 30 years while employed in a chemical plant.
The route of exposure was presumed to be inhalation with some concomitant
dermal exposure. He had fluoride deposits in almost all of his bones, but the
main accumulation was in the vertebrae, ribs, and pelvic bones (McGarvey and
Ernstene 1947). No other effects were observed that could be attributed to
the fluoride exposure. Another man exposed almost daily for 18 years to a
finely ground rock phosphate dust containing 3.88% fluoride had "thicker and
heavier" bones with a white, chalky material covering the surface as observed
by x-ray (Wolff and Kerr 1938). His bones also appeared more opaque when
compared by x-ray to normal bones.
No studies were located regarding musculoskeletal effects in animals
after inhalation exposure to fluoride.
Hepatic Effects
Fluorine. No studies were located regarding hepatic effects of fluorine
inhalation in humans. Mice exposed to fluorine exhibited coagulation necrosis
of the liver, periportal hemorrhages, and diffuse cloudy swelling (Keplinger
and Suissa 1968). These effects were generally observed after exposure to
concentrations near 50% of the LC50, i.e., at 303, 180, or 124 mg/m3 for 5,
30, or 60 minutes, respectively. Pathology occurred at a somewhat lower level
following a 15 minute exposure, i.e., 224 mg/m3, or about 40% of the LC50
Damage became apparent 7-14 days after exposure. Liver congestion was
reported in dogs, but not in other species subjected to repeated exposures to
fluorine (about 5 hours/day, 6 days/week) at a concentration that killed all 5
dogs by the 60th hour of exposure (Stokinger 1949).
Hydrogen Fluoride. Ten animals (five rabbits, three guinea pigs, and
two rhesus monkeys) were exposed via inhalation to 14.4 mg fluoride/m3 as
hydrogen fluoride 6-7 hours a day, for 50 days (Machle and Kitzmiller 1935).
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Fatty degeneration of the liver parenchyma, scattered focal necroses, and
fibroblastic encroachment of periportal spaces were observed in the guinea
pigs. Two of the three guinea pigs began losing weight after about 145 hours
of exposure, were withdrawn from the exposure regimen, and died about 2 weeks
later. Generalized fatty changes were also seen in two of four rabbits
sacrificed 7 months after exposure termination. These experiments used only a
few animals from each species, and the exposure measurement technology was not
very precise.
Hydrogen Fluoride and Fluoride Dusts. The occupational health study by
Chan-Yeung et al. (1983b) discussed above revealed no adverse effects on liver
function, as measured by levels of total bilirubin, serum glutamic oxaloacetic
transaminase (SGOT), and alkaline phosphatase.
Renal Effects
Fluorine. No studies were located regarding renal effects of fluorine
inhalation in humans. Mice exposed to fluorine exhibited focal areas of
coagulation necrosis in the renal cortex and focal areas of lymphocyte
infiltration in the cortex and medulla (Keplinger and Suissa 1968). The
percentage of the LC50 at which effects were observed increased with exposure
duration and ranged from -19% of the LC50, following a 5-minute exposure to
∼36% of the LC50, following 30- or 60-minute exposures. Damage became apparent
7-14 days postexposure.
Hydrogen Fluoride. Pathologically elevated serum creatinine and urea
levels were seen 24 hours after accidental dermal and inhalation exposure to a
mixture of 70%-80% sulfuric acid and 10% hydrofluoric acid at 150°C (Braun et
al. 1984). Neither the effect of the sulfuric acid nor the exposure levels
were known.
Degeneration and necrosis of the renal cortex was reported in 27/30 rats
exposed to 24 mg fluoride/m3 as hydrogen fluoride for 6 hours/day, 6 days/
week, for up to 30 days, but not in rats exposed to 7 mg/m3 (Stokinger 1949).
Pathological examination of rabbits and guinea pigs (n=3/species/exposure
level) exposed to hydrogen fluoride revealed tubular necrosis, congestion, and
edema (Machle et al. 1934). A variety of different exposure levels and
duration’s were tested, but the levels at which exposure-related effects were
seen were not reported. Rabbits (n=4) exposed via inhalation to 14.4 mg
fluoride/m3 as hydrogen fluoride 6-7 hours a day, for 50 days, developed
degeneration and necrosis of convoluted tubules, accompanied by fibrous tissue
replacement of cortical tissues (Machle and Kitzmiller 1935). Degenerative
and inflammatory changes were also seen in the single exposed monkey at
necropsy. The experiments described in both of these papers used a small
number of animals, and no control data were presented.
Hydrogen Fluoride and Fluoride Dusts. Increased incidence of
albuminuria (p<0.1) was observed in phosphate fertilizer plant workers with an
average urinary fluoride level of 4.6 mg/L (Derryberry et al. 1963). However,
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the testing method used in this study is considered hypersensitive (Dinman et
al. 1976a), and several other studies have found no effects. No signs of
renal effects, as measured by standard renal function tests, were seen in a
large cohort of aluminum workers exposed to total fluoride levels estimated to
be below 2.5 mg/m3 (Chan-Yeung et al. 1983b). Two other studies of aluminum
workers failed to find an increase in the incidence of albuminuria (Dinman et
al. 1976c; Kaltreider et al. 1972). Average postshift urinary fluoride levels
were ≤5.68mg/L (Dinman et al. 1976c) and ≤9.6mg/L (Kaltreider et al. 1972).
The exposed population included workers exposed to estimated air fluoride
levels of 4-6 mg/m3 (time-weighted average), of which 50% was gaseous fluoride
(presumably hydrogen fluoride) (Kaltreider et al. 1972).
The weight of evidence indicates that typical inhalational occupational
exposure to hydrogen fluoride and fluoride dust is not nephrotoxic. The
overall animal data indicate that inhalation exposure to sufficiently high
levels of hydrogen fluoride or fluorine can cause kidney damage, but the
relavance to human health and the potential nephrotoxic level cannot be
determined because of generally incomplete human and animal data. In
addition, only one animal experiment was located that conducted a histopathic
exam following fluorine exposure.
Dermal/Ocular Effects. Dermal/ocular effects have been seen following
whole body inhalation exposure of humans and animals to fluorine and hydrogen
fluoride. The effects are believed to be due to irritation caused by direct
dermal contact with these gases, so they are discussed in the dermal exposure
section (see Section 2.2.3).
Other Systemic Effects
Fluorine. Decreased weight gain was observed in rats, guinea pigs, and
rabbits exposed to 25 mg/m3 fluorine (and somewhat lower levels) for about
5 hours/day, 5 days/week for 35 days. While a decrease compared to the low exposure level
group is clear, no control animals were used, so the lowest
level with a significant change is unclear.
Hydrogen Fluoride. Pronounced weight loss shortly before death was
observed in rats exposed to a lethal level of hydrogen fluoride (24 mg/m3 for
6 hours/day, 6 days/week for 30 days). Guinea pigs exposed under the same
conditions lost weight following the third exposure week, even though there
were no deaths (Stokinger 1949). While a decrease compared to the low exposure
level group is clear, no control animals were used, so the lowest
level with a significant change is unclear. Animals surviving a lethal
exposure exhibited a body weight loss of 10-15% for up to a week after
exposure (Rosenholtz et al. 1963).
2.2.1.3 Immunological Effects
No studies were located regarding immunological effects in humans or




Fluorine. No studies were located regarding neurological effects in
humans of fluorine following inhalation exposure. Dogs exposed to 8 or 25 mg/m3
for 5-6 hours/day, 5-6 days/week for up to 35 days had seizures for prior to death
(Stokinger 1949). Because no further details were available, the
neurotoxic potential of fluorine cannot be evaluated.
Hydrogen Fluoride. The threshold of the light adaptive reflex was
measured as a marker for neurological effects in three subjects following
exposure to hydrogen fluoride at concentrations of 0.02, 0.03, or 0.06 mg/m3
fluoride (Sadilova et al. 1965). While the threshold level was determined to
be 0.03 mg/m3, it is not clear whether this response is due to irritation of
mucous membranes or is the result of an effect on cerebral cortical function.
Details of atmosphere generation were not provided.
Exposure to concentrations at about 50% of the LC50 values was reported
to cause general weakness and decreased activity in rats of a Wistar-derived
(Rosenholtz et al. 1963). Albino rats given 24-hour exposures to either 0.1
or 0.03 mg/m3 hydrogen fluoride for 5 months developed central nervous system
dysfunctions, as evidenced by diminished conditioned responses and increased
time before motor nerve response. Histological studies showed changes in the
nerve cell synapses of only those animals exposed to 0.1 mg/m3. A
concentration of 0.01 mg/m3 was found to be without effect on conditioned
responses, latency in motor nerve response, or neurohistological parameters.
When additional stresses were added (alcohol, 24-hour starvation), the
conditioned responses were extinguished more frequently (Sadilova et al.
1965). Some recovery in conditioned responses was seen following a l-month
recovery period in the animals exposed to 0.1 mg/m3. Animals exposed to
0.03 mg/m3 recovered completely.
All reliable LOAEL values for neurological effects of exposure to
hydrogen fluoride in each species and duration category are recorded in
Table 2-2 and plotted in Figure 2-2.
2.2.1.5 Developmental Effects
No studies were located regarding developmental effects in humans or
animals after inhalation exposure to fluorine, hydrogen fluoride, or fluoride.
2.2.1.6 Reproductive Effects
2.2.1.6.Reproductive Effects
Fluorine. Rats exposed to 25 mg/m3 fluorine for 95 hours over the course
of 21 days showed testicular degeneration (Stokinger 1949). No further
details were available. It is not clear whether this effect was seen both in
animals that died and in those that survived. Furthermore, it is not clear
whether this is a systemic effect or a result of irritation from dermal
contact with the gas.
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Hydrogen Fluoride. All four dogs exposed to 24 mg/m3 for 6 hours/day,
6 days/week for 30 days developed degenerative testicular changes and
ulceration of the scrotum (Stokinger 1949). This effect was not seen at
7 mg/m3, or in rabbits or rats at either exposure level. No further details
were available. Furthermore, it is not clear whether this is a systemic
effect or a result of irritation from dermal contact with the gas.
No studies were located regarding reproductive effects in humans after
inhalation exposure to fluorine, hydrogen fluoride, or fluoride, and no
studies were located regarding reproductive effects in animals after
inhalation exposure to fluoride.
2.2.1.7 Genotoxic Effects
No human in vivo data were located regarding the genotoxicity of
fluorine, hydrogen fluoride, or fluoride.
Hydrogen Fluoride. Data on the genotoxic effects, if any, following
inhalation exposure to hydrogen fluoride are very limited. Cell damage was
reported in bone marrow cells of unpedigreed female white rats exposed by
inhalation to hydrogen fluoride for 6 hours, 6 days a week, for 1 month, at
1.0 mg/m3 (Voroshilin et al. 1975). This was the only concentration tested.
The increased rate of damaged cells was due largely to an increase in
hyperploidy, an effect for which the biological relevance is unknown. These
investigators also tested for dominant lethal mutations in C57Bl mice and
found that the number of resorbed and developing embryos did not differ
significantly from those of the controls at the concentration tested.
Drosophila melanogaster eggs were collected from adults of two different
strains that were exposed for 3 or 6 weeks to 1.0 or 2.2 mg fluoride/m3 as
hydrogen fluoride, and reproductive parameters were measured as an indicator
of genotoxicity (Gerdes et al. 1971b). Both the number of eggs per female and
male fertility were significantly reduced, but the analysis did not indicate
the exposure level(s) or duration(s) at which the reduction was significant.
The maximum lethality to adults of one strain was 60%; under most of the test
conditions the lethality was ≤40%.
Other genotoxicity studies are discussed in Section 2.4.
2.2.1.8 Cancer
Hydrogen Fluoride and Fluoride Dusts. Most occupational exposure to
fluoride occurs as a result of inhalation of hydrofluoric acid fumes or dust
from cryolite or fluorspar. A cohort of cryolite workers in Denmark was
reported to have an increase in mortality and morbidity from respiratory
cancer compared with the national average (Standardized Mortality Ratio of
2.52 [95% confidence limit between 1.40 and 4.12], Standardized Incidence
Ratio of 2.5 [95% confidence limit between 1.6 and 3.51) (Grandjean et al.
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1985). The study authors stated that the increase can be explained by the
fact that the respiratory cancer death rate for the Copenhagen area is about
twice the national average for the birth cohorts from 1890 to 1929, so that
comparison with national rates may not be appropriate. Respiratory cancer
rates for the workers were slightly higher than those of the general population of
Copenhagen, but the difference was not significant. No explanation for the high
Copenhagen rates was offered.
Increased lung cancer rates have reported in several studies of aluminum
industry workers (Andersen et al. 1982; Gibbs and Horowitz 1979; Milham 1979),
but no correction was made for smoking and the workers were also exposed to
tars and polycyclic aromatic hydrocarbons. Similarly, fluorspar miners had
increased lung cancer rates, but they were exposed to elevated radon levels
(devilliers and Windish 1964). A cohort study of 21,829 workers in aluminum
reduction plants for ≥5 years did not find an increase in lung cancer, but did
report an increase in mortality due to pancreatic cancer, lymphohematopoietic
cancers, genitourinary cancer, and nonmalignant respiratory disease (Rockette
and Arena 1983). Only the effect on pancreatic cancer was statistically
significant. Increases in hematopoietic cancers and respiratory disease were
also reported by Milham (1979). Because of the confounding factors mentioned
above, and since no breakdown was done by fluoride exposure, these studies are
of questionable relevance to the issue of possible carcinogenicity of
inhalation exposure to hydrogen fluoride and/or fluorides.
A study was published describing a positive relationship between
increased lung cancer and residing near, or working in, the steel industry
(Cecilioni 1972). Possible occupational exposures to other carcinogenic
substances from steel and other industries were not considered. Carcinogenicity
via inhalation of fluoride is not considered to be likely by most
investigators reporting in the existing literature.
No studies were located regarding cancer in animals after inhalation
exposure to fluorine, hydrogen fluoride, or fluoride.
2.2.2 Oral Exposure
Because fluorine and hydrogen fluoride are gases, oral exposure to these
substances occurs only concomitant with inhalation exposure. Oral exposure to
hydrofluoric acid has been reported very rarely. Except where otherwise
indicated, the following sections regarding oral exposure discuss oral
exposure to fluoride.
Much of the research on fluoride exposure in humans has focused on the
ingestion of fluoride through supplemented public drinking water supplies.
Additional information comes from studies of areas with high natural fluoride
levels. Drinking water levels of other minerals may differ between
artificially fluoridated areas and areas with naturally high fluoride levels.
Chronic fluoride ingestion can affect bone structure and possibly nerve and
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muscle function. High skeletal fluoride levels can lead to skeletal
fluorosis, a disease characterized by increased bone density. The most severe
form of fluorosis can result in crippling deformities, but this is extremely
rare in the United States. Teeth mottling is another chronic effect that can
occur in children exposed to fluoride during tooth formation. A review of
studies concerning dental fluorosis found that in the surveyed cities with
water containing 0.7-1.2 ppm (the level to which water is fluoridated), an
average of 10%-20% of the children had barely noticeable changes in their
teeth, while up to 1% had brown spots due to fluoride (DHHS 1991). Based on
this result, the study concluded that total fluoride intake from multiple
sources has risen since the optimal water fluoridation levels were set.
Much of the data regarding toxic effects of oral exposure to fluoride
were obtained from studies using sodium fluoride. Fluoride is often added to
water in the form of hydrofluosilicic acid, so exposure to this chemical is
included in some epidemiological studies. Other studies investigate oral
exposure to calcium fluoride, hydrofluoric acid, cryolite, and fluoride in
rock phosphate. For all forms of fluoride discussed, doses are reported as
amount of the fluoride ion.
Conflicting results have been obtained from experiments addressing
whether fluorine is an essential element. Much of this conflict appears to
result from the great difficulty in preparing an animal diet that has
negligible amounts of fluoride, but otherwise allows normal animal growth and
development. Different conclusions have been reached by different official
organizations. The National Research Council (NRC) concluded that the results
do not justify a classification of fluorine as an essential element (NRC
1989), while the World Health Organization (WHO) lists fluorine as essential
for animal life, without providing supporting data (WHO 1973).
As discussed in Section 2.2.2.6, there have been suggestions that
fluoride can aid fertility by improving intestinal absorption of iron and
other trace elements (Messer et al. 1973; Tao and Suttie 1976). In a study
where fluoride was rigorously removed from dietary components, a total of
110 Wistar rats were observed over the course of four generations (Maurer and
Day 1957). There were no adverse effects compared to controls that received
the same diet and 0.28 mg fluoride/kg/day in drinking water. Animals fed the
low-fluoride diet were healthy, had sleek coats and healthy teeth, and had
similar weight gains to those of the controls. Low success in bringing pups
to weaning (50%) was reported for both the low-fluoride and control groups.
No fluoride was detectable in the diet (detection limit not reported), and
fluoride levels in femurs were ≤8.8ppm fluoride in bone ash. In a more
recent study, dose-dependent increases in daily weight gain of F344 rats were
observed when a low-fluoride diet was supplemented with fluoride (Schwarz and
Milne 1972). The fluoride provided by the basal diet varied but was sometimes
0.023 mg/kg/day and occasionally dropped below 0.002 mg/kg/day. However, the
results are likely to be due to other nutritional deficiencies that were
partially compensated by fluoride. Rats in both the control and low-fluoride
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groups had shaggy fur, loss of hair, and seborrhea. Fluoride was only
partially effective in correcting the bleached incisors found in the low fluoride group.
Bleached incisors have been related to deficiencies of
calcium, phosphorus, magnesium, iron, and vitamins E, D, and A. None of these
studies provide strong evidence that fluoride is an essential element.
2.2.2.1 Death
Fluoride. Based on numerous incidents of fatal fluoride poisoning,
Hodge and Smith (1965) estimated the certainly lethal dose (CLD) (without
treatment) for a 70-kg man at 5-10 g sodium fluoride, or 32-64 mg fluoride/kg
body weight. The faster uptake of fluoride to the bone in children helps to
clear fluoride from the bloodstream, so Heifetz and Horowitz (1986) did not
believe the CLD for children would be lower than that for adults. The safely
tolerated dose has been reported as 8-16 mg fluoride/kg, but no support was
provided for this conclusion (Heifetz and Horowitz 1986). As indicated below,
this dose may not be tolerated by very small children.
Fatal ingestion of sodium fluoride has been reported as early as 1899
(Sharkey and Simpson 1933). A summary of early fatalities indicates that the
primary symptoms were the sudden onset of nausea and vomiting, accompanied by
burning, cramp-like abdominal pains and diarrhea. Clonic convulsions and
pulmonary edema were reported in some cases; the pulmonary edema may have been
due to aspiration of vomitus. While a few of these deaths were suicides, most
of them resulted from accidental exposure to sodium fluoride when containers
of insecticide were mistaken for baking powder or epsom salts.
More recent information includes the case report of a 3-year-old boy who
swallowed 200 sodium fluoride tablets (1 mg fluoride each) for a dose of 16 mg
fluoride/kg body weight (Eichler et al. 1982). Immediately after ingestion,
he vomited and appeared to recover, but he collapsed 4 hours later. The boy
died 7 hours after fluoride ingestion. Upon autopsy, hemorrhagic edema of the
lungs, hemorrhagic gastritis, and massive cerebral edema were observed. The
hemorrhagic edema observed in the lungs was probably due to aspiration of the
gastric contents. Cloudy swelling was observed in the cells of the liver,
heart, and kidney. In another case, a 27-month-old child died 5 days after
ingesting about 100 fluoride tablets, for a dose of about 8 mg fluoride/kg
body weight (Whitford 1990). Based on this case and weight tables for 3-year-
old boys, Whitford (1990) calculated a probably toxic dose of about 5 mg
fluoride/kg body weight.
A comparison of death rates between U.S. cities with fluoridated water
and those with nonfluoridated water found no association between fluoride and
increased death rate (Erickson 1978). It is difficult to draw definitive
conclusions from this study because it is limited by dissimilarities between
the populations, which led to a need for multiple adjustments.
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In rats; LD50 values for sodium fluoride administered by oral gavage
range from 31 to 101 mg fluoride/kg (DeLopez et al. 1976; Lim et al, 1978;
Skare et al. 1986). These LD50 values for rats are for different strains with
variations in weight. Gender differences may also account for the reported
differences in LD50 values; an LD50 of 101 mg fluoride/kg was reported for male Sprague-
Dawley rats weighing 150-290 g, while LD50 values for female Sprague-Dawley rats weighing
112-184 g and 200-359 g were 52 mg/kg and 31 mg/kg,
respectively. An LD50 of 44.3 mg fluoride/kg was reported for mice (Lim et
al. 1978).
Hydrofluoric Acid. Six deaths were reported to have occurred between
1 and 6 hours following accidental or intentional ingestion of a rust remover
containing hydrofluoric acid (Menchel and Dunn 1984). No dose levels of
fluoride were reported. At autopsy, severe hemorrhagic gastritis was noted in
all cases. In one case, hemorrhage and necrosis of the pancreas were also
noted. A fatal case of hydrofluoric acid ingestion occurred when a 29-yearold
man drank a mouthful, thinking it was water (Manoguerra and Neuman 1986).
In spite of immediate vomiting, respirations were shallow within an hour, and
the patient died within 2 hours of exposure. Serum calcium and SGOT levels
were markedly depressed. Serum fluoride level was 35 ppm. Another study
reported six deaths due to hydrofluoric acid ingestion (Menchel and Dunn
1984). The major symptoms reported were nausea, thirst, and ulcerations of
the buccal mucosa, followed by the rapid onset of tetany and coma.
All reliable LD50 and LOAEL values for death in each species and duration
category are recorded in Table 2-3 and plotted in Figure 2-3.
2.2.2.2 Systemic Effects
The predominant systemic effects that have been observed following acute
oral exposures to sodium fluoride are hypocalcemia (resulting in tetany and
ventricular fibrillation, among other effects), hyperkalemia, and gastrointestinal pain;
fluorosis is the major effect of chronic exposure.
No studies were located regarding respiratory or dermal/ocular effects
in humans or animals after oral exposure to fluorine, hydrogen fluoride or
fluoride.
The highest NOAEL values and all reliable LOAEL values for systemic
effects in each species and duration category are recorded in Table 2-3 and
plotted in Figure 2-3.
Cardiovascular Effects. The cardiovascular effects of fluoride have
been attributed to hypocalcemia and hyperkalemia caused by high fluoride
levels. Fluoride can bind with serum calcium if the dose is sufficient and
cause hypocalcemia. Calcium is necessary for the functional integrity of the











decreased myocardial contractility, and possibly cardiovascular collapse
(Bayless and Tinanoff 1985). Hyperkalemia has been suggested as the cause of
the repeated episodes of ventricular fibrillation and eventual death that are
often encountered in cases of fluoride poisoning (Baltazar et al. 1980).
Approximately 2 hours after ingestion of 120 g of roach powder
(97% sodium fluoride) in an unsuccessful suicide attempt, a 25-year-old male
had severe toxic reactions that included tetany, multiple episodes of
ventricular fibrillation, and esophageal stricture (Abukurah et al. 1972).
Within 14 hours following exposure, the patient experienced 63 episodes of
ventricular fibrillation.
In two epidemiological studies, fluoride in the drinking water did not
increase the mortality rates from cardiovascular effects. One of these
studies was a report of 428,960 people in 18 areas of "high" natural fluoride
(0.4->3.5 ppm) in England and Wales and 368,580 people in control areas
(<0.2 ppm fluoride). The water supply for 52% of the "high" fluoride
population had average fluoride levels of ≥lppm (Heasman and Martin 1962).
Results indicated that there were no significant differences between areas
with different fluoride levels in mortality due to coronary disease, angina,
and other heart disease, as evidenced by Standard Mortality Ratios (SMRs).
The second study (Hagan et al. 1954) examined 32 pairs of cities in the United
States that contained 892,625 people in the high fluoride areas and 1,297,500
people in the control cities. A positive relationship between heart disease
and water fluoridation was reported, but these authors did not adjust for a
doubling of the members of this population over 75 years old during the period
of fluoridation under study (Jansen and Thomson 1974). In addition, this
study lacked statistical analysis and drew conclusions regarding trends that
were not obvious from the data presented. The large variation in the
presented data was not discussed. Doses of fluoride are difficult to estimate
for large populations, however, because most people are potentially exposed to
fluoride through a variety of sources, such as food, beverages, medicine, and
dental products.
By contrast, a comparison of Bartlett and Cameron, two Texas towns with
water supplies containing 8 ppm and 0.4 ppm fluoride, respectively, found a
significantly higher rate of cardiovascular system abnormalities in the town
with the lower fluoride level (Leone et al. 1954). The authors attributed the
finding of a significant result to the number of statistical tests that were
conducted in the study. However, it is interesting to note that a study of
300 North Dakota residents who drank water containing 4-5.8 ppm and 715 people
who drank water containing 0.15-0.3 ppm found a lower incidence of
calcification of the aorta in the high-fluoride group (Bernstein et al. 1966).
Significant differences were found in 45-54-year-old males (p<0.05), as well
as in males aged 55-64 years and 65+ years (p<0.01). This effect was not due
solely to differences in age distribution, because the incidence in the 55-64-
year-old, high-fluoride group was lower than the incidence in the 45-54-year-
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old, low-fluoride group. A crude analysis also found no association with milk
and cheese consumption.
About half of the male and female B6C3F1 mice that died as a result of
exposure to 52 mg fluoride/kg/day for 6 months as sodium fluoride in drinking
water had mineralization of the myocardium (NTP 1990); some female mice also
had myocardial degeneration.
Gastrointestinal Effects. The primary gastrointestinal effects
following both acute and chronic oral exposure to fluoride consist of nausea,
vomiting, and gastric pain. The irritation of the gastric mucosa is
attributed to fluoride (as sodium fluoride) forming hydrofluoric acid in the
acidic environment of the stomach (Hoffman et al. 1980; Waldbott 1981). The
uncharged hydrogen fluoride molecule can then penetrate cell membranes and
enter the neutral environment of the cytoplasm.
Thirty-four students (kindergarten through third grade) exhibited acute
gastrointestinal effects after drinking water from school water fountains that
provided a fluoride supplement designed to raise the water level to a range of
l-5 ppm (Hoffman et al. 1980). An accident with the delivery system resulted
in the water levels reaching 375 ppm; specific doses could not be calculated
but were estimated to range from 1.4 to 90 mg per child. In another case, a
16-year-old girl vomited and had abdominal pain immediately after accidentally
consuming 1 tablespoon of sodium fluoride (used as a dusting powder for
poultry) (Rao et al. 1969).
Of the 150 cases involving fluoride intake reported to a poison control
center from 1978 to 1979, most of the cases involved ingestion of less than
1 mg/kg fluoride, although exact doses could not be determined (Spoerke et al.
1980). Effects included nausea (13.9%), vomiting (77.8%), and diarrhea
(8.3%). These effects usually subsided within 24 hours. Symptoms of a more
serious nature were not reported.
Endoscopies were performed and biopsy samples taken from 12 healthy
volunteers either after no treatment (control) or 2 hours after drinking 20 mL
of a solution containing 20 mg fluoride as sodium fluoride (Spak et al. 1989).
Both treatment and control tests were preceded by overnight fasts, and at
least 2 weeks were allowed between endoscopies to allow for healing of any
iatrogenic injuries from the gastroscope. All subjects had six or more
petechiae (minute hemorrhages) or erosions after fluoride treatment, while
only one petechia or erosion was found in one control subject. Upon
microscopic evaluation of biopsies, irritation of the stomach was found in all
subjects after fluoride treatment, but none of the subjects showed stomach
irritation after fasting only. Nausea was present in only one-third of the
subjects, suggesting that nausea may not be the first sign of fluoride
irritation of the gastric mucosa. The study suffers from several limitations.
Only one dose was tested, the subjects were aware of whether or not they had
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received fluoride, it is unclear whether endoscopy videotapes were coded prior
to evaluation, and the order of test and control endoscopies does not appear
to have been randomized. For these reasons, this study has not been included
in Table 2-3 or plotted in Figure 2-3.
While high levels of fluoride clearly can cause gastrointestinal
irritation, it is unclear whether there are any gastrointestinal effects of
chronic exposure to fluoride in drinking water. Gastrointestinal tract
disorders were not evaluated in the Bartlett-Cameron study of the effect of
water containing 8 ppm fluoride (Leone et al. 1954). The sole evidence of an
effect comes from a study of twenty non-ulcer dyspepsia patients at an
outpatient clinic in India and 10 volunteers without gastrointestinal problems
from the surgical clinic (Susheela et al. 1992). While the drinking water
supplies of none of the controls had fluoride levels >l ppm, the water
supplies of 55% of the dyspepsia patients were at this level. In addition,
all of the dyspepsia patients and 30% of the controls had serum fluoride
levels >0.02 ppm (mean of the dyspepsia group, 0.1 ppm); all of the dyspepsia
patients and none of the controls had urine fluoride levels >0.l ppm (mean,
1.34 ppm). The study was compromised by small treatment size, undetermined
total fluoride doses, undetermined nutritional status of the subjects, and
lack of statistical comparisons. In addition, the appropriateness of the
control population was not clear.
Seventy-eight workers engaged in the crushing and refining of cryolite,
a mineral compound composed of sodium, aluminum, and fluoride, were examined
(Moller and Gudjonsson 1932). Although an average exposure period was not
presented, no workers with less than 2 years of exposure were included;
18 workers had been exposed for more than 10 years. Forty-two workers
reported evidence of gastrointestinal effects. The primary effect was nausea,
followed by loss of appetite and vomiting. Chronic indigestion was also
reported in these workers. The study authors stated the effects were due only
to cryolite dust being swallowed (either due to dust being deposited in the
mouth during mouth breathing, or due to deposition on the bronchial tree
followed by mucociliary action bringing the material to the epiglottis) and
absorbed through the gastrointestinal tract. They based this conclusion on
the fact that 21 enamel-, glass-, and sulphuric acid-industry workers exposed
by inhalation to fluorine gas (some for up to 40 years) revealed no evidence
of any effect on the stomach. In light of what is now known about the
absorption of fluorides through the lung, the cryolite workers probably were
exposed by both the oral and inhalation routes.
Decreased appetite, congestion of the duodenum, and mild diarrhea were
reported in sheep given a single intragastric dose of sodium fluoride as low
as 28.5 mg fluoride/kg via nasoesophageal catheter (Kessabi et al. 1985). It
is difficult to extrapolate possible human effects from this study because the
gastrointestinal system of ruminants (sheep, cows, goats) is quite different
from that of humans.
50
2. HEALTH EFFECTS
Thickening of the mucosa of the glandular stomach and punctate hemorrhages were
seen in F344/N rats given 19 mg fluoride/kg/day in drinking water for 26 weeks as sodium
fluoride (NTP 1990). Similar but less severe alterations were seen in some rats that
received 6.3 mg/kg/day. Stomach ulcers were also seen in some high-dose males and
females. Histologically identified stomach lesions included necrosis and hyperplasia. No
gastrointestinal effects were reported in B6C3F1, mice in this study at doses up to 52
mg/kg/day. No gastrointestinal effects were reported in the chronic portion of this study
at doses up to 9.1 mg/kg/day (mice) or 4.5 mg/kg/day (rats). Roughened duodenal mucosa
and a "cracked-clay" appearance of the absorptive cells was observed following daily
dosage of nine rabbits with 5 mg/kg fluoride via oral gavage for 24 months (Susheela and
Das 1988). The rabbit gastrointestinal system also differs from that of humans, and the
study is limited by the small number of rabbits per group and the use of only one dose.
Hematological Effects. The incidence of abnormal white blood cell
counts was significantly higher in Bartlett, Texas (8 ppm natural fluoride),
than in Cameron, Texas (0.4 ppm fluoride). However, the study authors did not
consider this finding as necessarily an effect of fluoride (Leone et al.
1954). No other significant hematological effects were observed.
As part of the 2-year NTP study of fluoride (NTP 1990) hematological
analyses were conducted at 27 and 66 weeks. No treatment-related effects were
observed at doses up to 4.5 mg/kg/day and 9.1 mg/kg/day in F344/N rats and
B6C3F1 mice, respectively.
Lactating Holstein cows were fed a mineral supplement containing soft
rock phosphate (6000 ppm fluoride) and a protein supplement containing
1,088 ppm fluoride (Hillman et al. 1979). Because consumption of minerals fed
ad libitum could not be determined accurately under farm conditions, no dose
estimates could be made. After 9 months, red blood cells per unit volume,
blood hemoglobin, hematocrit, and mean corpuscular volume were significantly
lower (p<0.05) in herds exhibiting evidence of high fluoride exposure. The
number of eosinophils increased with increasing urinary fluoride. Rabbits
administered 4.52 mg fluoride/kg/day by gavage for 6-12 months had
significantly decreased numbers of blood cells (e.g., erythrocytes,
leukocytes, thrombocytes, monocytes, neutrophils) and hemoglobin (Susheela and
Jain 1983). Similar, although not identical, results were seen in mice fed
5.2 mg fluoride/kg body weight (Pillai et al. 1988). These animals showed a
significant decrease in red blood cell count but a significant increase in
white cells. Although a dose-effect relationship cannot be determined from
single-dose studies, these studies suggest that the hematopoietic system may
be affected by oral exposure to fluoride.
Musculoskeletal Effects. Fluoride mottles teeth (dental fluorosis) and
results in thickened bones and exostoses (skeletal fluorosis) when ingested in
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large doses for an extended period of time. During development of the
deciduous and permanent teeth, excessive fluoride intake produces a
malformation of the enamel surface, which then becomes stained (Hodge and
Smith 1972). Fluoride causes mottled enamel by interfering with osteocytes
and impairing the work of ameloblast cells (Hodge and Smith 1972).
Several different methods have been developed for quantifying dental
fluorosis. Dean's index (Dean 1934) rates teeth as having class 0, no
fluorosis; class 1, very mild (opaque white areas irregularly covering ≤25%of
the tooth surface); class 2, mild (white areas covering 25%-50% of the tooth
surface); class 3, moderate (all surfaces affected, with some brown spots and
marked wear on surfaces subject to attrition); and class 4, severe (widespread
brown stains and pitting). People are classified according to the two most
severely affected teeth; the mean fluorosis index is the mean of the score
class. Other methods score tooth surfaces or relate fluorosis to the period
during which the developing dentitioncould be exposed to fluoride. Drying
teeth prior to scoring increases the frequency of observing opaque areas (DHHS
1991).
There is some evidence that levels of fluorosis have increased due to
the multiple, widespread sources of fluoride in food processed with
fluoridated water and dentifrices containing fluoride, in addition to the
water of fluoridated communities. Comparison of fluorosis levels in the
21 cities with fluoride levels ranging from <0.4 to 2.7 ppm that were surveyed
by Dean in the 1940s, and studies of dental fluorosis in 21 cities that were
conducted in the 1980s found that the prevalence and severity of dental
fluorosis correlated with the level of fluoride in the drinking water (DHHS
1991). During this 40-year period, the prevalence of fluorosis in areas with
<0.4 ppm fluoride increased from <l% to about 6%; nearly all of the increase
was in the very mild and mild categories. Both the prevalence and severity of
fluorosis increased in communities with 0.7-1.2 ppm fluoride, with prevalence
increasing from about 13% to about 22%. Most of the increase was in the very
mild and mild categories, which increased from 12.3% to 17.7%, and from 1.4%
to 4.4% of the population, respectively. The combined prevalence of the
severe and moderate categories went from 0.0% to 0.9%. While there were some
differences between the studies in the 1940s and those in the 198Os, such as
the subject population and examination conditions, they do not affect the
overall trends. Although total fluoride intake was not measured, these
studies indicate that intake has increased since the 1940s, because fluorosis
levels increased for all water fluoride levels.
Fluorosis levels in 1985 in communities with fluoride levels at about 1,
2, 3, and 4 ppm were compared with levels of fluorosis in the same communities
in 1980 (Heifetz et al. 1988). Both examinations included 8-10-year-old and
13-15-year-old children. The 13-15-year-old children in the follow-up study
had also participated in the initial study. While there were no marked
changes in fluorosis levels in 8-10-year-old children, both the prevalence and
severity increased in the 13-15-year-old children. Increases in the 1-ppm
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communities were mostly in the category of barely visible white spots.
However, the percentage of labial surfaces of incisors and canines from
children in the 2-ppm group that had brown mottling went from 0% to 7.6%.
Less marked increases in mottled and pitted teeth were seen in the higher dose
groups. The increased levels of fluorosis were attributed to increased
fluoride exposure from multiple sources.
While drinking water fluoride levels ranging from 0.7 to 3 ppm can
reduce the incidence of dental caries, susceptibility to caries can increase
at higher fluoride levels. Adolescents consuming water containing 5 ppm
fluoride since birth were evaluated for fluorosis and prevalence of caries.
The prevalence of dental fluorosis was 100%, with the 182 subjects showing
effects ranging from mild to severe. The incidence of dental caries increased
with increasing severity of fluorosis symptoms. The increase in caries was
apparently caused by a degenerative effect of high levels of fluoride on
ameloblast cells, resulting in porosity and hypoplasia of the tooth (Mann et
al. 1987).
In an early study, 78 workers engaged in the crushing and refining of
cryolite were examined. Thirty-nine workers showed evidence of skeletal
fluorosis in the form of dense calcification in the long bones, cartilage, and
in extreme cases, of the skull as well (Moller and Gudjonsson 1932). Although
an average exposure period was not presented, no workers with less than
2 years of exposure were included; some workers had been exposed for as long
as 40 years. The authors stated that the effects were due only to cryolite
dust being swallowed and absorbed through the gastrointestinal tract. They
based this conclusion on the fact that their examination of 21 workers exposed
to fluorine gas (some for up to 40 years) revealed no skeletal effects. In
light of what is now known about the absorption of fluorides through the lung,
the cryolite workers probably incurred both oral and inhalation exposures.
Signs of skeletal fluorosis range from increased bone density to severe
deformity, known as crippling skeletal fluorosis. Crippling fluorosis is
characterized by complete rigidity of the spine, often accompanied by kyphosis
(humpbacked) or lordosis (arched back). Reported cases are found almost
exclusively in developing countries, particularly India, and are associated
with malnutrition (Pandit et al. 1940). Tea consumption and high water
intake due to the tropical climate are probably also contributing factors. As
discussed in Chapter 5, tea is high in fluoride. High water intake would
increase the intake of fluoride from water. It is generally stated that a
dose of 20-80 mg/day (equivalent to 10 ppm in the water) is necessary for the
development of crippling skeletal fluorosis (NAS 1971a), but individual
variation, variation in nutritional status, and the difficulty of determining
water fluoride levels in such situations make it difficult to determine the
critical dose. Pandit et al. (1940) found severe skeletal fluorosis in people
who had consumed 13-24 mg/day for >15 years. Cases of kyphosis, fused
vertebrae, and marked exostoses (ossification of muscle attachments to bone)
were reported in an area of India with water supplies containing 1.2-16.2 ppm
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fluoride (Singh et al. 1963), but fluoride levels were not reported for the
water supplies used by the people with the most severe symptoms. Soil
fluoride levels were not reported. Kyphosis, lordosis, and wedging of dorsal
vertebra was reported in poorly nourished English children in 1932 (Kemp et
al. 1942). Water supplies ranged from 0.3-1.2 ppm. The study was marked by
small sample size and the absence of controls.
The incidence of early skeletal fluorosis in the United States is
unknown, since it appears that the early signs can only be identified
radiologically. A study of 116 people who had lived in an area with an
average of 8 ppm fluoride in the drinking water for at least 15 years found a
10%-15% incidence of fluoride-related bone changes (Leone et al. 1955).
Coarsened trabeculation and thickened bone were observed, but no exostoses.
A limited number of cases of crippling skeletal fluorosis due to oral
exposure have been reported in the United States. Where the doses are known,
they are generally 15-20 mg fluoride/day for over 20 years; two of the cases
were associated with renal disease, which would reduce fluoride excretion.
Two of the cases were associated with drinking large quantities of water with
>3.5 ppm fluoride. In the most severe case, a man who consumed at least 15 mg
fluoride/day by drinking over 4 liters of water with 3.5 ppm fluoride for
43 years developed kyphosis and severe joint stiffness. The diagnosis was
confirmed by radiological analysis; bone fluoride content at autopsy was
6,100 ppm of dried bone (Sauerbrunn et al. 1965). Complete neck and spine
rigidity was reported in a man who had ingested unspecified large volumes of
water containing 4-7.8 ppm fluoride and large volumes of tea for 55 years
(Goldman et al. 1971). A recent immigrant from Mexico developed symptoms
consistent with spinal cord compression (Fisher et al. 1989). Her tap water
in Mexico contained 3.9 ppm fluoride; fluoride levels in neighboring areas
ranged from 0.1 to 5.5 ppm. A 40-year-old woman with renal failure developed
progressive muscle weakness and severe pain in her ribs, back, and hip (Fisher
et al. 1981). Fluoride content of an ashed iliac crest bone was 10,000 ppm.
Questioning to determine her sources and intake of fluoride elicited the
information that she practiced geophagia, the custom of eating earth, which is
often a symptom of iron deficiency. The patient ingested about 15 mg fluoride/
day, of which 10 mg/day were from eating soil, 4.2 mg/day were from tea,
and 1.4 mg/day was from her drinking water, which had a fluoride content of
0.7 ppm. A 65-year-old woman who drank well water containing an undetermined
fluoride concentration for most of her life developed paresthesias of both
legs and pain in the back and chest (Bruns and Tytle 1988). The paresthesias
were considered secondary to bone deformities. The fluoride level in the
iliac crest bone was reported as 1,900 ng/L (sic) (normal is <140 ng/L);
urinary fluoride was 3.39 mg/L (normal, 0.2-1.0 mg/L). Two of the cases were
initially diagnosed as bone malignancies but recognized as fluorosis upon
further investigation (Bruns and Tytle 1988; Fisher et al. 1981).
Fluoride is found in all bone, with the concentration depending on total
fluoride exposure. The amount varies among different bones. Levels of
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fluoride in human bone are generally determined by biopsy of the iliac crest
bone, and are generally reported as ppm of bone ash. Normal bone contains
500-1,000 ppm fluoride (Boivin et al. 1988; Franke et al. 1975). Bone from
people with preclinical skeletal fluorosis, which is generally asymptomatic
and characterized by slight radiologically detectable increases in bone mass,
contains 3,500-5,500 ppm fluoride. Sporadic pain, joint stiffness, and
osteosclerosis of the pelvis are observed at 6,000-7,000 ppm, while chronic
joint pain, increased osteosclerosis, and slight calcification of ligaments
occur at 7,500-9,000 ppm. Crippling fluorosis is observed at fluoride bone
concentrations >10,000 ppm (Franke et al. 1975). The fluoride concentration
in bone increases with age (Zipkin et al. 1958). In a group of five people
ages 64-85 who had lived for at least 10 years in an area with water
containing 1 ppm fluoride, the average fluoride concentration of the iliac
crest bone was 2,250 ppm of bone ash.
Since fluoride increases bone density, it has been hypothesized that
fluoride could be used to treat osteoporosis. Additional support for this
hypothesis came from a study that found that women in a high-fluoride area
(4-5.8 ppm fluoride in the water) had lower incidences of decreased bone
density and collapsed vertebrae than did women in a low-fluoride area
(0.15-0.3 ppm) (Bernstein et al. 1966). There have been reports of successful
treatment of osteoporosis with fluoride. For example, one study reported that
intermittent dosing with sodium fluoride and calcium supplements reduced
vertebral and total fractures (Pak et al. 1989).
However, there is evidence that the newly formed bone following fluoride
treatment may be more brittle and more fracture-prone. The bones of a man
with severe skeletal fluorosis had increased compressive strength, but
decreased tensile strength and modulus of elasticity (a measure of stiffness,
or resistance to being strained by a load) compared to normal controls (Evans
and Wood 1976). However, only one subject was tested, and the fact that he
had been bedridden for the previous five years may have been a confounding
factor. A prospective, randomized, double-blind, placebo-controlled study of
202 women with postmenopausal osteoporosis ascertained the effect of
administering 34 mg fluoride/day as sodium fluoride (Riggs et al. 1990). Both
groups received 1500 mg calcium/day. Rigorous criteria excluded patients with
metabolic diseases. A total of 135 patients (66 in the treatment group and 69
in the control group) completed the full four years of treatment. Although
bone mineral density in the lumbar spine, femoral neck, and femoral trochanter
increased markedly in the treatment group, bone mineral density in the shaft
of the radius decreased 4%. There was no significant difference in the number
of new vertebral fractures between the treatment and control groups, although
the number of vertebral fractures in the fluoride group was slightly elevated
in the first year. In contrast, the level of nonvertebral fractures in the
fluoride group was 3.2 times that of the control group, with significant
increases in both the frequency and rate of fractures. Most of the increase
was due to increased incidences of incomplete ("stress") fractures, which
occurred 16.8 times more often in the treatment group. A parallel study was
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carried out with identical protocols, except that all of the women participated
in a supervised exercise program (Kleerekoper et al. 1989). There was
no significant difference between the treatment and control groups in vertebral
fracture rate or annual height loss. This study was only reported as an
abstract and has not been followed up in the literature, but it is included
here because of its importance in confirming the results of the Riggs et al.
(1990) study. Although the fluoride levels used in these two studies were
higher than used in some treatments of osteoporosis, there is no evidence that
lower fluoride doses would be more efficacious in reducing vertebral fracture
rates. In a smaller version of the Riggs et al. (1990) study, osteoporotic
women who received 22.6 mg fluoride/day as sodium fluoride with either
calcitriol or calcium had an increased incidence of hip fractures compared to
osteoporotic women who received placebo or calcitriol only (Hedlund and
Gallagher 1989). The study was limited by the small sample size (17-22/group). An MRL of
0.05 mg/kg/day was calculated based on a LOAEL of 0.48 mg/kg/day for increased fracture
rate in the Riggs et al. (1990) study, as decribed in the footnote to Table 2-3.
Prompted by the above results, researchers have examined the effect on
bone fracture rate of lower fluoride levels in drinking water. The most
thorough study to date compared three demographically similar communities in
rural Iowa. In the control community drinking water contained 1 ppm fluoride
and 67 ppm calcium, in the high fluoride community it had 4 ppm fluoride and
15 ppm calcium, and the high calcium community water had 375 ppm calcium and
1 ppm fluoride (Sowers et al. 1991). Women aged 55-80 years in the high
fluoride community had significantly faster loss of radial bone mass and a
two-fold increase in the rate of all fractures. The effects remained after
adjusting for age, body size and weight, total calcium intake, and hormone
use. Although the effect does not appear to be due to total calcium intake,
it is not clear whether the low calcium level in the high fluoride water
affected fluoride uptake. The high-fluoride water was naturally fluoridated,
while the water in the other two communities was artificially fluoridated.
Individual fluoride intake from beverages, but not other sources, was
calculated and found to correlate with fracture risk. A geographical
correlational study of 541,985 white women hospitalized for hip fractures
found a weak association (regression coefficient=0.0001, p=0.1) between hip
fracture incidence and fluoridation of water (Jacobsen et al. 1990). The
association was strengthened (regression coefficient=0.003, p=0.0009) after
correcting by county for other factors found to correlate with hip fracture
incidence (latitude, hours of sunlight, water hardness, income level, and
percentage of land in farms).
A recent ecologic cohort study compared the hip fracture rate for men
and women in a Utah community that had water fluoridated to 1 ppm with the
rate in two communities with water containing <0.3 ppm fluoride (Danielson et
al. 1992). Fluoridation began in the fluoridated community in 1966. The ageadjusted rate
was significantly elevated in both women (relative risk 1.27,
95% confidence interval 1.08-1.46) and men (relative risk 1.41, 95% confidence
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interval 1.00-1.81). In men, the rates in the fluoridated and nonfluoridated
communities were similar until age 70. From age 75 on, the difference between
the rates in the fluoridated and nonfluoridated areas increased with age. The
difference between the hip fracture rates in the fluoridated and nonfluoridated
areas increased for women in the 70- and 75-year age groups. However,
the fracture rates in women at ages ≥80years old were similar in the
fluoridated and nonfluoridated towns. The study authors attributed this to
the fact that women older than 80 years would have already gone through
menopause by the beginning of fluoridation, and so would have had less bone
remodeling and less incorporation of fluoride into the bone. The study
authors also suggested that the reason that they found an effect when other
investigators have not was the low levels of exposure to risk factors for
osteoporosis (smoking and alcohol) in the Utah populations. This was a well conducted
study that suggests that communities with fluoridated water have an
elevated risk of hip fracture. However, several possible confounding factors
were not examined. Calcium levels in the water, total calcium and vitamin D
intake, and individual fluoride intake were not determined. Estrogen use was
not evaluated, but was assumed to be similar since the communities were
similar distances from larger medical centers. In addition, estrogen levels
would not cause the effect in men.
A study in England and Wales also found increased rates of hip fractures
in men and women over age 45 as water fluoride levels increased up to 0.93 ppm
(Cooper et al. 1991). Hip fracture rates in 39 counties (standardized by age
and sex) were compared with water fluoride levels in those counties. In the
original analysis (Cooper et al. 1990), no significant correlation was found.
However, when the authors reanalyzed the data using a weighted least-squares
technique (weighting by the size of the population aged ≥ 45years) to account
for differences in the precision of the county-specific rates, a significant
positive correlation between water fluoride levels and hip fracture rates was
found (r=0.41, p=O.009). The correlation existed for both women (r=0.39,
p=0.014) and men (r=0.42, p=0.007) (Cooper et al. 1991). No effect of
fluoridation was found when the age-specific rates of femoral fractures were
compared for the 5 years prior to fluoridation and the 5 years after fluoridation in a
New York town (Goggin et al. 1965). The period of exposure to
fluoridated water may have been too short to observe an effect in this study.
In addition, as in the ≥80 age group of the Danielson et al. (1992) study,
most of the women in this study would have gone through menopause prior to
fluoridation of the water. Finally, fractures throughout the length of the
femur, rather than just hip fractures, were included in this study. A Finnish
study found decreased hip fracture rates in men of all age groups >50 years,
and in women age 70 and over (Simonen and Laitinen 1985). It is not clear why
this study differs from the other ones, but readmissions were included in the
study.
The weight of evidence from these experiments suggests that fluoride
added to water can increase the risk of hip fracture in both elderly women and
men. However, questions remain due to issues such as the lack of information
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on trends in hip fracture incidence and total individual fluoride consumption.
If this effect is confirmed, it would mean that hip fracture in the elderly
replaces dental fluorosis in children as the most sensitive endpoint of
fluoride exposure.
Evidence from animal experiments may provide insight into the mechanism
of the effects of fluoride on bones. The femurs of weanling male rats of a
Wistar-derived strain that were given ≥9.5mg fluoride/kg/day as sodium
fluoride for 2 weeks exhibited a marked decrease in the modulus of elasticity.
It is not clear if the change was analyzed statistically. No lower doses were
tested (Guggenheim et al. 1976). Musculoskeletal effects in albino rats
(strain not identified) following oral exposure of intermediate duration have
been investigated. After 30 days of exposure to 100 ppm of fluoride in water
(14 mg/kg), tibia bones were broken and allowed to heal (Uslu 1983). Collagen
synthesis was determined to be defective, and fracture healing was delayed,
when compared to the controls. Decreased bone growth and signs of fluorosis
were observed in rats given 19 mg/kg in their drinking water and adequate
calcium for 5 weeks; with elevated calcium levels, fluorosis was not observed
until the fluoride level reached 35 mg/kg (Harrison et al. 1984). Rats
administered 10.5 mg fluoride/kg/day for 5 weeks had significantly decreased
mineral content and increased proline content of tooth enamel (DenBesten and
Crenshaw 1984). According to the authors, chronic high levels of fluoride
interfere with the progressive deposition of mineral and withdrawal of organic
matrix and water that characterizes normal pre-eruptive enamel development.
Male mice administered 0.80 mg fluoride/kg/day for 4 weeks exhibited a
statistically significant increase in the bone formation rate and a slight but
statistically significant decrease in bone calcium levels (Marie and Hott
1986). The authors concluded that 0.80 mg fluoride/kg increased the
population of osteoblasts under the conditions of this experiment.
It is possible that the decreased level of bone resorption in the presence
of fluoride, and the associated lowered serum calcium levels, would lead
to secondary hyperparathyroidism in an attempt to maintain normocalcemia. To
address this issue, rats were dosed with 3.3 mg fluoride/kg in drinking water
for 46 weeks (Rosenquist et al. 1983). There were no changes in serum calcium
or parathyroid hormone levels, and no increase in parathyroid activity.
The sagittal crests were enlarged and/or deformed in three of six adult
female mink fed 9.1 mg fluoride/kg/day as sodium fluoride for 382 days
(Aulerich et al. 1987). The authors attributed the abnormalities of the
sagittal crests to increased osteoblastic activity. After about 210 days of
exposure, the females were mated. The mink kits were exposed during gestation
and during the suckling period, and were fed the same diets as their mothers.
Kits in the 5.0 mg fluoride/kg/day and over groups had dark mottling of their
teeth. Several of the kits had broken canines.
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Hepatic Effects. No studies were located regarding hepatic effects in
humans after oral exposure to fluorine, hydrogen fluoride, or fluoride.
Pale, granular hepatocytes, compatible with parenchymal degeneration,
were observed in mice administered 0.95 mg fluoride/kg/day in drinking water
for 7-280 days (Greenberg 1982a). Fatty granules were observed after 3 weeks.
Liver congestion was observed in sheep given a single intragastric dose of
fluoride as low as 9.5 mg fluoride/kg. Mild serum increases of liver enzymes
(glutamate dehydrogenase [GDH] and gamma-glutamyl transferase [GGT]) also
occurred in sheep administered 38 mg fluoride/kg (Kessabi et al. 1985). It is
difficult to use this result to predict to possible human effects because
ruminants (sheep, cows, goats) have gastrointestinal systems quite different
from that of humans.
Enlarged liver cells with multiple foci were seen in about half of the
male B6C3F1 mice that died after receiving 26 or 52 mg fluoride/kg/day for up
to 6 months as sodium fluoride in drinking water (NTP 1990). This change was
seen in all of the female mice that died at the 52 mg/kg/day dose level. No
liver effects were seen in a parallel experiment with F344/N rats at doses up
to 19 mg/kg/day. Similarly, no liver histopathology was seen in the chronic
portion of this study (NTP 1990), in which rats received total fluoride doses
(amount added to water plus endogenous fluoride in food) of about
4.5 mg/kg/day (rats) or up to 9.1 mg/kg/day (mice). Alkaline phosphatase
levels were significantly increased in male and female mice at the 66 week
interim sacrifice of the chronic study.
Renal Effects. One study was located in which ingestion of fluoride
appeared to be linked with renal insufficiency (Lantz et al. 1987). A
32-year-old man ingested 2-4 L of Vichy water (a highly gaseous mineral water
containing sodium bicarbonate and approximately 8.5 mg/L of fluoride) every
day for about 21 years. This exposure ended 4 years before his hospital
admission. The patient also had osteosclerosis and a moderate increase in
blood and urinary levels of fluoride. No teeth mottling was observed. The
authors could not find factors, other than fluoride, related to his
interstitial nephritis. No effect on the incidence of urinary tract calculi
or the incidence of albuminuria was found in the Bartlett-Cameron study of
people drinking water containing 8 ppm fluoride (Leone et al. 1954).
Congestion of the kidney was observed in sheep given a single
intragastric dose of fluoride as low as 9.5 mg fluoride/kg (Kessabi et al.
1985). An intermediate exposure study tested the effect of administering up
to 52 mg fluoride/kg/day to B6C3F1 mice (8-9/group) as sodium fluoride in
drinking water for 26 weeks (NTP 1990). Acute nephrosis characterized by
extensive multifocal degeneration and necrosis of the tubular epithelium was
believed to be the main cause of death in two of the four males exposed to
52 mg/kg/day that died, the single male that died after exposure to
26 mg/kg/day, and two of the four females in the high dose group that died.
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No kidney histopathology was observed at doses ≤17mg/kg/day in males or 126
mg/kg/day in females, or at doses up to 19 mg/kg/day in F344/N rats.
Changes in kidney histology were seen in mature Swiss mice given a dose
of sodium fluoride in drinking water for up to 280 days that was described as
the maximum dose that could be chronically tolerated, i.e., 1.9 mg/kg/day
(Greenberg 1986). Using a sensitive staining technique, increased collagen
levels were seen after about 45 days. Thickening of the Bowman's capsule,
edematous swelling of the tubules, and infiltrations of mononuclear cells were
also noticed. No kidney pathology was seen in a 2-year study in B6C3F1 mice
at doses up to 8.1 mg/kg/day (males) or 9.1 mg/kg/day (females), or in F344/N
rats at doses up to 4.1 mg/kg/day (males) or 4.5 mg/kg/day (females) (NTP
1990).
Other Systemic Effects. Fluoride has been shown to affect the endocrine
system in rats given 0.5 mg fluoride/kg/day as sodium fluoride in drinking
water every day for 2 months (Bobek et al. 1976). These animals showed
decreased thyroxine levels and an increased T3-resin uptake ratio.
It is possible that the decreased level of bone resorption in the
presence of fluoride, and the associated lowered serum calcium levels, would
lead to secondary hyperparathyroidism in an attempt to maintain normocalcemia.
To address this issue, rats were dosed with 3.3 mg fluoride/kg in drinking
water for 46 weeks (Rosenquist et al. 1983). There were no changes in serum
calcium or parathyroid hormone levels, and no increase in parathyroid
activity.
Final body weight was reduced by >40% relative to the controls in female
F344/N rats administered 25 mg fluoride/kg/day as sodium fluoride in drinking
water for 14 days; body weight in males was reduced by >10% at doses ≥6.3
mg/kg/day (NTP 1990). A clear and consistent effect on body weight of B6C3F1
mice was seen only at the high dose (69 mg/kg/day), which was lethal to males
(3/5), but not to females. In the intermediate-duration (6 month) phase of
the study, the body weight of mice administered 17 mg fluoride/kg/day was
reduced by 20%; it was reduced by 10% at 19 mg/kg/day in male and female rats.
F344/N rats and B6C3F1 mice given large doses of sodium fluoride in
drinking water for 14 days had reduced water intake (NTP 1990). Male and
female rats given 25 mg fluoride/kg/day drank about 30% less water than the
controls. Water consumption by male rats given 51 mg fluoride/kg/day was 50%
of controls, while it was 25% of controls for females. Similarly, mice given
69 mg fluoride/kg/day drank ≤60%the volume of water consumed by the controls.
This means that actual fluoride doses are lower than the estimates given here,
since these values were calculated assuming normal water intake. However, the
reduced water intake may have been due to the disagreeable taste of fluoride




A request to the American Academy of Allergy was made by the U.S. Public
Health Service for an evaluation of suspected allergic reactions to fluoride
as used in the fluoridation of community water supplies (Austen et al. 1971).
The response to this request included a review of clinical reports and an
opinion as to whether these reports constituted valid evidence of a
hypersensitivity reaction to fluoride exposure of types I, II, III, or IV
(Austen et al. 1971), which are, respectively, anaphylactic or reaginic,
cytotoxic, toxic complex, and delayed-type reactivity. The Academy reviewed
the wide variety of symptoms presented (vomiting, abdominal pain, headaches,
scotomata [blind, or partially blind areas in the visual field], personality
change, muscular weakness, painful numbness in extremities, joint pain,
migraine headaches, dryness in the mouth, oral ulcers, convulsions, mental
deterioration, colitis, pelvic hemorrhages, urticaria, nasal congestion, skin
rashes, epigastric distress, and hematemesis) and concluded that none of these
symptoms were likely to be immunologically mediated reactions of types I-IV.
No studies were located that investigated alterations in immune response
following fluoride exposure in humans.
In a study with rabbits administered 4.5 mg fluoride/kg/day as sodium
fluoride for 18 months, decreased antibody titers were observed (Jain and
Susheela 1987). These results were observed after 6 months of treatment; the
authors hypothesized that a threshold level is reached at which time the
immune system is impaired. However, as only one dose level (4.5 mg
fluoride/kg/day) was tested, no dose-effect relationships can be established.
2.2.2.4 Neurological Effects
Fluoride has been shown to interfere with glycolysis. (See Section 2.4
for a discussion of the effect of fluoride on various glycolytic enzymes.)
Because the central nervous system relies heavily on this energy source,
hypotheses have been advanced as to a mechanism for fluoride effects on the
central nervous system. Although effects on glycolytic enzymes could explain
the neuromuscular symptoms seen frequently in cases of fluoride poisoning
(e.g., tetany, paresthesia, paresis, convulsions), studies tend to indicate
that hypocalcemia caused by fluoride binding of calcium causes these symptoms
(Eichler et al. 1982).
No studies were located regarding neurological effects in animals after
oral exposure to fluorine, hydrogen fluoride, or fluoride.
2.2.2.5 Developmental Effects
Fluoride crosses the placenta in limited amounts and is found in fetal
and placental tissue (Gedalia et al. 1961; Theuer et al. 1971). No recent
developmental studies of conventional design in animals were located, and
results from existing animal studies are mixed.
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Analysis of birth certificates and hospital records for over 200,000
babies born in an area.with fluoridated water and over l,000,000 babies born
in a low fluoride area found no difference in the incidence of birth defects
attributable to fluoride (Erickson et al. 1976).
Bone morphology of weanling Sprague-Dawley rats from dams who received
21 mg fluoride/kg day for 10 weeks prior to breeding and during gestation was
examined with both light and electron microscopy. No pathological changes
were seen, suggesting that although fluoride is transported across the
placenta, the amount transported was not sufficient to affect fetal bone
development (Ream et al. 1983). There were no developmental effects of
fluoride in the first litter of an extended two-litter reproduction study in
UPj:TUC(SD)spf rats that were fed diets containing 23 mg fluoride/kg/day or
2.8 mg fluoride/kg/day (two litters from each dam) (Marks et al. 1984).
However, the second litters born to mothers in the high-fluoride group had a
higher number of abnormal newborns and affected litters than were found in the
low-fluoride group. The significance of this finding is unclear because the
effect was not analyzed statistically.
Wild and domestic animals may be more sensitive than are laboratory
animals to developmental effects of fluoride. Stunted growth (Krook and
Maylin 1979) and lameness (Maylin and Krook 1982) have been reported in calves
that foraged on land downwind of an aluminum plant. Severe dental fluorosis
confirmed high levels of fluoride ingestion. Mink kits that were born to
mothers fed 9.1 mg fluoride/kg/day and fed the same feed after weaning
exhibited a marked decrease in survivability (14% at 3 weeks, compared with
86% for the control) (Aulerich et al. 1987). There was no effect at the next
lower dose. No further clinical details were provided for these pups.
However, survival of the females exposed to that level was also decreased (17%
at the end of the trial [382 days], compared with 100% for the control), so it
is not clear if the kit effects were secondary to maternal toxicity. The only
clinical signs in the adult mink were general unhealthiness, hyperexcitabilitY,
and lethargy a few days before they died. No lameness was observed.
2.2.2.6 Reproductive Effects
Studies that reported an increased incidence of Down's syndrome in areas
of high fluoridation have not been replicated by several other investigations
(Berry 1958; Erickson et al. 1976; Needleman et al. 1974). No correlation was
found between fluoridation and Down's syndrome incidence (corrected for
maternal age) in a study of over 234,000 children in fluoridated areas and
over l,000,000 children in low-fluoride areas (Erickson et al. 1976).
Ascertainment was based on birth certificates and hospital records, but was
probably incomplete. Ascertainment was nearly complete in a study of over
80,000 children in fluoride areas and over 1,700,000 in low-fluoride areas, but
no age-specific rates were reported (Needleman et al. 1974). Similarly, a
study of the incidence of Down's syndrome in England did not find an
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association with the level of fluoride in water, but age-specific rates were
not determined and tea was not taken into account as a source of fluoride
(Berry 1958).
Animal studies provide conflicting results on any reproductive effect of
fluoride. Some authors have seen no effect on sperm abnormalities and no
accumulation of fluoride in the testes (Dunipace et al. 1989; Li et al. 1987a;
Skare et al. 1986), while others have seen reduced male fertility (Araibi et
al. 1989). Decreased female fertility has been observed at toxic levels in
Swiss-Webster mice (Messer et al. 1973), but there have also been suggestions
that fluoride can aid fertility by improving intestinal absorption of iron and
other trace elements (Messer et al. 1973; Tao and Suttie 1976).
Nearly complete infertility was observed in female Swiss-Webster mice
that were fed a low-fluoride diet (0.026 mg fluoride/kg/day) supplemented with
sodium fluoride in drinking water at a dose that resulted in a ≈20% decrease
in maternal weight gain (19 mg fluoride/kg/day). A higher dose (39 mg
fluoride/kg/day) resulted in 100% maternal lethality by the end of the
experiment; no litters were produced by this group. No effect was seen in two
generations receiving 9.5 mg fluoride/kg/day (Messer et al. 1973). A
progressive decline in litter production was observed in both generations fed
the low fluoride diet and provided deionized water. The authors suggested
that fluoride enhances absorption of iron and other trace elements, and the
effect at low fluoride levels was due to deficiency in these elements.
Webster mice fed 13mg fluoride/kg/day as sodium fluoride over three
generations showed no effects on litter size, weight of pups, and incidence of
stillbirth compared to mice fed 0.026 mg fluoride/kg/day (Tao and Suttie
1976). The mice in this study were fed the same basal diet as used by Messer
et al. (1973). While no reproductive effects were seen in the animals fed
high fluoride diets, a small but significant decrease in the size of the
fourth litter of the second generation was observed in the group that was fed
the low-fluoride diet and provided with distilled water. The authors
attributed the difference between the two studies to higher iron levels in the
diet of the latter study. Anemia was reported by Messer et al. (1973), but
not by Tao and Suttie (1976). Reproduction was not affected in minks fed
diets containing up to 9.1 mg fluoride/kg/day as sodium fluoride (Aulerich et
al. 1987).
In order to determine whether reproductive problems at a kennel were due
to fluoride, Sheltie dogs of proven fertility were fed untreated dog food
(50 ppm fluoride) or food to which rock phosphate was added to a level of
460 ppm fluoride (11.5 mg fluoride/kg/day) (Shellenberg et al. 1990).
Fluoride bioavailability was not determined. Decreased estrus rate and
increased incidence of missed pregnancies were observed in the high fluoride
groups. However, these changes were also observed in groups provided with
distilled water rather than well water. It is not clear whether the effect
could be attributed to high fluoride, along with nutritional deficiencies in
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the distilled water groups, or whether there was some other cause. Overall
reproductive performance was stated by the authors as "good" in an extended
two-litter reproduction study in UPj:TUC(SD)spf rats (two litters from each
dam). No major differences were reported between rats fed diets containing
2.8 mg fluoride/kg/day and those fed 23 mg fluoride/kg/day (Marks et al.
1984). The fluoride source in the high-fluoride feed was rock phosphate which
had been added to the feed as a mineral supplement. The rats absorbed enough
fluoride to develop dental fluorosis, but the total bioavailability of
fluoride in the diet was not determined.
Additional evidence for an effect of fluoride on female reproduction
comes from avian studies. Single Comb White Leghorn hens, Shaver Starcross-
288 variety exhibited treatment-related decreased egg production and decreased
shell size in the absence of maternal toxicity (Guenter and Hahn 1986).
Similarly, screech owls fed diets containing fluoride had decreased hatching
success and decreased egg size (Hoffman et al. 1985). Decreased calving rate
(Van Rensburg and de Vos 1966) and decreased milk production (Maylin and Krook
1982) have been reported in cows that ingested large amounts of fluoride.
Male CD rats fed 5 or 10mg fluoride/kg/day as sodium fluoride exhibited
a significant increase in the thickness of the peritubular membrane of the
seminiferous tubules (Araibi et al. 1989). Both treated'groups also exhibited
a significant decrease in the percentage of seminiferous tubules containing
spermatozoa and a significant decrease in serum testosterone. As a result,
there were fewer pregnancies and fewer offspring among treated animals.
These data are not supported by a study that found that oral
administration of up to 84 mg fluoride/kg as sodium fluoride to adult male
Sprague-Dawley rats did not induce deoxyribonucleic acid (DNA) strand breaks
in testicular cells and that testicular fluoride levels were only 10%-20% of
plasma levels. This suggests that even at high doses (84 mg/kg body weight is
the LD01, or dose that has been calculated to cause death in 1% of exposed
animals, for this species), fluoride does not accumulate in the testes (Skare
et al. 1986). However, actual effects on reproductive performance were not
investigated in this study. B6C3F1 mice administered sodium fluoride by
gavage at doses up to 32 mg fluoride/kg/day for 5 days and killed 30 days
later showed no sperm head abnormalities (Li et al. 1987a). Slides were coded
prior to evaluation to eliminate bias. Bone fluoride levels (1,375 ppm in the
high-dose group) indicated that the fluoride was absorbed. Similarly, another
well-conducted study (Dunipace et al. 1989) found that B6C3F1 mice
administered up to 23 mg fluoride/kg/day as sodium fluoride in water did not
accumulate fluoride in the testes and did not have an increased incidence of
abnormal sperm morphology. Bone fluoride levels (7,405 ppm in the humeri of
the high-dose group) showed that the fluoride was well-absorbed.
The highest NOAEL values and all reliable LOAEL values for reproductive
effects for each species and duration category are recorded in Table 2-3 and




No studies were located regarding genotoxic effects in humans following
oral exposure to fluorine, hydrogen fluoride, or fluoride were located.
Oral exposures in Swiss mice and Chinese hamsters have shown both
positive and negative results for chromosome aberrations and other measures of
genotoxicity. The doses that show positive results have been high enough to
produce clinical signs of toxicity and occasionally death (e.g., 59 mg
fluoride/kg body weight in Chinese hamsters) (Li et al. 1987b). The evidence
to date suggests that fluoride may be genotoxic via the oral route, but that
the doses required are very high.
Neither the incidence of abnormal sperm morphology nor micronucleated
polychromatic erythrocytes were increased in B6C3F1 mice fed a low-fluoride
diet and provided water containing fluoride as sodium fluoride for 21 weeks.
Control animals were provided distilled water. Four treatment levels up to
22.8 mg fluoride/kg/day (calculated on the basis of water intake) were tested.
There was no adverse effect of fluoride on body weight; no other clinical
signs were reported. This was a well-conducted test performed with coded
slides and appropriate controls. An increased frequency of chromatid breaks
was observed when Swiss mice were dosed with 18 mg fluoride/kg as sodium
fluoride for 24 hours (Pati and Bhunya 1987). Only one dose was tested, the
number of animals used was not specified, and the study authors did not
indicate whether the slides were coded. In another study, Chinese hamsters
received gavage doses of sodium fluoride at levels up to 59 mg fluoride/kg
body weight, and the rate of sister chromatid exchange in isolated bone marrow
cells was determined. At the high dose, 3/8 animals died. Sister chromatid
exchange was not increased, but cell cycle progression was impeded. Slides
were coded prior to analysis. The results imply that fluoride's primary
effect at these doses is a general cellular toxicity rather than interaction
with DNA (Li et al. 1987b).
Other genotoxicity studies are discussed in Section 2.4.
2.2.2.8 Cancer
Numerous epidemiological studies have examined the issue of a connection
between fluoridated water and cancer. The weight of the evidence indicates
that no such connection exists. However, all of the investigations were
ecologic studies, and the sensitivity limit of even the most sensitive
analysis in these studies appears to be a 10%-20% increase. Since any
carcinogenic effect of fluoride at the levels found in water supplies would
probably be below this level of sensitivity, a National Toxicology Program
(NTP) cancer bioassay was conducted to assess the effect of fluoride on cancer
incidence in animals (Bucher et al. 1991; NTP 1990). The NTP study found
equivocal evidence of a fluoride-related increase in osteosarcomas in male
rats, and no evidence of any fluoride-related neoplasm in female rats or male
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or female mice. A study sponsored by Proctor and Gamble (Maurer et al. 1990)
found no evidence of fluoride carcinogenicity in either male or female rats.
Both studies contain limitations that preclude strong conclusions. The NTP is
presently carrying out additional experiments on the relationship, if any,
between fluoride and cancer. The International Agency for Research on Cancer
(IARC) reviewed the literature on fluoride carcinogenicity in 1982. It
concluded that there is no evidence from epidemiological studies of an
association between fluoride ingestion and human cancer mortality, and the
available data are inadequate for an evaluation of the carcinogenicity of
sodium fluoride in experimental animals (IARC 1982). Several major cancer
bioassays of fluoride have been conducted since the IARC review.
Data suggesting that increased fluoride exposure from drinking water
supplies is associated with an increase in cancer incidence come from the
study published by Yiamouyiannis and Burk (1977) comparing the cancer
incidence rates in 10 U.S. cities with artificial fluoridation and 10 cities
without fluoridation. The authors of the study interpret these data as
showing that cancer mortality was higher in the cities with artificially
fluoridated water. Data from this study have been re-analyzed several times
in an attempt to further explore the hypothesis that fluoridation of water
supplies causes cancer (Chilvers 1982, 1983; Doll and Kinlen 1977; Hoover et
al. 1976; Kinlen and Doll 1981; Oldham and Newell 1977; Taves 1977). None of
these re-analyses provided evidence of a positive association between
fluoridation of water supplies and cancer of any of the sites considered. The
re-analyses attributed the positive association between fluoride exposure and
cancer reported by Yiamouyiannis and Burk (1977) to dissimilarities in age,
race, sex and demographic factors for the populations studied. Other studies
of large populations, both in the United States and Great Britain, have
identified no relationship between artificially or naturally occurring
fluoride in drinking water and an increase in cancer incidence (Griffith 1985;
Hoover et al. 1991; Kinlen 1975). An inverse relationship between fluoride
levels and cancer of the oral cavity and pharynx has been reported to occur in
Norway in populations whose drinking water contained low levels of fluoride
(0.05-0.5 mg/L) (Glattre and Wiese 1979). Although the authors offered no
detailed mechanism for the apparent protective effect, and did not conduct a
formal analysis of possible confounding factors, they did present data
indicating that biases due to tobacco consumption, rural and urban
differences, and differences in the population sizes of the examined
communities could.not be the cause of the reduced cancer rates.
A recent epidemiological study (Hoover et al. 1991) examined
>2,300,000 cancer deaths and >125,000 cancer cases in U.S. counties exposed to
artificially fluoridated drinking water for up to 35 years. Taking into
account the results of the NTP study described below, detailed analyses were
conducted of cancers of the joints and bones (especially osteosarcomas), and
cancers of the oral cavity and pharynx. The statistical evaluation was based
on analysis of time trends in the observed/expected (O/E) ratios relative to
duration of fluoridation. While elevated O/Es were observed for osteosarcomas
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in males, the O/E ratio was inversely related to duration of fluoridation.
Thorough analyses of incidences of oral cancers and cancers at a variety of
other sites were conducted by means of very sensitive statistical tests that
were designed to detect changes as small as 10-20%. No consistent correlation
between cancer incidence or mortality and duration of fluoridation was found.
An addendum to the report noted that the age-adjusted national incidence of
osteosarcoma increased by 18% in males for the years 1973-1980 and 1981-1987;
most of the increase was due to a 53% increase in males under 20 years of age,
and there was a larger increase in fluoridated than nonfluoridated areas. A
similar time-trend analysis to that done in the main report found no correlation
between the cancer incidence O/E ratio and duration of fluoridation.
Additional analyses also failed to find a relationship between osteosarcoma
incidence in males and exposure to fluoridated water.
In general, occupational fluoride exposures result in much higher intake
rates than does ingestion of artificially fluoridated drinking water. Actual
absorbed doses from occupational exposure are not available, but urinary
fluoride levels can reach 5.68 mg/L (Dinman et al. 1976c), compared with
normal levels of about 1 mg/L (Spencer et al. 1970). Studies regarding cancer
from occupational inhalational exposure to hydrofluoric acid fumes and dust
from cryolite were discussed in Section 2.2.1.8.
The NTP conducted two chronic oral bioassays of fluoride administered as
sodium fluoride (0, 25, 100, or 175 ppm) in drinking water, using F344/N rats
and B6C3F1 mice (Bucher et al. 1991; NTP 1990). The first study was
considered compromised for reasons that will be discussed below. However,
pathology data from the first study were used in determining the doses for the
second study. The diet used in the second study was specially formulated to
be low in fluoride, and contained 8.6 ppm fluoride; daily fluoride amounts
administered in the food for control and experimental groups was
0.43 mg/kg/day in rats and 1.1 mg/kg/day in mice. Based on the total amount
of fluoride ingested and the amount in the feces, and apparently assuming that
none of the fluoride found in the feces was absorbed, Bucher et al. (1991)
calculated that the average bioavailability of fluoride in the food over the
course of the experiment was 60%. Assuming complete absorption of fluoride in
the water, they estimated total fluoride intake (including fluoride in both
water and diet) of control, low-, medium-, and high-dose male rats as
0.2, 0.8, 2.5, and 4.1 mg/kg/day, respectively. Similarly, the high doses for
female rats, male mice, and female mice were 4.5, 8.1, and 9.1 mg/kg/day,
respectively.
The study found osteosarcomas in the bone of l/50 male rats in the middose
group and 3/80 of the high-dose male rats. An additional high-dose male
had an extraskeletal osteosarcoma in subcutaneous tissue. Examination of
radiographs did not reveal a primary site in bone for the extraskeletal tumor,
suggesting that it was a soft-tissue tumor that later ossified. No
osteosarcomas were found in the low-dose or control rats. One of the
osteosarcomas in the high-dose group was missed on radiographic examination
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and in the necropsy, and found only on microscopic examination. Three of the
tumors were in the vertebra and only one was in a long bone. This is unusual,
as Bucher et al. (1991) stated that chemically induced osteosarcomas usually
appear in the long bones, rather than in the vertebrae. Statistical analysis
found a significant dose-response trend in the four osteosarcomas of the bone
(p=0.027), but no significant difference (p=0.099) in a pairwise comparison of
the controls with the high-dose group. The probability value for the trend
test was decreased (p=0.010) when the extraskeletal osteosarcoma was included,
but the pairwise test was still not significant (p=0.057). Osteosarcomas are
rarely observed in control male rats in NTP studies; the historical incidence
is 0.6% (range 0%-6%). The rate in the high-dose group in this study was
3.75% or 5%, depending on whether the extraskeletal tumor is included. Tumor
rates could not be compared with the historical controls because the diet
generally used for NTP studies contains >20 ppm fluoride. Assuming the same
bioavailability of 60%, the study report states that this would place the
historical controls between the low- and mid-dose groups in the fluoride
study. Conversely, the more extensive bone examinations used in the fluoride
study, both at the macroscopic level and histologically, could have led to
higher bone tumor levels being observed than in historical controls.
The average fluoride level in the bones of male rats in the high-dose
group was 5,260 ppm. While similar bone fluoride levels were found in the
bones of female rats and male and female mice, there was no evidence of
treatment-related osteosarcomas in these groups. Osteosclerosis was observed
in high-dose female rats, suggesting a stimulatory or mitogenic effect on
osteoblasts (Marie and Hott 1986). Osteosclerosis was not observed in mice,
despite the higher dose. Osteosarcomas were observed in one low-dose male
mouse, one low-dose female mouse, and one control female mouse. There was
also one osteoma in a control female mouse. No osteosarcomas were observed at
mid- or high-dose levels in female rats or male or female mice. The study
authors stated that the absence of treatment-related osteosarcomas in female
rats and male and female mice may have limited relevance to the findings in
male rats. Results in the literature are mixed as to whether there is a sexlinked
response in bone tumor formation (Litvinov and Soloviev 1973; NC1 1978, both as cited in
NTP 1990).
Increased tumor incidence in rats or mice was noted in a few other
tissues, but was not considered biologically significant. For example, the
combined incidence of squamous cell papillomas and carcinomas in the oral
mucosa was marginally increased in the high-dose male and female rats and
thyroid follicular cell neoplasms were marginally increased in the high-dose
male rats. Neither increase was statistically significant, and both types of
neoplasms lacked a supporting pattern of increased pre-neoplastic lesions.
Similarly, increased levels of keratoacanthomas were observed in high-dose
female rats, but were not considered biologically significant because other
benign neoplasms arising from stratified squamous epithelium was found in the
controls. Malignant lymphoma and histiocytic sarcoma incidence in female
high-dose mice was marginally increased (combined rate 30%), but the increase
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was not considered biologically significant. The incidence was well within
the range of historical controls at the study laboratory (18%-48%) and at all
NTP laboratories (10%-74%). The incidence of hepatocellular neoplasms in male
and female mice of the treatment and control groups was higher than in
historical controls. The study authors noted similar increases in other NTP
studies that were conducted contemporaneously, and suggested that they may be
associated with increased animal weight. Hepatocholangiocarcinomas, which are
rare liver neoplasms, were identified in the original pathology examination in
five treated male mice, four treated female mice, and one control female
mouse. The Pathology Working Group reclassified all of the neoplasms (except
one in a high-dose female mouse and one in a control female mouse) as
hepatoblastomas, because they contained well-defined populations of cells that
resembled embryonal liver cells more closely than they did biliary cells. The
dose levels at which the reclassified hepatocholangiocarcinomas were found
were not reported.
Interpretation of this study is further complicated because higher doses
might have been tolerated in both the rat and the mouse studies (NTP 1990).
Fluoride-related tooth abnormalities found in the study included dental
attrition in males of both species that was dose-related in rats but not in
mice, dentine dysplasia in both genders of both species, and tooth deformities
in male rats. No other treatment-related toxic effects were found in any
group, and there was no evidence of decreased body weight gain in any group.
Higher fluoride levels may have affected the teeth of the male rats so
severely as to interfere with the animals' ability to eat. However, it
appears that the mice and possibly the female rats could have tolerated a
higher dose.
Based on the finding of a rare tumor in a tissue known to accumulate
fluoride, but not at the usual site for chemically-associated osteosarcomas, a
weakly significant dose-related trend, and the lack of supporting data in
female rats and mice of either gender, the NTP concluded that there was
"equivocal evidence of carcinogenic activity of sodium fluoride in male F344/N
rats." NTP defined equivocal evidence of carcinogenic activity to be a
situation where the results show "a marginal increase in neoplasms that may be
chemically related." NTP further concluded that there was no evidence that
fluoride was carcinogenic at doses up to 4.73 mg/kg/day in female F344/N rats,
or at doses up to 17.8 and 19.9 mg/kg/day in male and female B6C3F1 mice,
respectively.
The first chronic study in this series conducted by NTP was a 2-year
cancer study in B6C3F1 mice and F344/N rats using a semisynthetic diet
containing 2.1 ppm fluoride and fluoride provided, in drinking water as sodium
fluoride at 0, 10, 30, or 100 ppm. Several non-treatment-related clinical
signs developed in rats, including cornea1 lesions and head tilt. Analysis of
the diet revealed marginal to marked deficiencies in manganese, chromium,
choline, and vitamins B12 and D. Based on these findings, the study was
considered compromised, but the results were used to aid in dose selection for
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the second study. Only the following unverified pathology findings were
reported: (1) one osteosarcoma in the occipital bone of one low-dose male
rat; (2) one osteoma in the vertebra of a male control mouse; (3) one
subcutaneous osteosarcoma in one female high-dose mouse; and (4) no
osteosarcomas were found in female rats (male mice were not mentioned).
A study sponsored by Proctor and Gamble examined the carcinogenic
potential of sodium fluoride administered in feed to Sprague-Dawley rats
(Maurer et al. 1990). One group of controls was fed laboratory chow, and
another control group was fed a semisynthetic low-fluoride diet. The control
group fed the low-fluoride diet received 0.14 (males) or 0.18 (females) mg
fluoride/kg/day as sodium fluoride. The fluoride level in the laboratory chow
was not determined. Treatment groups ingested 1.8, 4.5, or 11.3 mg
fluoride/kg/day in the diet as sodium fluoride. Fluoride bioavailability was
not determined and water fluoride levels were not reported. However, the high
dose (11.4 mg fluoride/kg/day) was probably close to the MTD, since there was
a 30% decrease in body weight gains of both sexes. The study was terminated
early because of high mortality in all treatment and control groups. The
cause of the elevated level of mortality was not determined. Fluoride-related
toxicity was observed in the teeth, stomach, and bones.
Evidence of fluoride toxicity in the Maurer et al. study included doserelated
hyperostoses in males and females, tooth abnormalities, and stomach
inflammation. Fluoride levels in the bone ash of the high-dose males and
females were 16,761 and 14,438 ppm, respectively. Primary tumors in target
tissues as reported by the study authors 'were one fibroblastic sarcoma with
areas of osteoid formation in a high-dose male, one osteosarcoma in a low-dose
female, one chordoma in a mid-dose male, one chondroma each in a mid-dose male
and a low-dose female, one odontoma in a laboratory-chow control, and one
stomach papilloma in a low-fluoride control. Re-examination of tissue slides
as part of a review of the study by the Carcinogenicity Assessment Committee,
Center for Drug Evaluation and Research, Food and Drug Administration
(CAC/CDER/FDA) revealed an additional osteosarcoma in a low-dose female and
one osteosarcoma in a high-dose male. Statistical analysis of the incidence
of bone tumors found no dose-response relationship (CDER 1991).
Several limitations of the study were not apparent in the study report,
but were noted in the CAC review (CDER 1991). The low-fluoride diet may not
have allowed normal growth and development, since pale livers and gastric
hairballs were observed in all study animals except those fed laboratory chow.
The diet and water were often above specifications for minerals, ions, and
vitamins. A virus was found during the pretest period and its continued
presence during the study was suspected; this may have compromised the health
of the animals. The finding of bone tumors missed by the contract laboratory
raised questions about the adequacy of the examination at gross necropsy.
Finally, bone sections from only 50%-80% of the mid- and low-dose animals were
analyzed microscopically. The CAC review concluded that there are "flaws and
uncertainties in the studies that keep them from providing strongly reassuring
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data." However, the committee concluded that the study results reaffirm the
negative finding of the NTP study in female rats, and do not reinforce the
equivocal finding in male rats.
2.2.3 Dermal Exposure
Several human and animal studies investigating the health effects
following accidental dermal exposure to hydrofluoric acid were located. In
addition, many of the human and animal studies investigating the health
effects of inhalation exposure to fluorine or hydrogen fluoride found
dermal/ocular effects due to the irritating effects of these chemicals. (In
this section, hydrogen fluoride refers to the gas while hydrofluoric acid
refers to the liquid.) One study regarding dermal exposure to sodium fluoride
was located. Fluorine causes severe irritation of the eyes and skin and can
severely burn the skin at high concentrations. Hydrofluoric acid is a caustic
acid and can produce severe tissue damage either as the water solution, or in
the anhydrous form (hydrogen fluoride). The fluoride ion in hydrofluoric acid
can also rapidly penetrate the skin and cause systemic effects, especially
cardiac arrhythmias. If left untreated, death can result.
2.2.3.1 Death
Hydrofluoric Acid. Fatalities from dermal fluoride exposure occur most
frequently from accidental exposure to hydrofluoric acid in an occupational
setting. The actual systemic doses are seldom known. However, the extent and
severity of the burns, and occasionally, clinical chemistry values are
reported. Death following hydrofluoric acid burns to the extremities, in the
absence of inhalation exposure, is due to cardiac arrhythmias, with pronounced
hypocalcemia, hyperkalemia, and hypomagnesemia. Ion pump disruption is
thought to be the mechanism of systemic toxicity. Hydrofluoric acid exposure
of the face has also resulted in death due to respiratory insufficiency, but
the respiratory effects are likely to be due to concurrent inhalation
exposure. Depending on the extent of the body surface exposed and the
effectiveness of medical treatment, death usually occurs within a few hours
(Chan et al. 1987; Chela et al. 1989; Kleinfeld 1965).
A patient with hydrofluoric acid burns on his leg involving 8% of his
body surface area died from intractable cardiac arrhythmia, presumably
secondary to the depletion of ionized calcium by the fluoride ion (Mullett et
al. 1987). Serum fluoride level 4 hours after the burn injury was reported to
be 9.42 µg/mL, about 400 times the value reported as normal for that age and
sex. A 23-year-old man who sustained second and third degree burns of his
thighs, covering 9%-10% of his body surface area died of cardiac arrhythmia
17 hours after exposure (Mayer and Gross 1985). Serum fluoride was
4.17 µg/mL.
The death of a chemist who sustained first-and second-degree burns of
the face, hands, and arms when a vat containing hydrofluoric acid accidentally
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broke has been reported (Kleinfeld 1965). This 29-year-old male died 10 hours
after admission to the.hospital. Postmortem examination showed severe
tracheobronchitis and hemorrhagic pulmonary edema. A petroleum refinery
worker was splashed in the face with 100% anhydrous hydrofluoric acid
(Tepperman 1980). The burn produced acute systemic fluoride poisoning with
profound hypocalcemia and hypomagnesemia. The patient died less than 24 hours
after exposure. A young woman splashed in the face with hydrofluoric acid
died a few hours after exposure occurred (Chela et al. 1989). The autopsy
revealed severe burns of the skin and lungs, with pulmonary hemorrhagic edema
produced by hydrofluoric acid and its vapor.
No studies were located regarding lethality in humans after dermal
exposure to fluorine or fluoride, and no studies were located regarding
lethality in animals after dermal exposure to fluorine, hydrofluoric acid, or
fluoride.
2.2.3.2 Systemic Effects
No studies were located regarding gastrointestinal, hematological, or
musculoskeletal effects in humans or animals after dermal exposure to
fluorine, hydrofluoric acid, or fluoride.
The highest NOAEL values and all reliable LOAEL values for systemic
effects in each species and duration category of exposure to fluorine are
recorded in Table 2-4. The highest NOAEL and all reliable LOAEL values for
systemic effects in each species and duration category of exposure to hydrogen
fluoride or hydrofluoric acid are recorded in Table 2-5. All reliable LOAEL
values for systemic effects in each species and duration category for fluoride
are recorded in Table 2-6.
Respiratory Effects
Hydrofluoric Acid. Respiratory effects including pulmonary edema,
tracheobronchitis, and pulmonary hemorrhagic edema have been reported in
humans following acute dermal exposure of the face to hydrofluoric acid. (Chela
et al. 1989; Kleinfeld 1965). However, the pulmonary effects are likely to be
due to concomitant inhalation of the acid vapor. As two of these cases were
occupational accidents and the third was a homicide, no doses could be
estimated from the information provided.
No studies were located regarding respiratory effects in humans after
dermal exposure to fluorine or fluoride, and no studies were located regarding
respiratory effects in animals after dermal exposure to fluorine, hydrofluoric
acid, or fluoride.
Cardiovascular Effects. Cardiac arrhythmias are found following acute








et al. 1987). A man who received a hydrofluoric acid burn on the arm covering
5% of the body experienced repeated ventricular fibrillation episodes, but
survived following administration of intravenous calcium chloride,
subcutaneous calcium gluconate, and excision of the burn area (Buckingham
1988). These cardiovascular effects are believed to result from the strong
binding of fluoride to calcium, which produces hypocalcemia. Serum calcium is
critical for proper ion transport in neuromuscular synapses; hypocalcemia can
cause the ventricles not to contract properly.
No studies were located regarding cardiovascular effects in humans after
dermal exposure to fluorine or fluoride, and no studies were located regarding
cardiovascular effects in animals after dermal exposure to fluorine,
hydrofluoric acid, or fluoride.
Hepatic Effects
Hydrofluoric Acid. Elevated SGOT, serum glutamic pyruvic transaminase
(SGPT), and lactate dehydrogenase levels were found in a man who was splashed
in the face and on the neck with a mixture of 10% hydrofluoric acid and
sulfuric acid (Braun et al. 1984). The elevated SGOT and SGPT levels were
attributed to either muscle necrosis or temporary liver damage caused by toxic
metabolic products from necrotic tissue.
Renal Effects
Hydrofluoric Acid. A 49-year-old man who was splashed in the face and
on the neck with a mixture of hydrofluoric acid and sulfuric acid became
oliguric for a brief period on the day after the accident, and then became
anuric (Braun et al. 1984). Concomitant inhalation exposure is likely, and
the effect of the sulfuric acid is unknown.
Dermal/Ocular Effects. Skin, nose, and eye irritation have been
reported following dermal exposure to fluorine or hydrogen fluoride gas.
Longer contact with these chemicals, brief contact with high concentrations of
hydrofluoric acid, and longer contact with lower concentrations of
hydrofluoric acid can cause severe burns.
Fluorine. Volunteers (19-50 years of age) were exposed to 16 mg/m3
fluorine for 15 minutes without discomfort or irritation of the eyes or nose
(Keplinger and Suissa 1968). However, repeated exposures at this level for
3-5 minutes every 15 minutes over a 2-3 hour period caused slight eye and nose
irritation. Exposure was through a face mask that covered the eyes and nose
but not the mouth. Slight eye irritation was reported following exposure to
36 mg/m3 for 5 minutes. Exposure to 78 mg/m3 for 3 minutes caused eye
irritation and slight nose irritation. Exposure to concentrations ≥104mg/m3
were very irritating and became uncomfortable after a few seconds. After
exposure to 155 mg/m3 for 1 minute, the eyes burned and felt as though they
78
2. HEALTH EFFECTS
were covered by a skin. The skin felt sticky and slightly irritated. The
only effect of exposure to 155 mg/m3 for 30 seconds was severe eye and nose
irritation. Less irritation was reported when exposure was repeated at weekly
intervals. The study is limited by the small number of subjects and
incomplete description of exposure protocol.
Osborne-Mendel rats exposed to concentrations greater than or equal to
~25% of the LC50 (i.e., 263 mg/m3) for 5 minutes exhibited eye irritation
(Keplinger and Suissa 1968). In experiments with exposure for durations of
15-60 minutes, eye and nose irritation was reported only at ~50% of the LC50.
Similar results were obtained with Swiss-Webster mice, New England guinea
pigs, and New Zealand rabbits.
When the shaved backs of New Zealand rabbits were exposed to fluorine
gas under 40 pounds of pressure for 0.2-0.6 seconds at distances of
0.5-1.5 inches, the resulting burn appeared to be thermal, rather than
chemical in nature (Stokinger 1949). Exposure for 0.2 seconds produced an
ischemic area about ¼ inch in diameter, surrounded by an erythematous area.
This became a superficial eschar that sloughed off within 4 days, revealing
normal epidermis. The longer exposures produced a flash of flame that
resulted in combustion of hair, singeing, and erythema over an area several
times the area of the primary burn. Coagulation necrosis and charring of the
epidermis was also reported. The wound healed within 13 days. The burns
resembled those produced by an oxyacetylene flame, rather than those made by
hydrofluoric acid, and so were characterized as thermal, rather than chemical.
However, it is not clear if the difference from the hydrofluoric acid burn is
due to the shorter exposure to fluorine.
Rats exposed to 25 mg/m3 fluorine for 21 days, 5-6 hours/day exhibited
irritation of the eyes and of the nasal and buccal mucosa, and stiffened fur
(Stokinger 1949). Similar, but weaker symptoms appeared following exposure
under a similar regimen to 8 or 3 mg/m3,but no symptoms were seen following exposure to
0.8 mg/m3.  Few details were provided regarding the severity of symptoms seen at different
exposure levels.
Hydrogen Fluoride/Hydrofluoric Acid. Dermal exposure to hydrogen
fluoride can cause irritation of the skin and mucous membranes. Severe dermal
effects have not been reported from dermal exposure to hydrogen fluoride gas,
but it is not clear if this is because the gas does not cause such effects, or
because concentrations high enough to cause severe effects were not tested.
Dermal exposure to hydrofluoric acid results in extensive skin burns (Chela et
al. 1989). Hydrofluoric acid quickly penetrates into soft tissues and causes
necrosis. As a result of cell membrane destruction, the fluoride ion has easy
access to lymph and the venules, can be distributed rapidly, and can cause
significant adverse effects such as inhibition of glycolytic enzymes,




Marked conjunctival irritation and "smarting" of exposed skin occurred
in humans within 1 minute of exposure to hydrogen fluoride at about 95 mg
fluoride/m3 (Machle et al. 1934). This was the highest concentration that two
male volunteers could tolerate for more than 1 minute. At 48 mg fluoride/m3,
conjunctival and nasal irritation were still marked, and tickling and
discomfort of the nasal passages were reported. A concentration of 24.7 mg
fluoride/m3 produced mild irritation of the nose and eyes and irritation of
the larger air passages. This concentration could be tolerated for "several"
minutes (at least 3 minutes). The authors of this study reported some
difficulties with their measurements of exposure. Repeated exposures did not
reveal any habituation. Mild eye irritation was observed in five volunteers
exposed 6 hours per day for 10 days, to hydrogen fluoride at concentrations
averaging from approximately 2 to 4 mg/m3 (Largent 1960). This study is
limited by the inadequacy of both the experimental details and the description
of effects observed.
There are many reports of hydrofluoric acid skin burns in humans. In
one case, a 23-year-old man received fatal second- and third-degree burns over
9%-10% of his body from a 70% hydrofluoric acid spill (Mayer and Gross 1985).
The patient died 17 hours after exposure due to cardiac arrhythmias. Two case
studies of accidental dermal exposure of the hands to hydrofluoric acid
(5%-7%) reported serious dermal injury following exposures from 45 minutes to
6 hours (Roberts and Merigian 1989). Topical treatment with calcium gluconate
prevented loss of nails. Other case reports are discussed in Section 2.2.3.1.
Some evidence of delayed ocular damage due to persistence of the
fluoride ion was observed 4 days after a 3-year-old girl accidentally sprayed
a hydrofluoric-acid-containing product in her eyes (Hatai et al. 1986).
Opacification of the cornea1 epithelium and thrombosis of the conjunctival
vessels were seen. These changes were not permanent; after 30 days, the eyes
returned to normal, and vision was 20/20. However, it is difficult to
generalize from this report as the product contained both hydrofluoric acid
and phosphoric acid at unspecified concentrations.
Hydrogen fluoride produces irritation of the eyes, skin, and
conjunctivae in rats, and the severity of the effect is related to the
exposure concentration and duration (Rosenholtz and Ford 1962; Rosenholtz et
al. 1963; Wohlslagel et al. 1976). Levels approaching the LC50 can cause
cornea1 opacity and lesions of the face (Haskell Laboratory 1988), while
slight ocular and nasal irritation was observed in rats exposed to levels as
low as 6% of the LC50 (Rosenholtz et al. 1963). Rats exposed to hydrogen
fluoride (whole body) at a concentration of approximately 1,084 mg fluoride/m3
for 60 minutes were observed to have erythema of an unspecified severity of
the exposed skin (Wohlslagel et al. 1976).
Subcutaneous hemorrhages around the eyes and on the feet developed in
rats exposed to 7 or 24 mg/m3 for 6 hours/day, 6 days/week for 30 days
(Stokinger 1949). The effect was more severe at the higher exposure level.




The concentration of hydrofluoric acid and the length of exposure affect
the severity of dermal lesions (Derelanko et al. 1985). Rabbits exposed to a
hydrofluoric acid solution of 0.01% for 5 minutes had visible skin lesions,
whereas exposure to 2% hydrofluoric acid for 1 minute did not produce lesions.
A longer exposure of 1-4 hours to 2% hydrofluoric acid solution produced
necrotic lesions on the backs of rabbits (Derelanko et al. 1985). In similar
experiments involving the exposure of the conjunctivae of rabbit eyes to
hydrofluoric acid, McCulley et al. (1983) concluded that the greater severity
of hydrofluoric acid injuries compared to injuries from other inorganic acids
at comparable strengths probably results from the destruction of the cornea1
epithelium allowing substantial penetration of the fluoride ion into the
cornea1 stroma and underlying structures.
The application of 0.2 mL of a 47% hydrofluoric acid solution to the
shaved backs of New Zealand rabbits over a surface of 1¼ inches produced no
immediate reaction (Stokinger 1949). The material was held in place by
lanolin and allowed to dry for 24 hours. Within a few days of exposure,
erythema and dark spots of liquefaction necrosis appeared. Multiple eschars
were formed in the necrotic areas. These wounds healed more slowly than those
produced by fluorine gas. Healing did not near completion until 27 days after
exposure.
Fluoride. Sodium fluoride applied topically to the abraded skin of
Sprague-Dawley rats (0.5% or 1.0%) for 24 hours produced both morphological
and biochemical changes (Essman et al. 1981). At 0.5%, the abraded surface
showed focal superficial necrosis of the epidermis. At l.0%, the abraded
surface showed edema and vacuolization. There was marked edema of the dermis
with inflammation. Skin histamine concentrations were also increased following
application of 0.5% or 1% sodium fluoride to shaved-only or epidermally
abraded skin, although the variance of these measurements was quite high.
The highest NOAEL values and all reliable LOAEL values for dermal/ocular
effects of fluorine exposure for each species and duration category are
recorded in Table 2-4. The highest NOAEL and all reliable LOAEL values for
dermal/ocular effects of hydrogen fluoride exposure for each species and
duration category are recorded in Table 2-5. All reliable LOAEL values for
dermal/ocular effects of fluoride exposure are recorded in Table 2-6.
No studies were located regarding the following effects in humans and










No studies were located regarding cancer in humans or animals after
dermal exposure to fluorine, hydrofluoric acid, or fluoride.
2.3 TOXICOKINETICS
The majority of data on the toxicokinetics of fluoride focus on sodium
fluoride and hydrofluoric acid. Data regarding the toxicokinetics of calcium
fluoride and other fluorides in human or animals are limited. While
radioactive isotopes are useful in toxicokinetic studies, this use is limited
in studies of fluoride because the fluorine isotope 18F has a short half-life
(Wallace-Durbin 1954). Only one animal study and no human studies were
located regarding the toxicokinetics of fluorine.
2.3.1 Absorption
2.3.1.1 Inhalation Exposure
Data providing information on absorption rates exist on the inhalation
exposure of humans to mixtures of hydrogen fluoride and fluoride dusts, and
inhalation exposure of animals to hydrogen fluoride. Animal data also exist
showing that fluorine is absorbed.
Fluorine. No data were located regarding the absorption of fluorine in
humans. Hepatic and renal effects were observed in mice following exposure to
fluorine for periods up to 60 minutes (Keplinger and Suissa 1968). This
indicates that the fluoride ion was systemically available following the
exposure. Fluoride, rather than fluorine, is the agent that is toxicologically
active systemically, since fluorine is too reactive to be absorbed
unchanged. Similarly, the finding of elevated fluoride levels in bones,
teeth, and urine during intermediate-duration exposure to fluorine indicates
that fluoride is absorbed under these conditions (Stokinger 1949). No
information on absorption rate or extent is available.
Hydrogen Fluoride. A study in rats suggests that hydrogen fluoride is
absorbed primarily by the upper respiratory tract, and that removal of
hydrogen fluoride from inhaled air by the upper respiratory tract approaches
100% for exposures that range from 30-176 mg fluoride/m3 (Morris and Smith
1982). Furthermore, it is apparent that distribution to the blood is rapid.
Immediately following 40 minutes of intermittent exposure, plasma fluoride
concentrations correlated closely (correlation coefficient=0.98; p<0.01) with
the concentration of hydrogen fluoride in the air passed through the
surgically isolated upper respiratory tract. Plasma levels were not measured
at time points less than 40 minutes.
Hydrogen Fluoride and Fluoride Dusts. The absorption in humans of
inhaled hydrogen fluoride and fluoride dusts was demonstrated by Callings et
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al. (1952). Their study was conducted on two subjects exposed in the
laboratory to an atmospheric concentration of 5.0 mg fluoride/m3 as hydrogen
fluoride during an 8-hour period. Absorption of fluoride was evaluated by
monitoring urinary excretion of fluoride during and after exposure. Analysis
of 2-hour serial urine samples showed a peak fluoride level 2-4 hours after
cessation of exposure, which decreased to base levels within 12-16 hours after
exposure. Similar results were obtained using the same protocol to measure
urinary fluoride following exposure to air containing 5.0 mg fluoride/m3 as
rock phosphate dust (Collings et al. 1951). Another study reported clinical
observations of employees in the production of phosphate rock and triple
superphosphate (Rye 1961). Three employees were exposed to airborne fluoride
(2-4 ppm) composed of approximately 60% dust and 40% hydrogen fluoride gas.
Within 2-3 hours after exposure began, urinary fluoride levels increased from
0.5 to 4.0 mg/L and peaked 10 hours (7-8 mg/L) following cessation of
exposure. None of the subjects had prior occupational exposure to fluoride.
Although these studies demonstrate absorption of fluoride, none measure the
extent of fluoride absorption.
The data presented above show that the fluoride ion, as hydrogen
fluoride in fluoride-containing dusts, is absorbed by humans and animals
following acute inhalation exposure. The degree of absorption in humans has
not been determined. However, the demonstration that virtually 100% of
airborne hydrogen fluoride is deposited in the upper respiratory tract of
rats, combined with the appearance of fluoride in the urine of humans within
at least 2 hours and in the plasma of rats at least 40 minutes following
initiation of exposure, indicates that both forms of fluoride are rapidly and
completely absorbed by humans by this route. This conclusion is confirmed by
data presented in case reports of systemic effects following inhalation
(combined with dermal) exposure to hydrogen fluoride/hydrofluoric acid, as
discussed in, Sections 2.2.1 and 2.2.3.
Furthermore, although the data presented concern only acute exposures,
it is expected that virtually complete absorption would also be observed
during long-term exposure to low levels of fluoride in the air.
2.3.1.2 Oral Exposure
Data exist on absorption following oral exposure of humans and animals
to fluoride as sodium fluoride, calcium fluoride, and in bone meal. Data on
absorption rates exist only for sodium fluoride.
Fluoride. Ingested dietary fluoride is readily absorbed from the
gastrointestinal tract as the undissociated HF molecule by passive absorption
(Whitford and Pashley 1984). Since the neutral undissociated inconsistent  molecule can
penetrate cell membranes and be absorbed much better than the fluoride ion, decreasing
the stomach pH increases absorption. The absorption of soluble fluoride in humans is
rapid and extensive (97%) (Carlson et al. 1960a;Ekstrand et al. 1977b, 1983;
McClure et al. 1945) with maximum plasma fluoride
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concentrations attained as early as within 30 minutes following exposure
(Ekstrand et al. 1977b).
Absorption of ingested fluoride has been investigated in humans in a
number of studies. In a study by Carlson et al. (1960a), oral administration
of 1 mg fluoride (as sodium fluoride containing 18F) in 250 mL water resulted
in a maximum plasma fluoride concentration of 0.13-0.17 mg/L within
60 minutes. At 150 minutes following exposure, 18F was no longer detected in
the stomach. In another study, the plasma fluoride concentration after oral
administration of 4.5-10 mg fluoride as sodium fluoride tablets or gelatin
capsules to eight subjects peaked within 30 minutes of administration
(Ekstrand et al. 1977b). Similar observations were reported in children
receiving 0.5 mg fluoride as sodium fluoride tablets in water (Ekstrand et
al. 1983). Gastrointestinal absorption of fluoride in five men receiving a
diet supplemented with sodium fluoride and calcium fluoride in water and food,
and bone meal and cryolite in food was determined over a 5-day period (McClure
et al. 1945). Fecal excretion data indicated that sodium fluoride in food and
water, and calcium fluoride in water were extensively absorbed, while fluoride
in bone meal, cryolite, and calcium fluoride in food were not as completely
absorbed. About 13%-16% of the ingested fluoride was in the feces for the
well-absorbed species, while 30%-56% of the ingested dose of the poorly-
absorbedspecies appeared in the feces. As described below in Section 2.3.4.2, more recent
data indicate that a smaller percent of a sodium fluoride dose appears in the feces than
was reported here.
However, additional factors can affect absorption. The absorption of
fluoride as calcium fluoride is increased when the material is given with
meals (Trautner and Einwag 1987). The suggested explanation was that
increased residence time in the upper gastrointestinal tract increases
absorption. Fluoride is more completely absorbed from liquids than from solid
foods (McClure et al. 1945; Trautner and Siebert 1986). Concurrent ingestion
of other salts can increase or decrease absorption. Ingestion of 1320 mg
calcium/day as calcium carbonate reduced the absorption of fluoride (30 mg/day
as sodium fluoride, or 0.42 mg fluoride/kg/day) by 22% (Jowsey and Riggs
1978). This result could be due either to inhibition of absorption by
calcium, such as due to the insolubility of calcium fluoride, or due to the
alkalizing effect of the carbonate. Magnesium (Spencer et al. 1978b) and
aluminum antacids (Spencer et al. 1980a, 1980b) decreased absorption in
humans. In Sprague-Dawley rats, calcium and magnesium decreased absorption,
while phosphate and sulfate increased absorption (Stookey et al. 1964; Weddle
and Muhler 1954). Aluminum also decreased absorption in Sprague-Dawley rats
(Weddle and Muhler 1954). The effects of salts on fluoride absorption is
discussed further in Section 2.8.
Absorbed fluoride is likely to be passed on to the developing human
fetus. Placental accumulation of fluoride in humans has been demonstrated
following consumption of drinking water containing 0.55 ppm fluoride (Gedalia
et al. 1961). Furthermore, the fluoride concentration in the placenta
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(0.15 ppm) was higher than that in maternal blood (0.09 ppm). Fluoride
measurements from maternal uterine vessels and umbilical blood at caesarean
section revealed no difference between maternal and fetal levels (Armstrong et
al. 1970). However, a partial placental barrier may exist at high maternal
fluoride levels (Gedalia 1970). The use of fluoride supplements markedly
increased placental fluoride levels, while fluoride levels in fetal blood
remained almost constant. Placental transfer of fluoride to the developing
fetus has been demonstrated in rats (Theuer et al. 1971). A high dietary
level of fluoride (10 mg fluoride/kg/day) administered to pregnant rats as
sodium fluoride resulted in significantly higher fluoride levels in fetuses
than in the placenta.
Soluble fluorides are also rapidly and extensively absorbed from the
gastrointestinal tract of animals. Rats were administered 0.2 mg fluoride
(0.57 mg/kg/day) as sodium fluoride in solution, and absorption was monitored
at time points up to 90 minutes. Half of the ,dose was absorbed with
30 minutes and 86% of the dose was absorbed within 90 minutes (Zipkin and
Likins 1957). Oral administration of radiolabeled fluoride (0.08 mg fluoride/kg) to male
rats resulted in 89%-90% absorption after 8-10 hours (Ericsson 1958).
In summary, existing data indicate that all common forms of inorganic
fluoride are rapidly and extensively absorbed by humans. However, there are
differences in the extent of absorption between different forms of fluoride
and between fluoride in solution and fluoride incorporated in food, and the
presence of other ions can affect absorption. The highest degree of
absorption (virtually 100%) is seen with aqueous solutions of sodium fluoride.
Evidence from humans and animals indicates that absorption begins quickly
following ingestion, with studies in animals showing absorption beginning as
early as 30 minutes following exposure. Furthermore, the absorbed fluoride is
passed to the human fetus during pregnancy.
Most of the existing studies examine acute absorption of fluoride, and
there is no indication that absorption of fluoride would be less extensive
following low-level, long-term exposure. In the absence of such data, it is
expected that absorption would be virtually complete following chronic oral
exposure to low levels of most soluble forms of fluoride.
2.3.1.3 Dennal Exposure
Data exist on dermal absorption of hydrofluoric acid in humans and
animals, and limited quantitative rate data are available in animals.
Fluorine. Systemic effects have been observed following whole-body
exposure to fluorine (Keplinger and Suissa 1968; Stokinger 1949). However,




Hydrofluoric Acid. Dermal application of hydrofluoric acid results in
rapid penetration of the fluoride ion into the skin. Sufficiently large
amounts cause necrosis of the soft tissue and decalcification and corrosion of
bone in humans (Browne 1974; Dale 1951; Dibbell et al. 1970; Jones 1939;
Klauder et al. 1955). Systemic fluoride poisoning has been reported following
accidental dermal exposure to anhydrous hydrogen fluoride (Buckingham 1988;
Burke et al. 1973). Although the extent of the contribution of inhalation
exposure in these cases is not known, the reports suggest that hydrogen
fluoride is quickly absorbed into the body following dermal exposure.
However, these studies did not provide useful information concerning the
extent of fluoride absorption, or information on absorption of smaller doses.
Dermal absorption of hydrofluoric acid in albino mice of the d.d. strain
was inferred in a study by Watanabe et al. (1975). Mice were painted with
0.02 mL of 50% hydrofluoric acid, and the residual acid was wiped off after
5 minutes. The mice were then injected intraperitoneally with [14C]glucose
and analyzed by whole body radiography. Radioactivity levels in the liver,
renal cortex, lungs, and blood were elevated 30 minutes after injection. This
suggests that fluoride was absorbed through the skin and interfered with the
tissue distribution of glucose, No data were located on the extent of
absorption of fluoride in animals exposed dermally to hydrofluoric acid.
These studies indicate that fluoride as hydrofluoric acid is absorbed
through the skin in humans and animals. However, the degree of absorption is
not known, nor is it known whether other forms of fluoride would be absorbed,
and to what extent. Furthermore, it is expected that the relationship between
duration or concentration and degree of absorption would be affected by the
corrosive action of hydrofluoric acid. Therefore, prediction of the extent of
absorption following exposure to a low concentration of hydrofluoric acid
cannot be made based on the existing data.
2.3.2 Distribution
2.3.2.1 Inhalation Exposure
Fluorine. No data were located regarding the distribution of fluoride
following the inhalation exposure of humans to fluorine. In rats exposed to
25 mg/m3 fluorine for about 5 hours/day, 6 days/week for 21 days, markedly
elevated fluoride levels were observed in teeth and bone, the only tissues
that were analyzed (Stokinger 1949). Tooth fluoride levels were about
14 times the levels in controls and fluoride levels in the femur were about
6 times those in the controls. Similar concentration-related increases in
bone and tooth fluoride levels were observed at the lower concentrations (3
and 0.8 mg/m3.
Hydrogen Fluoride. No data were located regarding the distribution of
fluoride in humans following exposure to only hydrogen fluoride. Evidence
from studies in animals supports the inference from occupational studies of
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exposure to hydrogen fluoride and fluoride dust that fluoride is distributed
to the rest of the body when inhaled. Duration- and concentration-related
increases in tooth and bone fluoride levels were reported in the rat following
exposure to 7 or 24 mg/m3 for 6 hours/day, 6 days/week for up to 30 days
(Stokinger 1949). Fluoride levels in new bone were up to twice the levels in
old bone. The distribution of the fluoride ion was studied in the tissues of
rabbits, a guinea pig, and a monkey exposed to hydrogen fluoride at various
concentrations (1.5-1,050 mg/m3) and exposure times (Machle and Scott 1935).
The observation period ranged from 9 to 14 months. As might be expected,
based on the following discussion of human occupational exposure to fluoride
compounds, the fluoride ion accumulated chiefly in the skeleton of all three
species.
Several studies in animals have demonstrated that fluoride is widely
available through the blood, although actual concentrations in tissues other
than blood have, for the most part, not been reported. For example, whole
body exposure of male rats to levels ranging from 11 to 116 mg fluoride/m3 as
hydrogen fluoride for 6 hours resulted in a dose-dependentincrease in lung
and plasma fluoride concentrations (Morris and Smith 1983). In another study,
rats exposed to 84 mg fluoride/m3 as hydrogen fluoride by whole body exposure
had significantly elevated levels of fluoride in plasma and lungs 6 hours
post-exposure (Morris and Smith 1983).
Intermittent high level exposures may result in greater accumulation of
fluoride in bones and teeth than continuous exposure. Daily exposure of rats
to airborne concentrations of 8 mg hydrogen fluoride/m3 for a total of
124 hours resulted in a fluoride content of pooled teeth and bone
1.5-1.8 times the fluoride content of similarly pooled teeth and bones in a
group exposed to the same concentration on alternate days for a total of
62 hours (Stokinger et al. 1950). If exposure durations were simply additive
the ratio between fluoride concentrations in teeth and bone at the two
durations would be expected to be 2.0, rather than 1.5-1.8.
Hydrogen Fluoride and Fluoride Dusts. Limited information was located
on the distribution of inhaled fluoride in humans. However, reports of
skeletal fluorosis (Chan-Yeung et al. 1983b; Czerwinski et al. 1988;
Kaltreider et al. 1972) and elevated bone fluoride levels (Baud et al. 1978;
Boivin et al. 1988) after occupational exposure to hydrogen fluoride and
fluoride dusts indicate that fluoride is distributed to bone and accumulates
there.
Fluoride deposition in bone occurs mainly in regions undergoing active
ossification or calcification. If the source of fluoride exposure has been
removed, fluoride levels in bone decrease as the bone undergoes remodelling.
Areas of fluoride deposition during high-level exposure are distinguished by
highly elevated fluoride levels even after the average fluoride level of the
bone has returned to normal (Baud et al. 1978).
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Studies located indicate that the fluoride ion is distributed rapidly in
the bloodstream following inhalation exposure. Evidence in humans and animals
indicates that fluoride may be preferentially distributed to bones and teeth
following inhalation exposure.
2.3.2.2 Oral Exposure
Fluoride. Ingested soluble fluoride is rapidly absorbed and distributed
in humans. Epigastric counts were monitored by Carlson et al. (1960a) in
subjects who consumed sodium fluoride containing 18F in water (250 mL at
1 mg/L). Two-and-a-half hours after dosing, the remaining epigastric
(abdominal) counts were attributable to fluoride in the spine. Counts in
contracted biceps declined 50 minutes after ingestion and were undetectable
after approximately 4 hours. In contrast, counts in the femur declined only
15% from their peak value (at 50 minutes) after 4 hours.
Teeth and bone readily take up fluoride following oral exposure (Machle
and Largent 1943; McClure and Likins 1951; Suttie et al. 1958). While the
rate of fluoride uptake in human teeth may decrease with age (Jackson and
Weidmann 1959), it is apparent that the total fluoride content of teeth and
bone increases throughout life, and that the amount deposited is dependent on
the exposure concentration. A linear relationship was observed between
subject age and fluoride concentration in bone ash of lifetime residents of an
area with a drinking water supply containing 0.06 ppm fluoride, indicating
that bone fluoride levels increase with duration of exposure (Smith et
al. 1953). A linear relationship was also observed between the concentration
of fluoride in drinking water (ranging from 0.1 ppm to 4 ppm) and the
concentration in bone at autopsy in adult humans who had ingested the drinking
water (Zipkin et al. 1958). Average fluoride levels in the iliac crest bone
ash in people with drinking water fluoride levels of ≤0.3,1, and 4 ppm were
700, 2,300, and 6,900 ppm, respectively.
Long-term retention and accumulation of fluoride are primarily confined
to calcified tissue in humans (Wagner et al. 1958). Soft tissue
concentrations of fluoride do rise transiently following ingestion of fluoride
(Carlson et al. 1960b; Hein et al. 1956). Examination of autopsy samples from
23 individuals who had lived in an area where drinking water contained l-4 ppm
fluoride revealed no significant accumulation of fluoride in the heart, liver,
lung, kidney, or spleen (Smith et al. 1960). Fluoride concentration in the
aorta did increase with age; this was probably associated with increased
calcification of the aorta with age. Kidney fluoride levels can be much
greater than the levels in plasma (Whitford and Taves 1973).
Fluoride is redistributed as it is released during bone remodelling.
The short-term kinetics of this process was investigated in humans by
supplementing a diet of 4.4 mg fluoride/day with 9.1 mg fluoride/day as sodium
fluoride for 32 days (Spencer et al. 1975b). Urinary fluoride excretion was
elevated during the period of sodium fluoride supplementation, but dropped
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rapidly after it was removed. Urinary excretion returned to the presupplemented
levels within 12 days. Only 9.1% of the retained fluoride was excreted
during this period. .The progressive decrease over many years of bone fluoride
concentrations of skeletal fluorosis patients who have been removed from the
source of exposure indicates that there is a second, slower phase of fluoride
redistribution (Boivin et al. 1988). Limited data suggest that this phase
reduces fluoride levels by one-half in 20 years (Baud et al. 1978). This
slower phase may correspond to remodelling of the trabecular bone (WHO 1984).
A limited number of studies were located that determined the
distribution of fluoride in animal tissues following oral exposure. For
example, in a lamb sacrificed 2 hours after a one-time ingestion of sodium
fluoride containing 18F, the absorbed fluoride was found to be widely
distributed in the blood, bile, muscle, spleen, pancreas, liver, lymph node,
and skeleton (Perkinson et al. 1955). These results are consistent with a
short half-life in soft tissues.
In a study of rats exposed to 0.1% sodium fluoride in their diet for up
to 113 days, analysis of fluoride content in the bone at various intervals
revealed rapid uptake of the fluoride into bone (Suttie and Phillips 1959).
However, final fluoride levels in bone were inversely correlated with the
initial ages of the rats, suggesting that the rate of fluoride uptake
decreases with age.
Evidence from one animal study indicates that fluoride deposits in bone
are released as the bone undergoes normal absorption and redeposition (Guo et
al. 1988). Weanling rats were exposed to high levels of fluoride (50 mg
fluoride/L) in drinking water for 3 weeks to establish a baseline fluoride
level in bone. Fluoride levels in bone were determined following exposure to
a low-fluoride diet or a low-calcium, low-fluoride diet. Comparison of
control fluoride-treated rats to those fed low calcium diets (which
accelerates bone resorption and deposition) demonstrated that approximately
40% of the fluoride mobilized during bone resorption is not redeposited in the
skeleton (Guo et al. 1988). About 30% of the bone fluoride was lost in a
4 week period. Presumably, the fluoride that is not redeposited is excreted.
The high level of fluoride loading in the bone make it difficult to compare
this study with results from studies in humans.
Fluoride accumulates at least temporarily in the soft tissues of dairy
cows; however, differences between the bovine and human digestive systems
preclude firm conclusions based on this information alone. Soft tissue
concentrations of fluoride were measured in 20 dairy cows exposed to 0-50 ppm
(equivalent to 1.4 mg/kg/day) fluoride as sodium fluoride in the feed for
5.5 years (Suttie et al. 1958). Cows exposed to 50 ppm fluoride had residues
of fluoride mainly in the pancreas (4.2 ppm), kidney (19.3 ppm), and whole
blood (0.67 ppm). As in humans, bone-fluoride concentration corresponded to
the amount of fluoride ingested.
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Existing literature in humans indicates that continuous fluoride
exposure results in a build-up of fluoride levels in bone and teeth.
Furthermore, fluoride levels in bone are related directly to the level of
steady state intake. With the exception of the aorta (Smith et al. 1960) and
kidney (Whitford and Taves 1973), there is no evidence of accumulation or
retention of fluoride in soft tissues in humans. Upon cessation of exposure,
fluoride levels in bone are expected to decrease slowly; however, the time
period over which this would occur in humans is not known.
2.3.2.3 Dermal Exposure
No information was located in humans or animals regarding the
distribution of fluorine, hydrogen fluoride, or fluoride following dermal
absorption.
2.3.2.4 Other Routes of Exposure
Based on the results of a five-compartment computer model, Charkes et
al. (1978) calculated that about 60% of intravenously administered fluoride is
taken up by bone and the half-time for this uptake is about 13 minutes.
Perkinson et al. (1955) found initial rates of removal of fluoride from
sheep and cow blood to be 4l%/minute and 32%/minute of the intravenously
administered dose, respectively. These data suggest a rapid distribution of
fluoride and corroborate findings reported by other routes of administration.
Fluoride distribution in rats was examined during and after continuous
intravenous infusion of radiolabeled sodium fluoride at varying chemical dose
rates for 3 hours (Knaus et al. 1976). Blood, kidneys, and lungs contained
the highest fluoride concentrations at doses up to 3.6 mg fluoride/kg/hour,
but at 6 mg/kg/hour the fluoride content of the liver, spleen, and hollow
organs increased sharply, indicating that the dose exceeded the amount readily
processed by the excretory mechanisms of the body. In rat pups injected
intraperitoneally with 0.1 µg fluoride/g body weight as sodium fluoride
solution, significant increases in the fluoride content occurred in the
developing enamel and bone (Bawden et al. 1987). Thus, regardless of the
route of administration, some fluoride is deposited in teeth, bone, and soft
tissues of animals, and some is excreted in the urine, sweat and saliva.
2.3.3 Metabolism
Fluoride is believed to replace the hydroxyl ion (OH-) and possibly the
bicarbonate ion (HC03-) associated with hydroxyapatite--a mineral phase during
formation of bone (McCann and Bullock 1957; Neuman et al. 1950). The
resultant material is fluorapatite. Once absorbed, a portion of the fluoride
is deposited in the skeleton, and the remainder is excreted in the urine,
sweat, saliva, and feces within 24 hours (Dinman et al. 1976a, 1976b; McClure
et al. 1945). Thus, skeletal sequestration and renal excretion are the two
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major means by which the body prevents circulation of toxic amounts of
fluoride ion (Hodge 1961). Urinary excretion is markedly decreased in the
presence of diminished renal function (Kono et al. 1984).
The fluoride ion carried in human blood serum exists in two forms,
namely as an inorganic ion F and in combination with an organic molecule
(Halton et al. 1984). The toxicological significance, if any, of the latter
form is unknown. A portion of the circulating inorganic fluoride acts as an
enzyme inhibitor because it forms metal-fluoride-phosphate complexes that
interfere with the activity of those enzymes requiring a metal ion cofactor.
In addition, fluoride may interact directly with the enzyme or the substrate.
It is a general inhibitor of the energy production system of the cell (i.e.,
glycolytic processes and oxidative phosphorylation enzymes responsible for
forming ATP) (Najjar 1948; Slater and Bonner 1952). Although much is known
about enzyme inhibition by fluoride, the human health significance remains to
be determined.
In rats exposed to 84 mg fluoride/m3 as hydrogen fluoride by whole body
exposure an average of 90% of recovered fluorine was nonionized (Morris and
Smith 1983). This observation indicates that most of the fluorine in the




Fluorine. No data were located regarding excretion of fluoride
following human inhalation exposure to fluorine. Urinary fluoride levels were
increased in dogs and rabbits exposed to levels as low as 0.8 mg/m3 for
5-6 hours/day, 6 days/week for 35 days (Stokinger 1949). No quantitative data
were reported at this level, but urinary fluoride levels in rabbits exposed to
3 mg/m3 were 1.5 times normal. No further details were reported.
Hydrogen Fluoride. Studies in humans indicate that fluoride absorbed
from inhaled hydrogen fluoride over an 8-hour work shift is excreted even
during exposure, with urinary excretion peaking approximately 2-4 hours after
cessation of exposure (about 10 hours following beginning of exposure)
(Collings et al. 1951; Rye 1961). These studies have been discussed in
Section 2.3.1.
Overnight urinary fluoride excretion in dogs and rabbits exposed to
7 mg/m3 hydrogen fluoride for 6 hours/day, 6 days/week for 30 days was about





Fluoride. The principal route of excretion of ingested fluoride is via
the urine as demonstrated in a variety of species. In general, urine accounts
for about 50%-70% of the fluoride intake and feces accounts for 5%-10% (Machle
and Largent 1943; Spencer et al. 1970). Estimates of total excretion range
from about 50% (Spencer et al. 1970) to about 100% (McClure et al. 1945).
These varying estimates lead to widely varying estimates of the amount of
fluoride that is stored in the body. At least part of the discrepancy is due
to excretion in sweat. Because excretion in sweat is rarely measured, data on
the total amount of ingested fluoride that is excreted are often
underestimates. About 1% of fluoride intake is excreted into saliva (Carlson
et al. 1960a), although since saliva is swallowed, this amount does not enter
mass balance calculations. In species other than man, there is little
published information relating ingested fluoride concentrations and urine
fluoride concentrations over prolonged periods.
There is a striking linear relationship between the concentration of
fluoride in drinking water and in the urine of humans exposed continuously to
fluoride. However, plasma fluoride levels are reflected better by the urinary
fluoride excretion rate than by the concentration of fluoride in the urine
(Ekstrand and Ehrnebo 1983). Large amounts of fluoride were excreted for
prolonged periods by persons who lived for many years in areas with high
fluoride water levels and who subsequently moved to areas with low fluoride
levels (Likins et al. 1962). Individuals who had been chronically exposed to
a drinking water supply containing 1 mg fluoride/L (1 ppm) and then received a
single 5 mg dose of fluoride as sodium fluoride began excreting increased
amounts of fluoride in their urine less than 2 hours following exposure
(Zipkin and Leone 1957). Total 24-hour fluoride intake was estimated at
8.1 mg. Within 3 hours, 20% (1.6 mg fluoride) of the fluoride was excreted in
the urine; 54% (4.4 mg) was excreted in the urine within 24 hours. By 9 hours
after the fluoride bolus, the urinary fluoride excretion rate had almost
returned to the pre-exposure rate of about 0.1 mg/hr. In persons not
occupationally exposed to fluoride and not using water containing added
fluoride, fecal elimination is usually less than 0.2 mg/day (NAS 1971a).
Urinary fluoride excretion generally corresponds to 50%-70% fluoride
intake, depending on a number of factors (Machle and Largent 1943; Spencer et
al. 1970). In one study, baseline fluoride balance was determined by
monitoring fluoride in diet and water, and measuring excretion in urine and
feces in 10 people for four 6-week periods (Spencer et al. 1970).
Perspiration was not monitored. Average fluoride intake was 4.4 mg/day, of
which an average of 1.8 mg/day (41%) was retained (range 1.6-2.2 mg/day). An
average of 51% of the intake was excreted in urine, and 6.6% was excreted in
feces. The diet was then supplemented with 9 mg fluoride/day as sodium
fluoride for 30 days, and monitored as before. Average urinary and fecal
excretion as a percent of intake were comparable to the levels found in the
baseline study (54% and 6.4%, respectively). However, the ranges were larger
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during the increased fluoride intake. During supplementation, intake exceed
excretion by an average of 5.4 mg/day (39% of intake). After the sodium
fluoride supplementation was removed, retention of ingested fluoride dropped
to an average of 32% as stored fluoride was cleared from the body. In human
subjects consuming 6 mg fluoride daily in the diet (equivalent to
0.09 w/k/day), about half of the absorbed fluoride was excreted in the urine
(Machle and Largent 1943). Of 10 subjects with endemic fluorosis who ingested
8-18 mg fluoride/day, the fluoride balance ranged from an excess excretion of
30% to excretion that was 40% less than intake (Jolly 1976). In another
study, total fluoride intake was monitored in a healthy male subject who
consumed his normal diet, and was found to be about 0.5 mg/day (Machle et al.
1942). Fluoride excretion in feces and urine were monitored and determined to
be within 5% of intake. This study is limited by the use of only one subject.
Using radiolabeled fluoride, Carlson et al. (1960a) demonstrated that
51% and 63% of the fluoride filtered by the kidney was reabsorbed in two human
subjects, respectively. The inefficiency of the human kidney in reabsorbing
filtered fluoride results in the rapid urinary excretion of fluoride.
Fluoride excretion is decreased in acidic urine, probably due to reabsorption
of nondissociated HF (Ekstrand et al. 1980b). The renal fluoride clearance
rate is lower in children than in adults (Spak et al. 1985). Although this
study was conducted in children with suspected kidney disease or suspected
renal dysfunction, the conclusion was reached based on children with normal
glomerular filtration rates. Urinary fluoride concentration is markedly lower
in children than in adults, and increases with age from ages one to six
(Gedalia 1958). These studies indicate that children store more fluoride than
adults do, due to high uptake in developing bones.
Sweat can account for a significant percentage of fluoride elimination.
Subjects who ingested 3.7 mg fluoride in one day, of which 3 mg were from
naturally fluoridated water or water to which sodium fluoride had been added,
excreted about 19% of the ingested fluoride in sweat under comfortable
conditions (McClure et al. 1945). Under hot-moist conditions, the excretion
in sweat increased to 42%. Although water ingestion increased, the provided
drinking water was low fluoride, so fluoride retention decreased. In the only
other study located where fluoride in sweat was measured, up to 50% of
fluoride excretion under hot conditions was in sweat. Both studies were
compromised by the small number of subjects.
Limited data were located on excretion of ingested fluoride in animals.
The data support the observations in humans that fluoride is rapidly excreted
in urine. This was demonstrated by Chen et al. (1956), who measured renal
clearance of fluoride in female dogs. In dogs receiving drinking water
containing fluoride at 1 ppm, the renal fluoride clearance was 2.7 ml/minute,
and the fluoride:chloride clearance ratio was 19:l.
Evidence from studies in humans and animals demonstrates that excretion
of ingested fluoride occurs primarily in the urine, and to a lesser extent in
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the feces, sweat, and saliva. This excretion is rapid, occurring over a
period of hours (McClure et al. 1945; Spencer et al. 1970). As discussed
previously, a portion of the absorbed fluoride is sequestered in bone.
Continued secondary excretion of this pool of fluoride is expected based on
animal studies. It is also expected that this excretion would occur in the
urine.
2.3.4.3 Dermal Exposure
No studies were located regarding excretion of fluorine, hydrogen
fluoride, or fluoride in humans or animals following dermal exposure.
However, in the absence of evidence to the contrary, it is expected that
dermally absorbed fluoride would be sequestered in bone and excreted in urine
in a manner similar to that observed following oral or inhalation exposure.
2.4 RELEVANCE TO PUBLIC HEALTH
This section discusses the public health effects of fluorine, hydrogen
fluoride, and fluoride. Where data exist for more than one of these compounds
for a specific effect, the data will be discussed separately by chemical.
Fluorine. Limited data exist on the toxicity of fluorine, but similar
effects have been observed in humans and animals. Fluorine exposure occurs
only by inhalation or dermal exposure to the fluorine gas, and is most likely
to occur as occupational exposure. Because fluorine is highly reactive,
exposure at a hazardous waste site is likely to happen only if someone comes
in direct contact with material leaking from a pressurized container.
Fluorine can be lethal because of its highly corrosive nature.
Hydrogen Fluoride. Hydrogen fluoride (and the form as dissolved in
water, hydrofluoric acid) produces effects in humans and animals similar to
those produced by fluorine. The main health concern regarding hydrofluoric
acid is from occupational exposure. Because hydrofluoric acid reacts rapidly
to form fluoride salts, exposure to hydrofluoric acid at a hazardous waste
site is likely to happen only if someone comes in direct contact with material
leaking from a drum. Hydrofluoric acid can be lethal due both to its highly
corrosive nature and the propensity of the fluoride ion to be rapidly absorbed
and cause cardiac arrhythmias.
Fluoride. Exposure to fluoride at hazardous waste sites could result
from contamination of groundwater by fluoride salts or hydrogen fluoride. The
main health concern regarding sodium fluoride is likely to be from chronic
oral exposure in drinking water. Acute oral exposure to very large doses of
sodium fluoride as a result of accidental or intentional poisoning can produce
gastrointestinal effects and death at high doses, but the dosage in such cases
is often difficult to estimate. One study reported that a dose of about
16 mg/kg body weight to a child was lethal (Eichler et al. 1982). Chronic
exposure to fluoride can result in mottling of teeth and skeletal fluorosis.
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The severity of mottling increases with fluoride dose and ranges from almost
invisible opaque white spots to teeth with brown spots and pitting. Chronic
exposure to fluoride in drinking water at doses above 2 ppm during development
of the deciduous and permanent teeth, coupled with additional fluoride exposure
from food and dental products, can result in visible mottling. Recent
studies have found small white spots in about 20% of the children exposed to
water containing 1 ppm fluoride; <l% may have brown spots (DHHS 1991). Mild
dental fluorosis is considered a cosmetic effect; it is not necessarily a
precursor to skeletal fluorosis, but may be the most sensitive clinical
indicator of overexposure of children to fluoride. Due to the deposition of
significant amounts of fluoride in bone, the primary target system for intermediate and
chronic exposures of both humans and several animal species is the skeletal system.
Recent epidemiological studies suggest that elderly women
and men in communities with fluoridated water may have an elevated risk of hip
fractures (Cooper et al. 1991; Danielson et al. 1992; Jacobsen et al. 1990;
Sowers et al. 1991). The estimated safe and adequate dietary intake of
fluoride is 1.5-4.0 mg/day for adults and 2.5 mg/day for children (NRC 1989).
An MRL of 0.05 mg/kg/day was calculated for chronic oral exposure based on a LOARL
of 0.48 mg/kg/day for increased nonvertebral fracture rate in
osteoporotic women (Riggs et al. 1990). No MRLs were derived for intermediate
or acute oral exposure to fluoride, or inhalation exposure to fluoride for any exposure
duration or system category. This is because the human exposure data are not well
quantified with respect to individuals and the animal data do not provide reliable NOAELs
or LOAELs. For the same reasons, no MRLs have been derived for inhalation or oral
exposure to fluorine or hydrogen fluoride for any exposure duration or system category.
Furthermore, the animal data
providing reliable NOAELs and LOAELs for inhalation exposure to fluorine or
hydrogen fluoride are based on exposures of one hour or less. No MRLs have
been derived for acute, intermediate, or chronic duration dermal exposure to
fluorides or hydrofluoric acid because appropriate MRL methodology has not
been developed.
In response to public health concerns raised by equivocal findings of
carcinogenicity in male rats in a chronic oral NTP sodium fluoride study
(discussed below), the U.S. Department of Health and Human Services assembled
a committee of scientists to evaluate the risks and benefits of oral exposure
to fluoride (DHHS 1991). The report concluded that:
"Extensive studies over the past 50 years have established that individuals whose
drinking water is fluoridated show a reduction in dental caries. Although the
comparative degree of measurable benefit has been reduced recently as other
fluoride sources have become available in nonfluoridated areas, the benefits of
water fluoridation are still clearly evident. The health and economic benefits of
water fluoridation accrue to individuals of all ages and socioeconomic groups,
especially to poor children."
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The policy recommendations offered by the report include:
"The U.S. Public Health Service should continue to recommend the use of
fluoride to prevent dental caries."
"The U.S. Public Health Service should continue to support optimal
fluoridation of drinking water. Currently, the optimal level for water
fluoridation is between 0.7-1.2 parts per million, depending on mean
daily air temperature for a geographic area."
"The U.S. Public Health Service should sponsor a scientific conference
to recommend both the optimal level of total fluoride from all sources
combined (including drinking water) and the appropriate usage of fluoride
containing dental products in order to achieve the benefits of reduced
dental caries and to minimize the occurrence of dental fluorosis."
"In accordance with prudent health practice of using no more than the
amount necessary to achieve a desired effect, health professionals and
the public should avoid excessive and inappropriate fluoride exposure."
"The U.S. Food and Drug Administration should review the labeling
required for toothpaste and other fluoride containing products to ensure
that the public has adequate knowledge to make informed decisions about
their use, especially for young children (those under six years of
age)."
"Communities with high natural fluoride levels in the public drinking
water supply should comply with EPA regulations as mandated by the Safe
Drinking Water Act. The current primary and secondary maximum
contaminant levels are 4 and 2 parts per million, respectively."
Death. Animal data show that acute-duration (Keplinger and Suissa 1968;
Stokinger 1949) or intermediate-duration (Stokinger 1949) exposure to fluorine
can cause death due to its caustic effects on the respiratory tract. The
lethal concentration depends on the exposure duration. Although no data regarding lethal
effects of fluorine on humans were located, such effects would
be expected based on the chemical properties of fluorine and its observed
irritating effects on humans (Keplinger and Suissa 1968). There is some
animal data indicating that pre-exposure to low fluorine concentrations may
provide some resistance to the lethal effects of fluorine (Keplinger 1969).
Dermal exposure to hydrofluoric acid combined with inhalation of
hydrofluoric acid fumes can be fatal due to pulmonary edema or cardiac
arrhythmias (Kleinfeld 1965; Tepperman 1980). Dermal exposure only to
hydrofluoric acid can cause death due to cardiac arrhythmias (Mayer and Gross
1985; Mullett et al. 1987). The amount of hydrofluoric acid needed to produce
death is dependent on the strength of the acid, the percentage of the body
exposed, and the length of the exposure. Oral exposure to small amounts of
hydrofluoric acid can cause death or severe injury (corrosion of the
gastrointestinal tract, cardiovascular effects) (Menchel and Dunn 1984).
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Animal data support these results, but variations in the levels of inhalation
exposure to hydrofluoric acid resulting in death in animal studies preclude
the determination of levels that would cause death in humans (Rosenholtz et
al. 1963; Wohlslagel et al. 1976).
Human data indicate that at high doses, ingestion of sodium fluoride can
be fatal due to respiratory arrest or cardiac arrest. The certainly lethal
dose has been estimated at 32-64 mg fluoride/kg body weight (Hodge and Smith
1965). However, ingestion of less than one gram (14 mg/kg) has produced cases
of severe poisoning (Bell 1936; Greenwood 1940). Although precise levels can
not be established, clinical case studies and anecdotal reports indicate that
drinking water levels of fluoride as low as approximately 40 ppm (and probably
lower) cause nausea, vomiting, and diarrhea in humans. At higher levels these
symptoms and others may become severe enough to warrant hospitalization. It
is difficult to predict a level of fluoride in drinking water that will result
in death, because in most cases the ingested dose will be quickly ejected
(vomited), so that most of the dose exits without being absorbed into the
body. It is also difficult to predict the maximal volume of water that could
be ingested before nausea and vomiting would occur. Animal data provide
supporting evidence for the lethal effects of sodium fluoride following acute
oral exposure.
The amounts of fluorine, hydrogen fluoride, and fluoride found at waste
sites vary; each site should be evaluated on a case-by-case basis. However,
since hydrogen fluoride reacts rapidly with salts present in the soil and is
readily neutralized in dilute solutions, the public would be exposed to
hydrogen fluoride only by direct contact with material leaking from a waste
drum or its fumes. Instead, hydrogen fluoride at a waste site would normally
result in exposure to the fluoride ion.
Systemic Effects
Respiratory Effects. Inhalation exposure to fluorine has been observed
to cause respiratory tract irritation in people, and dyspnea and lung
congestion in animals (Keplinger and Suissa 1968). Pulmonary and nasal
irritation has also been reported following repeated exposures for about 30
days (Stokinger 1949). However, human (Lyon 1962) and animal (Keplinger 1969)
data suggest that pre-exposure to lower levels can reduce the respiratory
effects.
Acute lethal inhalation exposure of humans to hydrofluoric acid has
produced pulmonary edema (Chan et al. 1987; Chela et al. 1989; Tepperman
1980). Animal data provide supporting evidence for the respiratory effects of
hydrofluoric acid observed in humans. Acute inhalation exposure to
hydrofluoric acid has produced nasal irritation, respiratory distress,
pulmonary congestion, and intraalveolar edema in rats, rabbits, and guinea
pigs (Haskell Laboratory 1988; Rosenholtz et al. 1963; Wohlslagel et al.
1976). Similarly, intermediate-duration inhalation exposure caused pulmonary
hemorrhage and signs of inflammation (Machle and Kitzmiller 1935; Stokinger
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1949). The respiratory effects of hydrofluoric acid are attributed to its
highly corrosive properties.
Workers chronically exposed by inhalation to hydrogen fluoride and
cryolite dust have had decreased respiratory function measurements (Chan-Yeung
et al. 1983a).
Pulmonary edema observed after oral exposure to lethal quantities of
sodium fluoride (Sharkey and Simpson 1933) may be due to aspiration of the
gastric contents.
Cardiovascular Effects. Cardiovascular effects of systemic fluoride
poisoning are attributed to a combination of hypocalcemia and hyperkalemia due
to the poisoning of potassium pumps. Serum potassium levels are often not
measured in cases of fluoride poisoning, so much of the evidence for the
effect on potassium pumps comes from in vitro experiments and from the results
of intravenous administration of fluoride. However, hyperkalemia and cardiac
effects have been reproduced by the oral administration of sodium fluoride to
dogs (Baltazar et al. 1980). In dogs administered sodium fluoride
intravenously, the onset of ventricular fibrillation was better temporally
associated with increased serum potassium levels than with decreased calcium
levels. Exposure of erythrocytes to 10 mM sodium fluoride in vitro for
5 minutes produced a 50% increase in extracellular potassium levels measured
12 hours later (McIvor et al. 1987). This suggests that a mechanism of
fluoride toxicity involves hyperkalemia induced by poisoning of the potassium
Pump.
Severe cardiovascular effects have occurred in humans after dermal or
oral exposure at or approaching lethal levels of hydrofluoric acid or sodium
fluoride (Abukurah et al. 1972; Buckingham 1988; Mayer and Gross 1985). As
described above, cardiac arrhythmias in humans are thought to be caused by a
combination of hypocalcemia and hyperkalemia. No data are available on
whether inhalation exposure only to hydrogen fluoride could cause
cardiovascular effects, although there is one inconclusive report of
myocardial necrosis and congestion in rabbits exposed to hydrogen fluoride for
an unstated period (Machle et al. 1934). If it does, inhalation of large
amounts of hydrogen fluoride in contaminated air would be necessary to pose
risk of severe cardiovascular effects. However, these effects could occur,
for example, from dermal exposure to hydrofluoric acid found around hazardous
waste sites, depending on the strength of the acid solution.
Data from sodium fluoride poisonings support the mechanisms and effects
described above with hydrogen fluoride (Baltazar et al. 1980). Ingestion of
large amounts of fluoride in contaminated water would be necessary to pose a
risk of severe cardiovascular effects.
Gastrointestinal Effects. Data were not located regarding
gastrointestinal effects following ingestion of hydrofluoric acid, but due to
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its recognized caustic properties, it is assumed that severe gastrointestinal
effects (e.g., tissue necrosis) would result. There is an unconfirmed report
of nausea and gastrointestinal distress following inhalation exposure in
humans (Waldbott 1979), suggesting that this effect is not route-specific.
Ingestion of hydrofluoric acid clearly poses a risk of gastrointestinal
effects to humans. However, ingestion of hydrogen fluoride would probably
only occur in the event of a child eating material around a leaking waste
container in which hydrogen fluoride was discarded. Otherwise, hydrogen
fluoride contamination would lead to ingestion of fluoride in drinking water.
Symptoms of nausea, vomiting, and gastric discomfort have been reported
in humans following the ingestion of varying levels of sodium fluoride
(Hoffman et al. 1980; Rao et al. 1969). These effects are due to the
combination of sodium fluoride with gastric hydrochloric acid, which forms
hydrofluoric acid. Supporting evidence for gastrointestinal effects comes
from observations of marked stomach irritation (ulcers, necrosis) in F344/N
rats administered high levels of fluoride for 6 months (NTP 1990). Effects
have also been observed in sheep (Kessabi et al. 1985) and rabbits (Susheela
and Das 1988), but these animals may not be appropriate models for
gastrointestinal effects in humans. Ingestion of sodium fluoride clearly
poses a risk of gastrointestinal effects to humans, although this risk is
dose-dependent. Large-scale contamination of a water supply could raise water
fluoride levels high enough to cause gastrointestinal effects.
Hematological Effects. No studies on hematological effects of fluorine
in humans were located. However, no effects were seen on complete blood cell
count parameters in rats at exposure levels up to 50% of the LC50 (Keplinger
and Suissa 1968).
No signs of hematological effects as measured by routine blood counts
were seen in a large cohort of aluminum workers exposed to total fluoride
levels below 2.5 mg/m3 (Chan-Yeung et al. 1983b). However, anemia was
observed in an outdated occupational cohort study (Moller and Gudjonsson
1932). No white cell changes were noted.
Very limited animal data indicate that hematological effects may result
from exposure to fluoride (Hillman et al. 1979; Pillai et al. 1988; Susheela
and Jain 1983). Decreased red blood cell counts were reported in three
species (cows, rabbits, and mice) after gavage or oral dosing, suggesting that
there may be some risk for fluoride-induced anemia, depending on level of
exposure. White blood cells were increased in mice and decreased in rabbits
following oral fluoride exposure (Pillai et al. 1988; Susheela and Jain 1983).
There is no evidence that the hematopoietic system is a primary target
for fluoride, but the quality of most relevant studies is very low.  Hematologic changes
could result from high exposures to hydrogen fluoride or fluoride.
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Musculoskeletal Effects. The one intermediate-duration study of
inhalation exposure to fluorine found increased fluoride levels in bones and
teeth in rats exposed to fluorine for 21 days (Stokinger 1949). This suggests
that prolonged exposure to elevated fluorine levels could cause skeletal
fluorosis in humans. However, the high reactivity of fluorine means that
prolonged exposure at a hazardous waste site is highly unlikely.
Exposure to total fluoride levels of about 2.5 mg/m3 as hydrogen fluoride
or fluoride dusts for several years can cause skeletal fluorosis (Chan-Yeung
et al. 1983b; Kaltreider et al. 1972). This effect is supported by the
increased tooth and bone fluoride levels found following inhalation exposure
of rats to hydrogen fluoride for 30 days (Stokinger 1949). Such exposure is
not likely to occur at a hazardous waste site.
Human and animal data clearly indicate that fluoride accumulates in the
teeth and skeleton. Levels of up to about 1 ppm in drinking water have been
associated with a decreased number of dental cavities (DHHS 1991). Early
studies found fluoride treatment for Type I osteoporosis to be effective (Pak
et al. 1989). However, there is some evidence that although fluoride
increases bone mass, the newly formed bone may have reduced elasticity. A
carefully controlled four-year prospective study of postmenopausal
osteoporotic women receiving chronic oral fluoride doses of 34 mg/day found an
increase in non-vertebral fractures (Riggs et al. 1990). An chronic oral MRL
of 0.05 mg/kg/day was calculated from this study based on a LOAEL of
0.48 mg/kg/day. Ecologic epidemiological studies have also found suggestive
evidence that elderly women and men in communities with fluoridated water may
have an increased hip fracture rate (Cooper et al. 1991; Danielson et al.
1992; Jacobsen et al. 1990; Sowers et al. 1991). Skeletal fluorosis may
result when humans are exposed to chronic, high levels of fluoride; severe
cases are generally associated with malnourishment (Pandit et al. 1940).
Tooth mottling occurs in children orally exposed to fluoride during
development of their deciduous and/or permanent teeth (Heifetz et al. 1988;
Mann et al. 1987). Animal data for similar exposure conditions support the
human evidence (Uslu 1983). Therefore, adults may be at risk of developing
skeletal fluorosis and children may be at risk of developing mottled teeth if
exposed to fluoride for long periods of time. Fluoride causes mottled enamel
by interfering with osteocytes and impairing the work of ameloblast cells.
There is no clear evidence that dental fluorosis necessarily progresses to
skeletal fluorosis.
Hepatic Effects. No studies were located regarding hepatic effects of
fluorine inhalation by humans. Liver histopathology findings in Swiss-Webster
mice exposed to fluorine included coagulation necrosis, periportal
hemorrhages, and diffuse cloudy swelling (Keplinger and Suissa 1968). It is
not known whether such effects would be found in humans. Exposure of humans
to fluorine at hazardous waste sites is unlikely.
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No changes in levels of total bilirubin, SGOT, or alkaline phosphatase
were observed in workers exposed at levels below 2.5 mg/m3 (Chan-Yeung et al.
1983b).
No oral human data and very limited oral animal data exist on hepatic
effects following fluoride exposure. Mice administered 0.95 mg
fluoride/kg/day in drinking water for >7 days had pale, granular hepatocytes
(Greenberg 1982a). Enlarged liver cells were seen in B6C3F1 mice that died
after receiving 26 or 52 mg fluoride/kg/day as sodium fluoride in drinking
water for 6 months (NTP 1990). No liver effects were seen in F344/N rats
administered up to 19 mg/kg/day under the same regimen, or in rats or mice
given total fluoride (amount added to water plus endogenous fluoride in the
food) doses up to 4.5 mg/kg/day (rats) or 9.1 mg/kg/day (mice). Liver
congestion was observed in sheep given a single intragastric dose of fluoride
as low as 9.5 mg fluoride/kg and mild serum increases of liver enzymes were
found in sheep administered 38 mg fluoride/kg (Kessabi et al. 1985). However,
the different gastrointestinal systems of ruminants make it difficult to
determine the relevance of this study to human health.
The hepatotoxicity of fluoride in humans cannot be fully assessed at
this time.
Renal Effects. No studies were located regarding renal effects of
fluorine inhalation by humans. Kidney histopathology findings in Swiss-
Webster mice exposed to fluorine included focal areas of coagulation necrosis
in the renal cortex and focal areas of lymphocyte infiltration in the cortex
and medulla (Keplinger and Suissa 1968). It is not known whether such effects
would be found in humans. Exposure of humans to fluorine at hazardous waste
sites is unlikely.
Severe renal effects (anuria, elevated serum creatinine levels) were
reported in workers splashed in the face with hydrofluoric acid (Braun et al.
1984). Concurrent dermal and inhalation exposure in these cases is likely.
The weight of evidence from studies of workers who were chronically exposed to
hydrogen fluoride and fluoride dusts indicates that no renal toxicity is seen
at the exposure levels that have existed for the past 20 years. Toxicity was
measured using renal function tests and assays for albuminuria (Chan-Yeung et
al. 1983b; Dinman et al. 1976a; Kaltreider et al. 1972).
Very limited human and animal data exist on the renal effects of
fluoride (Kessabi et al. 1985; Lantz et al. 1987; NTP 1990). However, studies
indicate that persons with impaired renal clearance may be unusually
susceptible to the effects of fluoride (Juncos and Donadio 1972; Spencer et
al. 1980a). While there is evidence that fecal excretion of fluoride may be
increased in those with lower renal clearance, it is not clear whether the
increase is enough to compensate for decreased renal excretion. A case report
of one man may provide evidence that renal insufficiency may be linked to high
intake of fluoride (up to 0.48 mg/kg/day) (Lantz et al. 1987). Acute
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nephrosis was considered the main cause of death in mice administered 26 or
52 mg fluoride/kg/day as sodium fluoride in water (NTP 1990). No renal
pathology has been seen in animals maintained for long periods on high levels
of fluoride in drinking water.
Weanling Sprague-Dawley rats injected intraperitoneally with 14 or 22 mg
fluoride/kg as sodium fluoride exhibited altered renal function and
histopathological changes (Daston et al. 1985). Profound diuresis and
decreased urinary osmolality were observed, particularly in the first 48 hours
posttreatment. Glucosuria and hematuria also were observed, as were renal
tubular lesions. Only minor changes were observed in suckling rats injected
under the same protocol. The control rats were untreated, rather than being
injected with a control substance, so the changes could be due to the high
level of salts injected.
Since elevated fluoride levels appear in the kidney (Whitford and Taves
1973) and the kidney plays a major role in fluoride excretion (Machle and
Largent 1943; Spencer et al. 1970), one might expect the kidney to be a target
organ for fluoride toxicity. Renal pathology definitively and specifically
attributed to exposure to fluorine, hydrogen fluoride, or fluoride has never
been reported in healthy humans. However, the animal data suggest that
fluorine or fluoride at near lethal levels may damage the kidney (Keplinger
and Suissa 1968; NTP 1990). Pre-existing renal impairment affects the
excretion of fluoride.
Dermal/Ocular Effects. Results from human exposure show that fluorine
is highly irritating to the eyes and nose (Keplinger and Suissa 1968).
Similar results have been obtained from animal experiments (Keplinger and
Suissa 1968). However, exposure of humans to fluorine at hazardous waste
sites is unlikely.
Dermal and ocular effects have occurred in humans exposed to
hydrofluoric acid dermally and to atmospheric hydrogen fluoride. Because
hydrofluoric acid is caustic and the fluoride ion is rapidly absorbed through
the skin, severe burns, tissue damage, and even death can result. The
severity of the damage depends on a number of factors (e.g., the length of
exposure, the strength of the acid solution, the percentage of the body
exposed, and the treatment utilized) (Buckingham 1988; Chela et al. 1989;
Hatai et al. 1986). Animal data support the human data and indicate that
hydrofluoric acid produces severe skin and ocular damage, which if severe
enough is not reversible. Cleanup workers and members of the public who come
in direct contact with material leaking from waste drums could be at risk of
the effects of dermal exposure to hydrofluoric acid.
Immunological Effects. Very limited human and animal data were located
to evaluate the immunological effects of fluoride. The American Academy of
Allergy has reviewed a number of cases of human fluoride exposure and
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concluded that none of the health effects seen with oral exposure to fluoride
constitute an immune reaction. One animal study reported reduced antibody
titers in rabbits administered 10 mg fluoride/kg/day for 9 months. No other
doses were tested, and no mechanism proposed. The existing database does not
permit a complete assessment of the immunotoxic potential of fluoride.
Neurological Effects. There are few data on the neurological effects of
fluorine, hydrogen fluoride, or fluoride exposure in humans or animals. Dogs
exposed to lethal concentrations of fluorine for up to 30 days had seizures
before they died (Stokinger 1949).
Inhaled hydrogen fluoride produced a significant increase in the
sensitivity to light at a dose of 0.03 mg/m3 for periods of 5-40 minutes, but
the effect may have been due to irritation of mucous membranes by hydrofluoric
acid. These data are supported by animal data that showed that rats
continuously exposed for an intermediate duration to a low concentration
exhibit histological changes in the synapses of nerve cells (Sadilova et al.
1965). There are some data suggesting that,nonspecific neurological effects
(headaches, paresthesia, vertigo) occasionally occur in cases of fluorosis
(Waldbott 1979).
The nervous system in humans does not appear to be a major target for
fluorides, although convulsions and paresthesia have been observed in cases of
acute fluoride poisoning. Hypocalcemia produced when fluoride binds with
serum calcium may be a cause of these effects.
Developmental Toxicity. Fluoride crosses the placenta in limited
amounts and is found in fetal and placental tissue (Gedalia et al. 1961;
Theuer et al. 1971). An epidemiological study of water fluoridation found no
increase in birth defects in fluoridated areas (Erickson et al. 1976). No
conventional well-designed studies regarding developmental toxicity of
fluoride were located, and the existing animal literature contains conflicting
results. Very limited animal data were located on the developmental effects
of fluoride. One reproductive study indicated no change in the number of
abnormal pups born to rats orally exposed to 21 mg fluoride/kg/day (Ream et
al. 1983). Calves exposed to fluoride deposited on forage from aluminum plant
emissions were stunted (Maylin and Krook 1982) and lame (Krook and Maylin
1979). The relevance to public health cannot be ascertained at this time.
Reproductive Toxicity. No data exist on the reproductive effects of
fluoride in humans. Studies that reported an increased incidence of Down's
syndrome in areas of high fluoridation have been refuted on reanalysis with
consideration of place of residence and age of mother (Berry 1958; Erickson et
al. 1976; Needleman et al. 1974). No data on reproductive effects in
occupational cohorts exposed to higher-than-background levels of fluoride were
found. Data from animal studies are inconsistent. One animal study found
that the reproductive system of male rats is a target for fluorides (Araibi et
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al. 1989), while others found that fluoride does not accumulate in the male
reproductive system (Skare et al. 1986) and does not cause sperm abnormalities
(Dunipace et al. 1989; Li et al. 1987a). There is some evidence that fluoride
at toxic levels can lower fertility in mice (Messer et al. 1973). Adverse
reproductive effects of fluoride have also been observed in cows (Van Rensburg
and de Vos 1966), dogs (Shellenberg et al. 1990), and various avian species
(Guenter and Hahn 1986; Hoffman et al. 1985). At this time, reproductive
toxicity resulting from exposure to fluoride cannot be fully assessed or ruled
out due to inadequacies in the database, including conflicting findings.
A decline in litter production was observed in mice fed a low-fluoride
diet (Messer et al. 1973). This result was not replicated by Tao and Suttie
(1976). These authors suggested that the results of Messer et al. (1973) were
due to an iron deficiency that was partially corrected by fluoride enhancing
absorption of trace elements.
Genotoxicity. In general, positive genotoxicity findings occurred at
doses that are highly toxic to cells and whole animals. Lower doses were
generally negative for genotoxicity. Tables 2-7 and 2-8 present the results
of the most recent assays. All in vitro experiments discussed in this section
were conducted with sodium fluoride or potassium fluoride. All doses are
given as amount of fluoride.
A dose-related increase in chromosome aberrations was observed in bone
marrow cells isolated from Swiss mice that received intraperitoneal doses of
sodium fluoride (4.5, 9.1, and 18 mg fluoride/kg) for 6, 24, or 48 hours (Pati
and Bhunya 1987). Increases were seen in the frequency of chromatid breaks,
fragments, and exchanges. The study authors included gaps in their analysis,
but the biological significance of gaps is unclear. However, the dose-related
increase in aberration frequency remained when gaps were not included. There
was no indication of the number of animals used, or whether the slides were
coded prior to analysis. This study also reported increased levels of
micronucleated polychromatic erythrocytes at all intraperitoneal doses tested
(i.e., ≥4.5mg fluoride/kg).
While sodium fluoride has been shown to be mutagenic in both mouse
lymphoma L5178Y cells and human lymphoblasts without S9 activation, the lowest
significant doses of chemical were 400 µg/mL for the mouse cells and 440 µg/mL
for the human cells (Caspary et al. 1988). Potassium fluoride was positive
for mutagenic activity at the thymidine kinase locus in mouse lymphoma cells
both with and without S9 activation. Approximately three-fold increases in
mutant frequency were observed for concentrations in the 500-700 µg/mL range
that reduced the relative total growth to approximately 10% (Caspary et
al. 1987).
As part of the NTP cancer assay, the induction of chromosome aberrations





independent laboratories (NTP 1990). The study was well-designed, and slides
were coded prior to analysis. An increased aberration frequency was reported
by one laboratory at doses ≥182µg fluoride/ml. The type of aberrations was
not reported. The second laboratory only tested doses up to 91 µg/mL, and did
not see a positive effect. Increased levels of breaks and gaps were observed
in Syrian hamster embryo cells exposed for 16 hours to 45 µg/mL fluoride
(Tsutsui et al. 1984b). As noted earlier, the biological significance of gaps
is questionable. There was no indication that slides were coded prior to
analysis. Evidence of a clastogenic effect of sodium fluoride was also
observed in Chinese hamster ovary (CHO) cells (Aardema et al. 1989). Sodium
fluoride, at fluoride concentrations up to 57 µg/mL, did not produce
chromosome aberrations in cultured human lymphocytes (Thomson et al. 1985).
Another study reported increased chromosome aberrations at 9 and 18 µg
fluoride/mL as sodium fluoride (Albanese 1987).
Tests for sister chromatid exchanges have been negative in much of the
recent work on fluoride genotoxicity (Li et al. 1987b; Thomson et al. 1985;
Tong et al. 1988). However, sister chromatid exchanges were increased at
fluoride doses ≥31µg/mL in a well-conducted assay using coded slides (NTP
1990). Sodium fluoride inhibited cell cycle progression; a delayed harvest
time was necessary in order to observe a positive result. Harvest time may
not be able to fully account for the different results, since at least one of
the recent assays with a negative result also used a delayed harvest time (Li
et al. 1987b). In general, sister chromatid exchange assays are more
sensitive but less informative than chromosomal aberration, unscheduled DNA
synthesis, or DNA repair assays. The mechanism and ultimate significance of
sister chromatid exchange formation is not yet understood. Sodium fluoride
also induced unscheduled DNA synthesis in cultured human diploid fibroblasts
(Tsutsui et al. 1984c).
Negative results have generally been obtained in the Salmonella
typhimurium/mammalian microsome reverse mutation assay (Martin et al. 1979;
NTP 1990; Tong et al. 1988). However, the validity of this assay for studying
fluoride is questionable because the high concentration of chloride ions in
the agar medium used in the assay may interfere with fluoride uptake.
While the genotoxic status of fluoride appears to be contested, a more
generally-accepted mechanism for the effects of fluoride suggests that
fluoride acts as a general "protein poison" at high doses, possibly inhibiting
DNA repair enzymes (Caspary et al. 1987, 1988). This would be consistent with
high-dose effects, delayed cell cycle kinetics, and an effect on DNA repair
enzymes, all of which have been seen with doses of fluoride higher than
10 µg/mL. Alternative theories suggest that fluoride may hydrogen-bond with
thymine in DNA, distorting the structure of the DNA strand. The mixed results
of the genotoxicity studies indicate that further assessment of the effect of
fluoride on enzymes in metabolic pathways may be warranted.
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Cancer. Although excess cancer rates have been reported in some
occupational groups exposed to hydrogen fluoride and fluoride dusts, these
studies were not controlled for the multiple substance exposures to which
industrial workers are generally exposed (Andersen et al. 1982; Cecilioni
1972; Gibbs and Horowitz 1979; Milham 1979; Rockette and Arena 1983). An
increase in the lung cancer rate was reported in cryolite workers, but
comparison with the surrounding city rather than nationwide rates removed this
effect (Grandjean et al. 1985). Because of these multiple exposures and the
problems inherent in all occupational studies in identifying appropriate
referent populations, only limited evidence from such studies is specifically
relevant to the investigation of possible carcinogenic effects of long-term
dermal exposure to hydrofluoric acid and inhalation exposure to hydrogen
fluoride and/or fluoride dusts in human beings.
Cancer mortality rates in areas with low or high fluoride levels in
drinking water have been compared in several studies (Griffith 1985; Hoover et
al. 1976; Kinlen 1975; Oldham and Newell 1977). When these populations are
compared with appropriate adjustments made for differences in demographic
composition, degree of industrialization, and confounding exposures from other
natural or man-made sources of fluoride, these studies provide no
statistically significant evidence that an increased level of fluoride in
water is associated with an increase in cancer mortality.
Animal data on the carcinogenicity of fluoride are limited. The results
of the chronic oral sodium fluoride carcinogenicity study conducted in rats
and mice by the NTP (Bucher et al. 1991; NTP 1990) have been reviewed and
judged to show equivocal evidence of carcinogenicity in male rats of one
strain (based on the dose-related presence of the rare bone cancer
osteosarcoma), and no evidence of carcinogenicity in female rats and male and
female mice. The NTP considers evidence of carcinogenic activity to be
equivocal when the results show a marginal increase in neoplasms that may be
chemically related. A number of factors influence the relevance of these
studies to human health. As with most animal cancer studies, administered
doses were much higher than those to which humans would be exposed. However,
since fluoride accumulates in the bone over time, the fluoride levels in the
high-dose male rats after a 2-year exposure was similar to the levels reported
in people with a lifetime exposure to water with 4 ppm fluoride (Zipkin et al.
1958). Bone development also occurs over a larger proportion of the lifetime
in rats than in humans. While ossification in humans is generally complete by
18 years of age, or less than a third of the human lifetime, ossification in
rats is not complete until after the first year of life (half the life-span).
Finally, the fluoride levels in the diet of the control animals meant that the
controls ingested several times more fluoride on a mg/kg body weight basis
than is ingested by people whose drinking water is fluoridated. While this
could limit the study's sensitivity, no osteosarcomas were observed in the
control group. Another cancer bioassay in rats (Maurer et al. 1990) found no
evidence of carcinogenicity in male or female rats in a study of fluoride
added to a semi-synthetic low-fluoride diet. Although the fluoride dose of
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the controls was lower, the control animals still received more fluoride than
do most people in fluoridated areas. Several limitations affect the strength
of the conclusions from this study, including high mortality in treatment and
control groups, evidence that the diet may have been inadequate, and possible
inadequacies in the pathological examination.
2.5 BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in
biologic systems or samples. They have been classified as markers of
exposure, markers of effect, and markers of susceptibility (NAS/NRC 1989).
A biomarker of exposure is a xenobiotic substance or its metabolite(s)
or the product of an interaction between a xenobiotic agent and some target
molecule(s) or cell(s) that is measured within a compartment of an organism
(NAS/NRC 1989). The preferred biomarkers of exposure are generally the
substance itself or substance-specific metabolites in readily obtainable body
fluid(s) or excreta. However, several factors can confound the use and
interpretation of biomarkers of exposure. The body burden of a substance may
be the result of exposures from more than one source. The substance being
measured may be a metabolite of another xenobiotic substance (e.g., high
urinary levels of phenol can result from exposure to several different aromatic
compounds). Depending on the properties of the substance (e.g., biologic
half-life) and environmental conditions (e.g., duration and route of exposure),
the substance and all of its metabolites may have left the body by the
time biologic samples can be taken. It may be difficult to identify individuals
exposed to hazardous substances that are commonly found in body tissues
and fluids (e.g., essential mineral nutrients such as copper, zinc, and
selenium). Biomarkers of exposure to fluoride are discussed in Section 2.5.1.
Biomarkers of effect are defined as any measurable biochemical, physiologic,or
other alteration within an organism that, depending on magnitude,
can be recognized as an established or potential health impairment or disease
(NAS/NRC 1989). This definition encompasses biochemical or cellular signals
of tissue dysfunction (e.g., increased liver enzyme activity or pathologic
changes in female genital epithelial cells), as well as physiologic signs of
dysfunction such as increased blood pressure or decreased lung capacity. Note
that these markers are often not substance specific. They also may not be
directly adverse, but can indicate potential health impairment (e.g., DNA
adducts). Biomarkers of effects caused by fluoride are discussed in
Section 2.5.2.
A biomarker of susceptibility is an indicator of an inherent or acquired
limitation of an organism's ability to respond to the challenge of exposure to
a specific xenobiotic substance. It can be an intrinsic genetic or other
characteristic or a preexisting disease that results in an increase in
absorbed dose, biologically effective dose, or target tissue response. If
biomarkers of susceptibility exist, they are discussed in Section 2.7,
"POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE."
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2.5.1 Biomarkers Used to Identify and/or Quantify Exposure to Fluorine,
 Hydrogen Fluoride and Fluoride
There is extensive literature regarding fluoride levels in biological
tissues such as urine, teeth, and bone as indices of exposure. Since it does
not produce any metabolites, the fluoride ion itself is the measured
indicator. The most commonly used medium for identifying fluoride exposure is
urinary levels (Ekstrand et al. 1983). Several investigators have used this
parameter to detect exposure to sodium fluoride through drinking water (Zipkin
et al. 1956) or by ingestion (i.e., toothpaste or diet) (Ekstrand et al.
1983). Occupational exposure to hydrogen fluoride is also evaluated from
urine fluoride levels (Yoshida et al. 1978).
Urinary fluoride levels are generally around ≤lmg/L when the water
supply contains ≤1ppm fluoride (Schamschula et al. 1985; Venkateswarlu et al.
1971; Zipkin et al. 1956). Only one report was located of urinary fluoride
levels following acute poisoning. Following dermal exposure to about 5 g
hydrofluoric acid over 2.5% of the body surface (along with concomitant
inhalation exposure), the urinary fluoride level in the first sample obtained
3.5 hours after the accident was 87.0 mg/L (Burke et al. 1973). It is
difficult to determine urine levels that are associated with chronic effects
such as skeletal fluorosis, because no studies that report urinary fluoride
levels, accurate exposure levels, duration of exposure, and health effects
were located. Probably the most complete study reports average urinary
fluoride levels of 9 mg/L following inhalation exposure to 2.4-6.0 mg/m3 for
an unspecified period of time (Kaltreider et al. 1972). Marked evidence of
fluorosis was seen in these workers. In another study (Dinman et al. 1976c),
the average postshift urinary fluoride level after 3-5 working days was
5.7 mg/L (range, 2.7-10.4). No exposure levels were available, but they were
reported to be lower than in the plant where urinary fluoride levels were
9 mg/L. In spite of 10-43 years of occupational exposure, no signs of
skeletal fluorosis were seen. This study may provide urinary fluoride levels
that are not associated with skeletal fluorosis, but any sensitive workers may
have left such work and not been included in the study. These studies are
describe in more detail in Section 2.2.1.2. Urinary fluoride levels up to
13.5 mg/L have been reported in areas of India where skeletal fluorosis due to
high water fluoride levels (up to 16.2 ppm) is prevalent (Singh et al. 1963).
Other media that have been used to measure fluoride exposure include
plasma (Ekstrand et al. 1983), saliva (Peterson et al. 1987), and tooth enamel
(McClure and Likins 1951). Plasma fluoride is often employed as an indicator;
however, it does not always show a clear correlation to fluoride exposure,
even when measurements are conducted soon after exposure (Whitford and
Williams 1986). The normal plasma fluoride level is about 0.01 mg/L (Ikenishi
et al. 1988; NAS 1971a). A plasma fluoride level of 35.2 mg/L was measured in
a case of fatal oral hydrofluoric acid poisoning (Manoguerra and Neuman 1986).
No studies regarding normal serum fluoride levels were located, but a level of
2 mg/L was reported in a case of severe oral poisoning with 53 g fluoride as
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sodium fluoride (Abukurah et al. 1972). Multiple episodes of ventricular
fibrillation and tetany occurred, but the patient recovered following stomach
lavage and treatment.
The biomarkers mentioned above can be used for acute exposure to
fluoride. Concentrations can peak within 1 hour after exposure since fluoride
is rapidly absorbed from all routes of exposure. Fluoride salts possess a
peculiar "soapy-salty" taste that enables some individuals to recognize that
they are consuming large quantities of fluoride. With chronic exposures, such
as from drinking water containing fluoride, urinary fluoride levels initially
increase, and then reach a constant level. In workers, post-shift urinary
levels differ from pre-shift levels since fluoride exposure during the work
day is absorbed rapidly into the body. However, these measurements may not
always be useful for quantifying chronic exposure because fluoride can
accumulate in bones (Carlson et al. 1960a). It may be retained in the
skeletal tissues for a long period after the end of exposure, and later
reenter circulating blood to be reabsorbed or excreted in urine. Furthermore,
background tissue/fluid levels may affect these measurements since fluoride is
prevalent in the environment from dietary sources. Calcium, which is a major
element in the body, may interfere with biological fluoride measurements due
to its ability to bind fluoride (Richards et al. 1982). This may prevent the
quantitation of exposure, because plasma and urine fluoride levels may be
unaffected. An important factor in biological fluid fluoride concentration is
pH (Ekstrand et al. 1980a). When urine is alkaline, fluoride urine excretion
increases and is followed by a decline in plasma fluoride.
Bone fluoride levels can be used to quantitate long term fluoride
exposure (Boivin et al. 1988; Baud et al. 1978). However, this requires a
bone biopsy, so bone fluoride levels are most frequently measured after
clinical signs appear. As described in Section 2.2.2.2, the fluoride level
found in bone varies between bones and increases with age. That section also
describes fluoride levels in normal bone, and levels associated with various
effects.
2.5.2 Biomarkers Used to Characterize Effects Caused by Fluorine,
      Hydrogen Fluoride, and Fluoride
Because soft tissues do not accumulate significant levels of fluoride
over long periods of time, effects of chronic exposure to fluoride first
appear in the musculoskeletal system. Chronic oral fluoride exposure can
produce dental fluorosis (Duxbury et al. 1982), and higher levels of oral or
inhalational exposure can lead to skeletal effects (Kaltreider et al. 1972;
Leone et al. 1955). Dental fluorosis is characterized by mottling and erosion
of the enamel. Children are particularly susceptible since their teeth are
still developing. Thus, teeth mottling, staining, erosion, hypoplasia, and
excessive wear are possible markers of effect for fluoride exposure (Walton
1988). In recent studies, about 22% of children exposed to 0.7-1.2 ppm
fluoride in drinking water had very mild to mild dental fluorosis,
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characterized by small white spots on the teeth (DHHS 1991). Brown spots
appeared on the teeth .of 7.6% of the children exposed to 2 ppm fluoride in
water. In adults, skeletal changes may occur from prolonged exposure.
Alteration in bone density or derangement of trabecular structure can be
detected by radiographs, and can indicate fluoride toxicity. However, these
are nonspecific changes and can be associated with other exposures. Other
metals can sequester in the skeleton, and produce similar changes observed in
radiographs. Exostosis, apposition of new bone, ossification of ligaments and
tendon insertions, and metastatic aberrant growth of new bone appear to be
much more specific and constant findings in fluorosis (Vischer et al. 1970).
Skeletal fluorosis has been reported following inhalation exposure to
2.4-6.0 mg/m3 for an unspecified duration (Kaltreider et al. 1972). As
discussed in Section 2.2.2.2, nutritional status plays a large role in
determining the oral fluoride exposure levels that lead to this effect. In
the few cases of skeletal fluorosis in the United States for which doses are
known, they are generally 15-20 mg/day for over 20 years (Bruns and Tytle
1988; Sauerbrunn et al. 1965).
No well-documented information was located regarding biomarkers of
effect for fluoride, although there are studies in which cellular changes
occurred after fluoride exposure. Increases in glucose or lipid metabolism
have been reported in tissues after exposure to fluorides (Dousset et al.
1984; Shearer 1974; Watanabe et al. 1975). Changes in erythrocyte enzyme
activities including enolase, pyruvate kinase, and ATPase were found in
chronically exposed workers in conjunction with slightly increased fluoride
levels in the body (Guminska and Sterkowicz 1975). These alterations may
explain the decreased red blood cell counts observed in other studies (Hillman
et al. 1979; Susheela and Jain 1983). However, none of these enzyme
alterations are specific to fluoride exposure. No information is available
regarding how long these effects last after the last exposure. The enzymatic
effects were measured within a few hours of a single fluoride treatment, while
the red blood cell effects were seen as a result of chronic exposure.
There is evidence that in patients with skeletal diseases the proportion
of dialyzable and nondialyzable hydroxyproline peptides serves as an index of
bone collagen turnover. A decreased proportion of nondialyzable
hydroxyproline peptides in the urine of fluorosis patients indicates either a
decreased rate of synthesis of new collagen or an increased utilization of
newly formed collagen for matrix formation. This marker offers potential for
an early, although nonspecific, indication of altered bone metabolism after
long-term fluoride exposure (Anasuya and Narasinga Rao 1974). No information
is available regarding how long this lasts after chronic exposure. Sudden
hyperkalemia and hypocalcemia are effects seen with fluoride intoxication due
to the marked potassium efflux from intact cells caused by fluoride (McIvor et
al. 1985). These ionic shifts are the only serologic marker of effect that
have been identified, and these changes are not unique to fluoride. They last




2.6 INTERACTIONS WITH OTHER CHEMICALS
The absorption of fluoride from the gastrointestinal tract of humans
and/or animals is affected by the presence of several minerals including
calcium, magnesium, phosphorus, and aluminum (Rao 1984). These effects are
discussed in Section 2.8. No reliable data on interactions that exacerbate
negative effects of fluoride were located.
2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
Existing data indicate that subsets of the population may be unusually
susceptible to the toxic effects of fluoride and its compounds. These
populations include the elderly, people with deficiencies of calcium,
magnesium, and/or vitamin C, and people with cardiovascular and kidney
problems.
Because fluoride is excreted through the kidney, people with renal
insufficiency would have impaired renal clearance of fluoride (Juncos and
Donadio 1972). Fluoride retention on a low-protein, low-calcium, and lowphosphorus diet
was 65% in patients with chronic renal failure, compared with
20% in normal subjects (Spencer et al. 1980a). Serum creatinine levels were
weakly correlated (r=0.35-0.59) with serum fluoride levels (Hanhijarvi 1982).
People on kidney dialysis are particularly susceptible to the use of
fluoridated water in the dialysis machine (Anderson et al. 1980). This is due
to the decreased fluoride clearance combined with the intravenous exposure to
large amounts of fluoride during dialysis. Impaired renal clearance of
fluoride has also been found in people with diabetes mellitus and cardiac
insufficiency (Hanhijarvi 1974). People over the age of 50 often have
decreased renal fluoride clearance (Hanhijarvi 1974). This may be because of
the decreased rate of accumulation of fluoride in bones or decreased renal
function. This decreased clearance of fluoride may indicate that elderly
people are more susceptible to fluoride toxicity.
Poor nutrition increases the incidence and severity of dental fluorosis
(Murray and Wilson 1948; Pandit et al. 1940) and skeletal fluorosis (Pandit et
al. 1940). Comparison of dietary adequacy, water fluoride levels, and the
incidence of skeletal fluorosis in several villages in India suggested that
vitamin C deficiency played a major role in the disease (Pandit et al. 1940).
Calcium intake met minimum standards, although the source was grains and
vegetables, rather than milk, and bioavailability was not determined. Because
of the role of calcium in bone formation, calcium deficiency would be expected
to increase susceptibility to effects of fluoride. No studies in humans
supporting this hypothesis were located. Calcium deficiency was found to
increase bone fluoride levels in a two-week study in rats (Guggenheim et al.
1976) but not in a 10-day study in monkeys (Reddy and Srikantia 1971). Guinea
pigs administered fluoride and a low-protein diet had larger increases in bone
fluoride than those given fluoride and a control diet (Parker et al. 1979).
Bone changes in monkeys following fluoride treatment appear to be more marked
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if the diet is deficient in protein or vitamin C, but the conclusions are not
definitive because of incomplete controls and small sample size (Reddy and
Srikantia 1971). Inadequate dietary levels of magnesium may affect the toxic
effects of fluoride. Fluoride administered to magnesium-deficient dogs
prevented soft-tissue calcification but not muscle weakness and convulsions
(Chiemchaisri and Philips 1963). In rats, fluoride aggravated the
hypomagnesemia condition, which produced convulsive seizures. The symptoms of
magnesium deficiency are similar to those produced by fluoride toxicity. This
may be because of a fluoride-induced increase in the uptake of magnesium from
plasma into bone.
Some people with cardiovascular problems may be at increased risk of
fluoride toxicity. Fluoride inhibits glycolysis by inhibiting enolase
(Guminska and Sterkowicz 1975; Peters et al. 1964). It also inhibits energy
metabolism through the tricarboxylic acid cycle by blocking the entry of
pyruvate and fatty acids and by inhibiting succinic dehydrogenase (Slater and
Bonner 1952).
There is evidence that daily doses of 34 mg fluoride (0.48 mg/kg/day)
increases the risk of nonvertebral fractures in women with postmenopausal
osteoporosis (Riggs et al. 1990). Postmenopausal women (Danielson et al.
1992; Sowers et al. 1991) and elderly men (Danielson et al. 1992) in
fluoridated communities may also be at increased risk of fractures.
2.8 MITIGATION OF EFFECTS
This section will describe clinical practice and research concerning
methods for reducing toxic effects of exposure to fluorine, hydrogen fluoride,
and fluoride. However, because some of the treatments discussed may be
experimental and unproven, this section should not be used as a guide for
treatment of exposures to fluorine, hydrogen fluoride/hydrofluoric acid, or
fluoride. When specific exposures have occurred, poison control centers and
medical toxicologists should be consulted for medical advice.
In all cases of acute high-level exposure to fluorine, hydrogen
fluoride/hydrofluoric acid, or fluoride, the focus of mitigation is to limit
further absorption and to complex or remove the free fluoride ions from the
blood while maintaining the proper electrolyte balances. The majority of
relevant acute high-level exposure situations for which mitigation information
is available involve dermal and/or inhalation exposure to hydrofluoric acid or
gaseous hydrogen fluoride. Some information is also available regarding
mitigation of chronic oral exposure to fluoride.
Fluorine. Inhalation exposure to fluorine is treated very similarly to
inhalation exposure to hydrogen fluoride. The source of exposure is removed
and water used to decontaminate the patient. The eyes are washed with saline
if necessary, and magnesium oxide paste can be applied (Bronstein and Currance
1988; Stutz and Janusz 1988).
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Hydrogen Fluoride/Hydrofluoric Acid. In cases of dermal and inhalation
exposure, the exposed persons are first removed from the source of exposure,
and any particles or.excess liquids are removed by brushing or blotting
(Bronstein and Currance 1988). Thorough irrigation with cold water or saline
is then done to further limit absorption through exposed skin and eyes.
Irrigation is followed by washing the affected skin with an alkaline soap and
water (Bronstein and Currance 1988; Dibbell et al. 1970). Persistent pain is
an indication that large amounts of free fluoride ions remain. In such cases,
magnesium oxide paste is applied or the exposed skin is soaked in cold
solutions of magnesium sulfate, calcium salts, or quaternary ammonium
compounds (benzalkonium chloride, benzethonium) (Browne 1974; Goldfrank et al.
1990; Haddad and Winchester 1990). However, the evolving standard of
treatment for mild to moderate burns involves massaging the affected area with
a penetrating calcium gluconate gel, to avoid problems with magnesium oxide
precipitating (Borak et al. 1991; Browne 1974; Goldfrank et al. 1990).
In cases of subungual invasion or moderate to severe burns in which
there is immediate tissue damage, intradermal injections of calcium gluconate
solution (Ellenhorn and Barceloux 1988; Goldfrank et al. 1990; Haddad and
Winchester 1990), along with surgical debridement of the saturated skin
(Buckingham 1988; Dibbell et al. 1970; Goldfrank et al. 1990) will limit the
local and systemic toxic effects. However, intra-arterial infusions of
calcium gluconate are often preferred to intradermal injections due to the
ability of the infusions to deliver more calcium to the burn site, better
distribution of calcium in the tissues, and the need for only a single
injection, as opposed to an injection for every square centimeter of affected
dermal tissue (Haddad and Winchester 1990). Additionally, in burns involving
the hands, multiple intradermal injections pose the risk of elevating tissue
pressures and forcing the removal of the nails (Ellenhorn and Barceloux 1988;
Goldfrank et al. 1990). One source reports that calcium gluconate injection
was successfully used in at least 96 cases without causing damage (Browne
1974). The therapeutic effects of calcium gluconate, magnesium acetate, and
magnesium sulfate on hydrofluoric acid burns of shaved Sprague-Dawley rats
were compared using intradermal and subcutaneous injection (Harris et al.
1981). Although this study found that injection of calcium gluconate, but not
the magnesium compounds, was irritating in the absence of a burn, and the
duration, depth, and area of lesions were reduced with the magnesium compounds
compared with calcium gluconate, no reports were located of using intradermal
injection of magnesium compounds in humans. It is not clear if this
contradicts the results of Browne (1974), and if any difference is due to
species differences. The presence of unbound fluoride ions indirectly results
in nerve stimulation, and thus pain is the best indicator of when further
treatment is required (Browne 1974; Dibbell et al. 1970). Therefore,
anesthetics are not used, except in those cases of subungual exposure that
require the removal of the nail (Browne 1974).
In cases of severe burns affecting large areas (>20%) of the body
surface, the patient is monitored for signs of systemic fluoride poisoning,
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including hypocalcemia, hypomagnesemia, and hyperkalemia, which may cause
life-threatening neuromuscular paralysis. In such cases, calcium and
magnesium supplements, temporary cardiac pacing, and intravenous injections of
calcium gluconate, diazepam, and lidocaine are used (Abukurah et al. 1972;
Goldfrank et al. 1990; Haddad and Winchester 1990). Intravenous injection of
sodium bicarbonate and dextrose/insulin, along with oral administration of
sodium polystyrene sulfonate, which may slowly reduce the body burden of
potassium, can counteract hyperkalemia (Haddad and Winchester 1990). Fluoride
is rapidly excreted by the kidney. The excretion is increased by alkalinizing
the urine using intravenous sodium bicarbonate; sodium bicarbonate also
combats acidosis (Haddad and Winchester 1990). Hemodialysis is reserved for
severe cases due to renal failure or severe hyperkalemia (Haddad and
Winchester 1990; Morgan 1989). Strong diuretics such as furosemide or
ethacrynic acid also help protect against renal failure and enhance fluoride
excretion (Abukurah et al. 1972).
Fluoride. Ingested fluoride is rapidly absorbed from the gastrointestinal
tract, but calcium and magnesium salts, antacids, and milk interfere with the absorption
by binding the fluoride ion and removing the residual fluoride from the esophagus
(Ellenhorn and Barceloux 1988; Goldfrank et al. 1990; Haddad and Winchester 1990; Morgan
1989). Gastric lavage with solutions of calcium gluconate, calcium carbonate, calcium
lactate, calcium chloride, calcium hydroxide, calcium- or magnesium-based antacid, or
aluminum hydroxide gel aid in decontaminating the gastrointestinal tract due to their
action in precipitating the fluoride in the gut (Ellenhorn and Barceloux 1988; Haddad and
Winchester 1990; Morgan 1989). No attempt is made to neutralize the acid with orally
administered sodium bicarbonate, due to the resulting exothermic reaction (Bronstein and
Currance 1988). Most authorities discourage emesis due to the formation of hydrofluoric
acid in the stomach (Bronstein and Currance 1988; Haddad and Winchester 1990). As in
cases of severe hydrofluoric acid burns, the patient's electrolyte balance and
electrocardial signs are monitored for indications of acute fluoride poisoning, and
calcium gluconate is administered intravenously if a large dose was ingested (Abukurah et
al. 1972; Ellenhorn and Barceloux 1988; Haddad and Winchester 1990).
The major treatment strategies for long-term, low-level exposure to
fluorides are removal of the source of exposure and administration of
compounds that reduce intestinal absorption. Skeletal fluorosis has been
reported to be partially reversed 8-15 years after the elevated exposure ended
(Grandjean and Thomsen 1983). Sclerosis of the trabecular bone in ribs,
vertebral bodies, and pelvis faded, but calcification of muscle insertions and
ligaments was not altered. The absorption of fluoride from the gastrointestinal tract of
humans and/or animals is affected by the presence of several minerals including calcium,
magnesium, phosphorus, and aluminum (Rao 1984). With the exception of aluminum hydroxide,
no studies were located regarding the therapeutic use of these materials in humans.
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Humans administered aluminum hydroxide (as antacid) had a significant
increase in the fecal fluoride excretion and a decrease in the urinary
excretion of fluoride Spencer and Lender 1979; Spencer et al. 1980a). These
results can be explained by a reduction in gastrointestinal absorption of
fluoride due to aluminum's ability to form fluoride complexes (Spencer et
al. 1981). This effect also occurred in persons with chronic renal failure,
suggesting antacids could be used to counteract adverse effects of fluoride in
this population.
Calcium binds with fluoride after oral exposure, which reduces the
bioavailability of fluoride. In humans, calcium and/or phosphorus
administration (as bone meal, cryolite, or calcium fluoride) decreased the
absorption of fluoride (Machle and Largent 1943; McClure et al. 1945).
In another study, added calcium had only a limited effect on the intestinal
absorption of fluoride in humans (Spencer et al. 1975c, 1980b). The
discrepancy between these studies may be due to differences between the
absorption of fluoride in calcium fluoride or in a form that must first
be homogenized, and the absorption of fluoride in the presence of added
calcium.
Plasma fluoride concentrations were higher in pigs fed calcium-deficient
diets than in pigs fed diets with calcium (Richards et al. 1982).
Administration of both calcium and phosphorus reduced the skeletal uptake of
fluoride in rats compared to that following high calcium administration
(McClure and Mitchell 1931).
Magnesium may decrease the intestinal absorption of fluoride because it
tends to form slightly soluble complexes with fluoride (Kuhr et al. 1987).
The results of human and animal studies investigating this interaction appear
to differ. Several studies have found no significant effect from orally
administered magnesium oxide on either fecal or urinary fluoride excretion in
humans (Spencer et al. 1977a, 1977b, 1978a). Humans administered magnesium
along with fluoride as therapy for osteoporosis had diminished joint pain and
resorbed periarticular calcium phosphate deposits (Kuhr et al. 1987).
Magnesium appeared to reduce the adverse effects of fluoride when it was used
as a treatment for osteoporosis.
Simultaneous gavage administration of magnesium and fluoride reduced
skeletal uptake of fluoride in rats (Stookey et al. 1964; Weddle and Muhler
1954). Administration of both magnesium and calcium reduced the deposition of
fluoride in bones (Stookey et al. 1964). Another study in rats found that the
level of dietary magnesium is a significant factor in the bioavailability of
dietary fluoride (Cerklewski 1987). These differences between humans and




Techniques that increase bone turnover or bone resorption might be
effective in reversing skeletal fluorosis. However, no information on such
techniques were located.
2.9 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of
ATSDR (in consultation with the Administrator of EPA-and agencies and programs
of the Public Health Service) to assess whether adequate information on the
health effects of fluorides is available. Where adequate information is not
available, ATSDR, in conjunction with the NTP, is required to assure the
initiation of a program of research designed to determine the health effects
(and techniques for developing methods to determine such health effects) of
fluorides.
The following categories of possible data needs have been identified by
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed.
2.9.1 Existing Information on Health Effects of Fluorine, Hydrogen
 Fluoride, and Fluoride
The existing data on health effects of inhalation, oral, and dermal
exposure of humans and animals to fluorine, hydrogen fluoride, and fluoride
are summarized in Figures 2-4 through 2-6, respectively. The purpose of these
figures is to illustrate the existing information concerning the health
effects of fluorine, hydrogen fluoride, and fluoride. Each dot in the figure
indicates that one or more studies provide information associated with that
particular effect. The dot does not imply anything about the quality of the
study or studies. Gaps in this figure should not be interpreted as "data
needs" information.
There are many case reports and epidemiological studies investigating
the health effects of hydrogen fluoride in humans by the inhalation and dermal
routes, and the health effects of fluoride compounds by the inhalation and
oral routes. There are also limited data from experimental human exposure to
fluorine. Most human studies of the health effects of oral exposure to
fluoride are case reports of acute and chronic oral exposure to sodium
fluoride, and human studies of the health effects of dermal exposure to
fluorides are generally case reports of acute dermal exposure to hydrofluoric
acid.
Human fatalities have resulted from both oral exposure to sodium
fluoride and dermal exposure to hydrofluoric acid. Dermal exposure to






fumes. Human studies and case reports have investigated the effects of
nonlethal oral doses of sodium fluoride, although only after acute exposure.
These exposures have resulted in mostly gastrointestinal effects and
consequences of hypocalcemia (e.g., nervous system and cardiovascular
effects). Exposure to fluorine gas causes respiratory, ocular, and dermal
irritation in humans after acute exposure. One study on chronic exposure to
fluorine was located. Chronic human studies have generally examined health
effects in workers exposed to hydrogen fluoride or fluoride-containing dusts
by inhalation, and populations exposed to ionic fluoride through drinking
water. These studies have investigated the relationship between fluoride and
neurological and reproductive effects and cancer.
Studies conducted on animals have been fairly extensive, and have
focused on the health effects following inhalation of hydrogen fluoride and
oral exposure to fluoride. A few studies on inhalation exposure to fluorine
also exist. Dermal studies in animals are limited to those investigating
dermal and ocular effects from exposure to fluorine, hydrofluoric acid and
sodium fluoride. A number of studies on the genotoxicity of fluoride were
located.
2.9.2 Data Needs
The following section will discuss data needs by category and by
chemical (fluorine, hydrogen fluoride, and fluoride). Although the
toxicological data on fluorine are severely limited, such data are not needed,
since fluorine is so reactive that human exposure at hazardous waste sites is
unlikely.
Acute-Duration Exposure. Inhalation of fluorine can cause respiratory
irritation, dyspnea, and death (Keplinger and Suissa 1968; Stokinger 1949).
Inhalation of concentrated hydrofluoric acid fumes can cause pulmonary edema,
hyperkalemia, hypocalcemia, and death (Chela et al. 1989; Kleinfeld 1965;
Tepperman 1980). Acute dermal exposure to hydrofluoric acid will cause burns
(Chela et al. 1989; Kleinfeld 1965; Mullett et al. 1987; Tepperman 1980).
Gastrointestinal upset (Hoffman et al. 1980; Rao et al. 1969), cardiovascular
disturbances, or death can result from accidental consumption of large amounts
of sodium fluoride or other soluble fluoride salts (Eichler et al. 1982;
Sharkey and Simpson 1933). The toxicity and pharmacokinetic data at the
present time are not sufficient to derive acute duration MRLs for inhalation
of fluorine or hydrogen fluoride or oral exposure to sodium fluoride because
the exposure data in humans are not well quantified. Regarding acute oral
toxicity, it should be mentioned that because the rat does not vomit, this
would not be an appropriate model to use to determine levels of exposure that
cause gastrointestinal distress. In addition, there is no way of determining
if the animal is suffering from gastrointestinal discomfort. Further
information concerning the levels of oral exposure to sodium fluoride, calcium
fluoride, or hydrofluoric acid that cause acute effects in humans such as
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gastrointestinal distress would be useful because there are populations
surrounding hazardous waste sites that might be exposed to these forms of
fluoride for brief periods.
Intermediate-Duration Exposure. Target organs for intermediate exposure
of humans to fluorine, hydrogen fluoride or sodium fluoride are not known,
although data from animal experiments provides some indication. Intermediateduration
inhalation exposure to fluorine or hydrogen fluoride can cause respiratory effects in
animals similar to those seen following acute exposure (Stokinger 1949). Bone and tooth
fluoride levels were elevated, suggesting that these could also be target organs for
intermediate exposure to fluorine or hydrogen fluoride. One might also expect that the
musculoskeletal system may be a target of intermediate-duration oral exposure to
fluoride. Studies in mice (Greenberg 1986; NTP 1990) suggest that the kidney may also be
a
target of near-lethal fluoride levels, but there is no data from such high
exposures in humans. The toxicity and pharmacokinetic data at the present
time are not sufficient to derive MRLs or identify target organs for either
inhalation or oral exposure because the exposure data in humans are not well
quantified. Further information concerning the levels of oral exposure to
sodium fluoride or calcium fluoride, and inhalation exposure to hydrogen
fluoride that cause effects such as fluorosis in humans would be useful
because there are populations surrounding hazardous waste sites that might be
exposed to these forms of fluoride for intermediate duration’s.
Chronic-Duration Exposure and Cancer. Small amounts of ionic fluoride
given chronically in the drinking water are recognized as being beneficial to
human teeth (DHHS 1991), but the mechanism of action is not well understood.
Chronic exposure of children to excessive amounts of fluoride can result in
mottled teeth (fluorosis) (Hodge and Smith 1972; Mann et al. 1987), but
variations in methods of reporting dental fluorosis make it difficult to
thoroughly compare studies. The development of a method for quantitating
dental fluorosis that is sensitive, specific, reliable, and acceptable to the
public would help in determining the fluoride doses leading to varying degrees
of fluorosis. Epidemiological evidence exists that the incidence and severity
of fluorosis has increased in the United States (DHHS 1991; Heifetz et al.
1988). Further examination of the etiology and trends in prevalence may be
useful. Chronic inhalation exposure to high levels of hydrogen fluoride and
fluoride dusts, or chronic oral exposure to high doses of fluoride can cause
skeletal deformities and joint pain (Bruns and Tytle 1988; Goldman et al.
1971; Fisher et al. 1981; Kemp et al. 1942; Leone et al. 1955; Moller and
Gudjonsson 1932; Pandit et al. 1940; Sauerbrunn et al. 1965; Singh et al.
1963). Some data from case studies are available regarding nutritional states
that exacerbate fluorosis (Kemp et al. 1932; Pandit et al. 1940).
Epidemiological studies addressing the effect of nutrition on the prevalence
and severity of dental and skeletal fluorosis may be useful. Recent studies
indicate that fluoride may increase the rate of hip fractures in elderly men
and women (Danielson et al. 1992; Sowers et al. 1991), particularly women with
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osteoporosis (Riggs et al. 1990). A chronic oral MRL was derived for fluoride
based on increased risk of nonvertebral fractures. Analytical epidemiological
studies of the association, if any, between bone fractures and factors such as
fluoride intake, fluoride blood levels, diet, and body levels of nutrients
such as calcium may be useful. Target organs other than bones and teeth for
chronic exposure to fluoride for humans are not known. There is some evidence
of hepatic (Greenberg 1982a) and renal (Daston et al. 1985; Kessabi et al.
1985) effects of fluoride in animals, but minimal information regarding
possible effects in humans. Additional studies specifically addressing
effects on these systems may be useful, especially since people with renal
dysfunction are sensitive to fluoride.
The osteosarcoma rate in males living in fluoridated areas has increased
markedly in recent years, but thorough statistical analyses concluded that the
effect is not due to fluoridation (Hoover et al. 1991). Nonetheless,
analytical epidemiology studies to determine the risk factors for osteosarcoma
may be useful. Such studies should include analysis of fluoride exposure and
bone levels of fluoride. Case-control studies of people with osteosarcoma
could be particularly useful. The NTP oral carcinogenicity study for sodium
fluoride concluded that there is equivocal evidence that fluoride is a
carcinogen in male rats, but not in female rats or mice of either gender (NTP
1990). Higher doses may have been attainable in female rats and mice of both
genders. Another rat carcinogenicity study found no evidence that fluoride is
a carcinogen (Maurer et al. 1990), but was limited in several different
aspects. Additional animal cancer bioassays may be useful in addressing this
issue. Additional systemic effects may be understood after further
investigation. The toxicity and pharmacokinetic data at the present time are
not sufficient to derive chronic MRLs for inhalation of fluorine, hydrogen
fluoride or other fluoride compounds, because the exposure data in humans are
not well quantified with respect to individuals. Further information
concerning the levels of oral exposure to sodium fluoride or calcium fluoride,
and inhalation exposure to hydrogen fluoride that cause effects in humans such
as fluorosis would be useful because there are populations surrounding
hazardous waste sites that might be exposed chronically to these forms of
fluoride.
The existing data do not demonstrate that fluoride is a human
carcinogen. The epidemiological studies indicate that a carcinogenic effect
of fluoride is not likely to be a health risk. However, evidence of
genotoxicity suggests that further mechanistic data would be useful (Caspary
et al. 1987; Caspary et al. 1988; NTP 1990).
Genotoxicity. There is a significant database on the genotoxicity of
fluoride compounds in several species and several cell types. However, the
results from well-characterized systems are much more limited and additional
well-designed experiments would be useful in resolving contradictory data.
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The results have been inconsistent in many instances, but a consensus is
developing that at toxic levels (greater than 10 µg/mL, and usually seen at
greater than 40 µg/mL), there may be a general inhibition of enzymes,
including the DNA polymerases (Caspary et al. 1987, 1988). While sodium
fluoride may not be directly reactive with DNA, biochemical studies would be
useful for establishing a mechanism for the cellular toxicity seen at high
doses of fluoride compounds.
Reproductive Toxicity. No definitive data were located regarding
reproductive effects in humans of hydrogen fluoride inhalation or oral
exposure to fluoride. Reports of an increased incidence of Down's syndrome
have been refuted (Berry 1958; Erickson et al. 1976; Needleman et al. 1974).
Reduced fertility was seen after exposure of female mice to fluoride levels at
or above the maximum tolerated dose (Messer et al. 1973). Sixty days of oral
exposure to sodium fluoride was observed to cause changes in the seminiferous
tubules of CD rat testes and a decreased number of offspring (Araibi et al.
1989). The significance to reproduction in humans of histological changes
observed in rats is not known. Sperm abnormalities were not increased in
B6C3F1 mice exposed to fluoride in water (Dunipace et al. 1989; Li et al.
1987a), but were increased in Swiss mice that received intraperitoneal
injections of sodium fluoride (Pati and Buhnya 1987). Additional support for
an adverse effect of high fluoride levels on reproduction comes from studies
in dogs and birds (Guenter and Hahn 1986; Hoffman et al. 1985; Shellenberg et
al. 1990; Van Rensburg and de Vos 1966). Further data concerning reproductive
organ pathology following a 90-day oral or inhalation study would be useful to
clarify the current data on reproductive effects, given that there are
populations surrounding hazardous waste sites that might be exposed to
fluoride compounds.
Developmental Toxicity. There are no studies in humans or animals
regarding the developmental effects of inhaled hydrogen fluoride. Similarly,
there are no recent studies of conventional design in animals of the
developmental effects of oral fluoride. There was no difference in the
incidence of birth defects between fluoridated and nonfluoridated towns in one
epidemiological study (Erickson et al. 1976). There was no fluoride-induced
increase in the number of abnormal offspring in a two-generation reproduction
study in Sprague-Dawley rats that drank water containing sodium fluoride (Ream
et al. 1983). Adverse developmental effects of oral fluoride exposure have
also been observed in calves (Krook and Maylin 1979; Maylin and Krook 1982)
and mink (Aulerich et al. 1987). However, there is a general paucity of data
concerning developmental endpoints for fluoride compounds. Further data
concerning exposure to fluoride compounds by the oral and inhalation routes
for developmental endpoints would be useful.
Immunotoxicity. A review of human studies has shown that fluoride in
drinking water has no adverse effects on immunologically mediated reactions or
allergies (Austen et al. 1971). This suggests that the immune system is not a
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sensitive target for fluoride toxicity following oral exposure. Additional
information is probably not needed at this time.
Neurotoxicity. Because fluoride interacts with calcium ions needed for
effective neurotransmission, fluoride can affect the nervous system. However,
while acute effects on the nervous system have been observed in humans, it is
not known whether chronic exposure to hydrogen fluoride or fluoride can cause
nervous system effects. Human and animal studies have shown minor changes in
neurological function after inhalation exposure to hydrogen fluoride. Overt
signs or behavioral signs of neurotoxicity were not noted, except for
alterations in conditioned responses and evidence of depression observed in
rats (Sadilova et al. 1965). Further neurological testing may be warranted to
ascertain the conditions involved and the extent to which the nervous system
is a target organ for fluoride toxicity.
Epidemiological and Human Dosimetry Studies. Since fluoride is
available in the drinking water in many communities, many epidemiological
studies have been conducted regarding its health effects. Epidemiological
studies of people who have been exposed to hydrogen fluoride and other
fluoride compounds occupationally have also been performed (Czerwinski et al.
1988; Chan-Yeung et al. 1983a; Chan-Yeung et al. 1983b; Kaltreider et al.
1972). Because of the wide use of fluoride in industry and dental hygiene, it
is likely that subpopulations vary in their level of exposure to fluoride.
Human dosimetry studies exist that indicate that fluoride levels in the urine
can be used as an indication of recent exposure (Carlson et al. 1960a;
Collings et al. 1952; Machle and Largent 1943). Additional studies
correlating environmental measurements of fluoride with urinary excretion data
and health effects would be useful for establishing a dose response for health
effects in humans.
Biomarkers of Exposure and Effect. The level of fluoride in urine is
the best biomarker of acute exposure (Ekstrand et al. 1983; Hodge and Smith
1977). However, because chronic exposure to fluoride results in sequestration
in bone, levels in the urine cannot be correlated with levels of chronic
exposure (Carlson et al. 1960a). This biomarker is specific for acute and
intermediate duration exposure to this chemical.
The most sensitive biomarkers of effect for fluoride are alterations in
teeth and bones following chronic exposure (Knaus et al. 1976). Of these,
tooth alterations are more sensitive, but they occur only during childhood
(DHHS 1991; Heifetz et al. 1988). Changes in glucose or lipid metabolism
(Dousset et al. 1984; Shearer 1974; Watanabe et al. 1975), and in erythrocyte
enzyme activities (Guminska and Sterkowicz 1975) have been noted following
acute exposure. Specific biomarkers of effects following acute exposures have
not been well identified, and would be useful in monitoring short-term
effects, such as might be expected to occur in hazardous waste site workers.
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Absorption, Distribution, Metabolism, and Excretion. Data exist that
indicate that a high percentage of hydrogen fluoride is rapidly absorbed
following acute inhalation exposure (Collings et al. 1952; Rye 1961). Rates
of absorption differ between human studies, because the reported times to peak
urinary fluoride levels are different (2-4 hrs vs. 10 hrs) (Collings et al.
1952; Rye 1961). One human study reports absorption of fluoride from acute
inhalation of rock phosphate dust, with time to peak urinary fluoride of
10 hours, and similar excretion kinetics to that found following hydrogen
fluoride inhalation (Rye 1961). One acute animal study described the rate and
extent of absorption following inhalation exposure to hydrofluoric acid
(Morris and Smith 1982). Data on chronic absorption, extent of absorption,
and potential for saturation were not located but would be useful for
predicting potential effects in persons exposed to hydrogen fluoride or
fluoride dusts at low levels over extended periods of time.
Soluble fluoride is rapidly and almost completely absorbed following
oral exposure of humans or animals (Armstrong et al. 1970; Carlson et al.
1960a; Ekstrand et al. 1977b, 1983; Ericsson 1958; McClure et al. 1945;
Whitford and Pashley 1984; Zipkin and Likins 1957). However, the degree of
absorption is affected by a number of other factors (Rao 1984).
Although dermal absorption has not been studied per se, toxicity
following acute dermal exposure to hydrofluoric acid (e.g., hypocalcemia)
provide adequate evidence that this is a significant route of exposure (Browne
1974; Dale 1951; Dibbell et al. 1970). However, it should be noted that in
some cases the effects reported for dermal exposure may have been caused by
inhalation of hydrofluoric acid fumes as well as injury to skin. The existing
data on dermal exposure to sodium fluoride (Essman et al. 1981) are not
sufficient to determine absorption. Because hydrofluoric acid readily
dissolves in water, and reacts readily with a number of compounds and metals,
contamination of water or the ground would result in the formation of fluoride
salts. Therefore, populations surrounding hazardous waste sites would be more
likely to be exposed dermally to fluoride salts than to hydrofluoric acid.
However, cleanup workers or members of the public who came into contact with
leaking drums could be dermally exposed to hydrofluoric acid. Additional
animal studies regarding rate and extent of absorption following dermal
exposure would be useful for clarifying the effects seen following dermal or
inhalation exposure.
The development of systemic effects following whole body exposure to
fluorine indicates that fluorine is absorbed (Stokinger 1949). The rate and
extent of absorption are not known.
Regardless of the route of administration, fluoride is found in the
plasma (Morris and Smith 1983; Perkinson et al. 1955), and accumulates in
bones and teeth. Elevated fluoride levels are also found in the kidney
(Whitford and Taves 1973) and aorta (Smith et al. 1960). Further information
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concerning distribution would be useful to determine if there are target
organs of fluoride exposure in addition to the skeletal, gastrointestinal, and
cardiovascular systems. In addition, while it is known that elevated bone
fluoride levels decrease with time if the exposure source is removed, more
information about the kinetics of this process would be useful.
Fluoride interacts with other elements, particularly in bone formation
(McCann and Bullock 1957; Neuman et al. 1950). The ion is also known to
interact with enzymes in the body (Capozzi et al. 1967; Cimasoni 1966; Halton
et al. 1984; Smith et al. 1959). Although there are extensive data on in
vitro inhibition of enzymes, very few data exist regarding the biological
significance of these interactions. Several glycolytic enzymes are inhibited
at fluoride concentrations of 38 ppm (Capozzi et al. 1967). A few enzymes
have been identified that are inhibited at in vitro concentrations <lO ppm
(Cimasoni 1966; Smith et al. 1959). Further information on the biological
significance of these enzyme reactions would be useful for assessing the
mechanisms by which fluoride affects human health.
The excretion of fluoride in the urine of humans following inhalation or
oral exposure is well characterized in its relationship to recent fluoride
exposure (Ekstrand et al. 1983; Hodge and Smith 1977). However, while it is
known that bone fluoride concentration increases with age (Smith et al. 1953),
the total steady-state excretion level when people are chronically exposed to
low-levels of fluoride is not well characterized. Reliable data are also
lacking regarding the contribution of sweat to fluoride excretion. Data are
lacking concerning excretion following dermal exposure; however, there is no
evidence to suggest that excretion following dermal exposure would differ from
that following oral or inhalation exposure.
Comparative Toxicokinetics. Because fluoride is frequently available in
the drinking water, abundant human data exist concerning the kinetics of
fluoride in humans. Fewer data were located for animals that are considered
to be appropriate models for humans. Human and animal data exist that
indicate that the most likely target organs (bones and teeth) are similar
across species for intermediate and chronic duration exposures (Derryberry et
al. 1963; Machle and Scott 1935; Wagner et al. 1958). However, as mentioned
before, the lack of a vomit reflex in rats may preclude their use as an animal
model for acute oral exposure to fluoride compounds.
There is good evidence that there are marked species and strain
differences regarding tolerance to increased levels of oral fluoride. For
example, beef and dairy heifers show susceptibility to levels as much as
100 times lower than those causing some degree of pathology in laying and
breeding hens (Suttie 1980). Additional data from studies that provide
directly comparable pharmacokinetic data from several species would be useful
for establishing the best species for extrapolating to human effects.
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Mitigation of Effects. Methods have been published for limiting oral
and dermal absorption of fluoride compounds (Bronstein and Currance 1988;
Goldfrank et al. 1990; Haddad and Winchester 1990) and for counteracting the
hypocalcemia, hypomagnesemia, and hyperkalemia that are produced by fluoride
in acute high-level exposure situations (Abukurah et al. 1972; Ellenhorn and
Barceloux 1988; Haddad and Winchester 1990). Although there is a report in an
animal model that intradermal injection of magnesium acetate or magnesium
sulfate is more effective than injection of calcium gluconate (Harris et al.
1981), a report of human case studies found that the calcium gluconate method
was 100% effective and did not cause tissue damage (Browne 1974). Therefore
it is not clear whether intradermal injection of magnesium acetate or
magnesium sulfate should be explored. The only information located on
treatment strategies for long-term exposures to excessive amounts of fluorides
involved reducing exposure either by removing the source or reducing
absorption. Fluoride excretion can be increased by the administration of
aluminum hydroxide as antacid (Spencer et al. 1980a). Other studies show that
fluoride absorption is decreased in the presence of calcium (Machle and
Largent 1943; McClure et al. 1945), especially in combination with carbonate
(Jowsey and Riggs 1978), although these studies were not designed to develop
treatment strategies. Strategies for increasing bone turnover might also be
useful, but no investigations of such methods were located. Research on using
dietary supplements or increasing bone turnover for mitigating adverse effects
of chronic exposure to fluoride would be helpful, especially in the case of
chronic exposure to drinking water which has been contaminated with fluoride.
2.9.3 On-going Studies




3. CHEMICAL AND PHYSICAL INFORMATION
3.1 CHEMICAL IDENTITY
The common synonyms and other information for fluorine, hydrogen
fluoride, and sodium fluoride are listed in Table 3-1.
3.2 PHYSICAL AND CHEMICAL PROPERTIES
Important physical and chemical properties of fluorine, hydrogen





4 . PRODUCTION, IMPORT, USE, AND DISPOSAL
4.1 PRODUCTION
Fluorine, hydrogen fluoride, sodium fluoride, and calcium fluoride form
a diverse and widely used group of related chemicals. The sources of these
chemicals vary. The fluoride chemical industry is based mainly on fluorspar
(calcium fluoride), which has been mined since the late 18th century for use
in the production of steel (Grayson 1980). This compound is found mainly in
the Illinois-Kentucky region. Average annual U.S. production for the years
1972-1978 is estimated at 118,000-225,000 metric tons (Grayson 1980). Future
mining is expected in Tennessee, Colorado, and Alaska. Another source of
fluoride chemicals is the processing of phosphate rock, which releases
fluorine as gaseous hydrogen fluoride. The preferred raw materials for
hydrogen fluoride manufacture are acid-grade fluorspar and sulfuric acid.
Sodium fluoride is produced by reacting hydrofluoric acid and sodium
carbonate. Very pure calcium fluoride is made by the reaction of hydrofluoric
acid with precipitated calcium carbonate.
The total commercial production of fluorine in the United States and
Canada is approximately 5,000 tons/year, of which 70%-80% is used to produce
uranium hexafluoride for nuclear power applications. The current growth rate
of hydrogen fluoride production is approximately 0.5%. The rate has decreased
over the past few decades, from 10% annually in the 1940s and 1950s, to 5% in
the 1960s, then to 3% in the early 1970s (Grayson 1980). Information on
recent production volumes of these chemicals was not located. Table 4-l shows
the number of facilities in each state that manufacture and process hydrogen
fluoride, the intended uses of the product, and the range of maximum amounts
of hydrogen fluoride that is stored on site. The data listed in Table 4-l are
derived from the Toxics Release Inventory (TRI) of EPA (TR188 1989). Because
only certain types of facilities are required to report, this is not an
exhaustive list. Neither fluorine nor sodium fluoride or any other fluoride
salt are listed on TRI.
4.2 IMPORT/EXPORT
The United States imports more than 80% of its fluorspar, the primary
source of fluorine and its compounds. The imports originate primarily from
Mexico, the Republic of South Africa, Spain, and Italy. The most recent data
indicate that in 1977, 885,000 metric tons were imported. In 1975, 1,200
metric tons of fluorspar were exported, primarily to Canada (Grayson 1980).
4.3 USE
Fluoride compounds are used in a wide range of fields. The steel
industry is the largest consumer of fluorides, followed by the chemical
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Molecular fluorine has been used as an oxidizer in rocket fuels, in the
production of metal1ic.s and other fluorides, and in glass, enamel, and brick
production (Greenwood 1969; Windholz 1976). Currently, molecular fluorine is
used by most manufacturers for the production of various inorganic fluorides.
With the discontinuance of liquid fluorine as a rocket fuel oxidizer, demand
for this form has virtually ceased (Grayson 1980). The fluorine-18 isotope
has been found to be effective in bone scanning. When used as a replacement
for the conventional x-ray process, the amount of radiation exposure received
by the patient is reduced (Gerber et al. 1972).
The main use of sodium fluoride is as a drinking water additive for
prevention of dental caries. It is also used as a rodenticide and insecticide
(mainly for roaches and ants), as a disinfectant for fermentation apparatus in
breweries and distilleries, in wood preservation, and in rimmed steel
manufacture (Markuson 1947; Windholz 1976).
Calcium fluoride, the primary compound used by the fluoride chemical
industry, has been used as a flux in steel manufacturing since the
introduction of the open-hearth process. In 1977, the two primary uses of
calcium fluoride were the production of hydrofluoric acid and steel making,
accounting for 519,000 metric tons and 504,OOO metric tons of calcium
fluoride, respectively. The total amount of calcium fluoride used in that
year is estimated at 1,063,000 metric tons (Grayson 1980). Other uses are
frosting glass and enamels, coating welding rods, transmittal of ultraviolet
rays in the optical industry, fluoridation of drinking water, paint pigment,
and as a catalyst in wood preservation (Windholz 1976).
Prior to 1930, hydrogen fluoride was used mainly for glass etching and
polishing, foundry scale removal, and minor production of metal fluorides
(Grayson 1980). In 1977, 40% of hydrogen fluoride use was devoted to aluminum
production and 37% to production of chlorofluorocarbons. Other uses include
uranium processing, petroleum alkylation, and stainless steel pickling
(Anonymous 1970; Grayson 1980; Windholz 1976). A sharp decrease in demand for
hydrogen fluoride occurred in 1978 when the United States prohibited the use
of chlorofluorocarbon gases in pressure packaging (Grayson 1980).
4.4 DISPOSAL
Limited information on the required disposal practices of fluoride
compounds was located. Fluorine can be disposed of by conversion to gaseous
fluoride salts (Grayson 1980). No information could be located on levels
disposed of via these methods. Industrial practices include reaction with
solid disposal agents such as alumina, limestone, lime, and soda lime;
reaction with superheated steam; and scrubbing with caustic solutions.
Potassium hydroxide and sodium hydroxide are used in spray column caustic
scrubbing systems. Potassium hydroxide is preferred because of the higher
solubility of the resulting potassium fluoride (Grayson 1980). During the
manufacture of wet-process phosphoric acid, waste liquors and slurries that
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5. POTENTIAL FOR HUMAN EXPOSURE
5.1 OVERVIEW
Fluorides enter the environment naturally through the weathering of
rocks and minerals and by emissions from volcanoes. The greatest amount of
the total volume of fluorides in the environment is released from natural
sources, in particular volcanoes and oceans. However, the greatest
concentrations are found near anthropogenic point sources. Fluorides are
found in soil, air, water, and in most foods, from both natural and
anthropogenic sources, though rarely as molecular fluorine. It is highly
electronegative and therefore reacts vigorously with other compounds. The
dominant fluoride compound in a particular medium is the most stable compound
in that medium. For example, the dominant species in air is hydrofluoric
acid, but even this species will not persist in the air for long periods.
Anhydrous hydrogen fluoride will react with moisture in the air and form
hydrofluoric acid, which will gradually settle to the ground or be dispersed
with the wind. Calcium fluoride is most common in alkaline soils, and
fluoroaluminate complexes are most common in acidic soils. Thus, exposure to
hydrofluoric acid would occur at a hazardous waste site only if someone came
in contact with material leaking from a storage container or breathed
contaminated air before it was dispersed. Once in a stable form, fluoride
persists in the environment for a relatively long time unless transformed to
another compound or decomposed by radiation.
The general population is exposed to fluoride through consumption of
drinking water, foods, and dentifrices, primarily in the form of sodium
fluoride and stannous fluoride. Populations exposed to relatively high
concentrations of fluoride include workers in fluoride-processing industries
and individuals residing near such industries. These individuals may be
exposed to higher than background concentrations as a result of the levels of
hydrogen fluoride and dusts from fluoride compounds in the air, and from
foodstuffs produced within the vicinity that have collected excess fluoride
from the environmental media. Populations near hazardous waste sites may be
exposed to high levels of fluoride by similar routes, although no information
has been located to support this.
EPA has identified 1,334 NPL sites. Fluorides have been found at 130 of
the sites. Fluorine and hydrogen fluoride have been found at 28 and 19 sites,
respectively. Because fluorine is a gas, it could exist at a hazardous waste
site only in a pressurized cylinder. Alternatively, fluoride contamination
may be generically listed as fluorine contamination. We do not know how many
of the 1,334 NPL sites have been evaluated. As more sites are evaluated by
EPA, these numbers may change (Hazdat 1992). The frequency of these sites
within the United States (including all sites with fluoride, hydrogen
fluoride, or fluorine contamination) can be seen in Figure 5-l.
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5.2 RELEASES TO THE ENVIRONMENT
According to TRI, an estimated total of 12,934,848 pounds of hydrogen
fluoride were released to the environment (air, land, water, and underground
injection wells) from manufacturing and processing facilities in the United
States in 1987, as can be seen in Table 5-1 (TR188 1989). Facilities are
required to report releases if they are in Standard Industrial Classification
(SIC) codes 20-39 and meet other reporting criteria. The quality of the TRI
data must be viewed with caution since the 1987 data represent first-time,
incomplete reporting of estimated releases by these facilities. Not all
sources of chemical wastes are included, and not all facilities that should
have reported release data have done so. Neither fluorine nor sodium fluoride
or other fluorides are listed on TRI.
5.2.1 Air
Natural sources of atmospheric fluoride releases include volcanoes,
minerals, and oceans. The greatest total amount of natural fluoride is
contributed by volcanoes, primarily in the form of hydrogen fluoride. Passive
degassing of volcanoes has been estimated to contribute between 5x1010 and
5X1012 g/year (0.067 to 6.7 million tons/year), and between 5x109 and 5x1010 g
(0.0067-0.067 million tons) is explosively erupted each year (Symonds et al.
1988). Weathering of fluoride-containing rocks and minerals also contributes
to the atmospheric burden of fluoride in the form of soil minerals (NAS
1971a). Another source of undetermined quantity is sea salt aerosol, which
releases small amounts of gaseous hydrogen fluoride and fluoride salts into
the air. The marine aerosol is potentially a major source of tropospheric
hydrogen fluoride, though confined to the air over the oceans (Friend 1989).
Anthropogenic releases of fluoride into the atmosphere totaled
155,300 tons/year from the major fluoride-processing industries measured
between 1964 and 1970 (EPA 1980a). The major contributors were steel, brick
and tile, and aluminum manufacturing, combustion of coal, and production of
phosphorus and phosphate fertilizer (EPA 1980a; NAS 1971a). Since this study,
regulations have been established that set emissions standards for aluminum
manufacturing (EPA 1980b) and phosphate fertilizer plants (EPA 1975). No data
were located on global anthropogenic fluoride releases since the emissions
limits have been implemented. Fluoride can also enter the atmosphere from the
manufacture and use of pesticides such as sodium fluoride, sodium fluorosilicate,barium
fluorosilicate, and cryolite particularized in the form of
dusts and sprays (NAS 1971a).
According to TRI, an estimated total of 11.4 million pounds of hydrogen
fluoride were released to the atmosphere from manufacturing and processing
facilities in the United States in 1987 (TRI88 1989). As discussed above,
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since approximately 16,000 tons are emitted each year from combustion
processes that are probably not included in the TRI database (NAS 1971a).
5.2.2 Water
Natural sources of fluoride released to surface waters include wet
deposition of atmospheric fluorides, and weathering of fluoride-containing
rocks and soils through which groundwater flows. In the western regions of
the United States, rocks and soils have greater than average concentrations of
fluoride; as a result, greater amounts of fluorides leach into the groundwater.
Leaching from alkaline igneous rocks, dolomite, phosphorite, and volcanic glasses gives
rise to high-fluoride waters (EPA 1980a; NAS 1971a).
The ocean is another natural source of fluoride.
Near industrial sources, precipitation provides an even greater
concentration of fluorides, because of increased levels in the ambient air.
In the manufacture of wet-process phosphoric acid, waste liquors and slurries
are produced that contain sodium and potassium fluorosilicates, hydrofluoric
acid, and fluorosilicic acid. In coastal areas, these wastes are disposed of
in the sea. In other areas, large ponds are constructed to contain this waste
and may contribute to the atmospheric burden by volatilization and water
runoff (NAS 1971a). Fluorides are also added to many community water supplies
to achieve a concentration of 0.7-1.2 ppm, which helps decrease the incidence
of dental caries (DHHS 1991).
According to TRI, an estimated total of 204,544 pounds of hydrogen
fluoride were released to surface waters from manufacturing and processing
facilities in the United States in 1987 (TRI88 1989). However, as discussed
above, these data must be viewed with caution.
Fluoride has been detected in an estimated 1.04% of the surface water
samples and 3.94% of the groundwater samples analyzed for the 2,783 hazardous
waste sites participating in EPA's Contract Laboratory Program (CLP);
geometric mean concentrations for the positive samples were not reported
(CLPSD 1988). Note that the Contract Laboratories Program Statistical
Database (CLPSD) includes data from both NPL and non-NPL sites.
5.2.3 Soil
Natural sources of fluorides released to soils include weathering of
minerals, precipitation of atmospheric fluorides, plant and animal wastes, and
sedimentation of undissolved fluorides in water. Soils may contain fluoride
in the form of several different minerals including biotite, muscovite,
hornblende, apatite, and fluorspar (NAS 1971a). Man-made sources are
primarily fertilizers, particularly super phosphates, and industrial releases
(EPA 1980a; NAS 1971a). In a study by Oelschldger (1971), fertilization with
superphosphates added to the soil 8-20 kg fluoride/hectare. Fluoride loss
through seepage water averaged between 52 and 208 µg/L, depending upon levels
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of clay, lime, and fluoride in the water and the run-off (OelschMger 1971).
Fluoride-containing pesticides, mentioned above, may add significantly to soil
levels, although quantitative information on this source was not located.
Soil contamination by atmospheric fluorides near an industrial source
reflected the gradient of fluoride deposition. In one study, the total
fluoride concentration was found to decrease over a distance of 8.8 km from
2,700 to 616 µg/g fluoride and the water extractable fraction from 292 to
10 µg/g fluoride (Polomski et al. 1982).
Fluoride has been detected in an estimated 0.12% of the soil samples
analyzed for the 2,783 hazardous wastes sites participating in EPA's CLP;
geometric mean concentrations for the positive samples were not reported
(CLPSD 1988). Note that the CLPSD includes data from both NPL and non-NPL
sites.
According to TRI, an estimated total of 1.3 million pounds of hydrogen
fluoride were released to soils from manufacturing and processing facilities
in the United States in 1987 (TR188 1989). However, as discussed above, these
data must be viewed with caution.
5.3 ENVIRONMENTAL FATE
5.3.1 Transport and Partitioning
Gaseous and particulate fluorides are transported to the atmosphere from
the earth's crust via volcanic emissions and entrainment of soil particles.
The gaseous fluorides are primarily hydrogen fluoride and silicon
tetrafluoride. Vaporization and aerosol formation are the most important
processes involved in partitioning of fluorides between surface waters and the
atmosphere. Atmospheric fluorides are transported to soils and surface waters
through wet and dry deposition processes (NAS 1971a).
Transport and partitioning of fluoride compounds depend primarily on the
availability of reactants and on the physical properties of the specific
compounds, such as water solubility and volatility. Fluorides in surface
waters that are not volatilized to the atmosphere can partition to sediments
or biota (Carpenter 1969; NAS 1971a). Precipitation of insoluble fluorides
from surface waters is dependent on the amount of calcium present for
complexing (EPA 1980a). Industrial waste ponds containing fluorosilicic acid
and hydrofluoric acid partially vaporize,, introducing silicon tetrafluoride
and hydrogen fluoride into the air. High concentrations of fluorosilicic acid
favor greater concentrations of silicon tetrafluoride (NAS 1971a).
Fluorides in soils are transported to surface waters through leaching of
particulate-bound fluorides or by addition of fluoride-containing particulate
matter to the water (NAS 1971a). Leaching removes only a small amount of
fluorides from soils. For example, Oelschldger (1971) reported that about
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0.5%-6.0% of the yearly increment of fluoride added to forest and agricultural
areas was lost in the leaching process.
In soils with high calcium or aluminum content, fluorides form
persistent complexes. In sandy, acidic soil, water-soluble forms predominate.
Fluoride compounds with high water solubility can be absorbed into vegetation.
Particulate forms of fluorides may also be, deposited on vegetation by light
rains and wind. Fluoride accumulates primarily in the skeletal tissues of
terrestrial animals that consume fluoride-containing foliage.
Fluorides released into marine environments have been shown to
accumulate in some aquatic organisms. In a study by Hemens and Warwick
(1972), toxic effects due to fluorosis were observed in species of mussel,
mullet, crab, and shrimp in an estuary where waste from an aluminum plant was
released. There is an no information in the literature on the movement of
fluoride through the terrestrial or aquatic food chains.
5.3.2 Transformation and Degradation
5.3.2.1 Air
The predominant mode of degradation of inorganic fluorides in the air is
hydrolysis. Silicon tetrafluoride, a major industrial pollutant, reacts with
vapor in air to form hydrated silica and fluorosilicic acid. Molecular
fluorine hydrolyzes to form hydrogen fluoride and oxygen. Hydrolysis of
uranium hexafluoride, which is used in nuclear power applications, also
produces hydrogen fluoride as well as nonvolatile uranyl fluoride. These
compounds are then removed from the atmosphere by condensation or nucleation
processes. Hydrogen fluoride is stable and the most abundant species.
Fluorides emitted by industries in the form of particulate matter are stable
compounds that do not hydrolyze readily. ' Particulate compounds have low
solubility and usually return as dusts. Particulate compounds that persist in
the atmosphere are decomposed by radiation (NAS 1971a).
5.3.2.2 Water
In dilute solutions and at neutral pH, dissolved fluorides are usually
present as the fluoride ion (F-) (Bell et al. 1970). As pH decreases, the
proportion of F- decreases, while HF2- and nondissociated hydrogen fluoride
increase. Levels of nondissociated hydrogen fluoride also increase in
concentrated solutions. In sea water, fluorides exist in equilibrium.
Calcium carbonate precipitation dominates the removal of dissolved fluoride
from sea water. The next most important removal mechanism is incorporation
into calcium phosphates (Carpenter 1969). Undissolved fluoride is generally
removed by sedimentation (EPA 1980a). The residence time of fluoride in ocean
sediments has been computed at 2-3 million years (Carpenter 1969).
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5.3.2.3 Soil
Fluorides tend to persist in most soils, predominantly as aluminum
fluorosilicate complexes in acidic soils and calcium fluoride in alkaline
soils. The retention of fluoride in alkaline soils depends largely upon the
aluminum content. Soluble fluoride compounds are almost completely fixed in
soils as calcium fluoride at pH 6.5 or above if sufficient calcium carbonate
is available (Brewer 1966). Sandy, acidic soils favor the development of
soluble forms of fluoride (Shacklette et al. 1974). Several species of plants
have the capacity to convert soluble fluoride obtained from the soil into
carbon-fluorine compounds such as monofluoroacetic acid, ω-fluoro-oleic acid,
ω-fluoropalmitic acid, and ω-fluoromyristic acid (Marais 1944; Ward et al.
1964).
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
5.4.1 Air
The amount of fluoride measured in ambient air depends on the amount of
fluoride emitted from a point source, the distance from the source, the
meteorologic conditions, and the topography of the area (Davis 1972). In a
study by Thompson et al. (1971) of 9,175 urban air samples in the United
States in 1966, 1967, and 1968, 88% registered no detectable quantity of
fluorides. Only 18 measurements (0.2%) exceeded 1.00 µg/m3, the maximum being
1.89 µg/m3. Even lower levels were found in samples taken from rural areas.
Of 7,700 air samples analyzed in the United States by the National Air
Pollution Control Administration in 1966 and 1967, 97% had no detectable
fluoride. The lower limit of detectability was approximately 0.05 µg/m3
(Yunghans and McCullen 1970).
Fluoride is often concentrated in the atmosphere near industrial
operations. An aluminum factory that began operating in 1958 in Oregon raised
the average fluoride content of foliage in cherry and peach trees from 13 ppm
to 65 and 76 ppm, respectively. The highest average values measured were
196 ppm and 186 ppm, respectively, recorded in September 1960 (NAS 1971a). In
1976, fluoride levels were measured downwind of an aluminum plant that emitted
34 kg fluoride/hour; total fluoride concentration was about 0.66 µg/m3 (Krook
and Maylin 1979). The installation of scrubber devices has reduced emissions
from aluminum plants, but no data were located on ambient air levels since
their installation. These high concentrations decrease with increasing
distance from the industrial source.
5.4.2 Water
Fluoride levels in water vary according to location and proximity to
emission sources. Surface water concentrations generally range from 0.01 to
0.3 mg/L and usually do not exceed this upper level. The fluoride content of
groundwater generally ranges from 0.02 to 1.5 ppm (EPA 1980a; Fleischer 1962).
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Groundwater levels are higher than surface water levels because their content
is influenced more by the minerals and rock through which they flow (EPA
1980a; NAS 1971a; WHC 1984). Water with high salinity has higher levels of
fluoride, as in the Great Salt Lake with a fluoride concentration of 14 ppm
(EPA 1980a). Sea water contains more fluoride than fresh water, ranging from
approximately 1.4-1.5 ppm (Bowen 1966; Carpenter 1969; Goldschmidt 1954).
Levels in surface and groundwater at hazardous waste sites have not been
reported by CLPSD.
5.4.3 Soil
Fluorides are widely distributed in the earth's crust. The mean
fluoride content in mineral soils ranges from 200 to 300 ppm (Bowen 1966; NAS
1971a; Worl et al. 1973). The chief fluorine-containing minerals are
fluorspar, cryolite, and fluorapatite. In soils with high concentrations of
these minerals, the soil fluoride content is much higher and may range from 7
to 38 g/kg (Smith and Hodge 1979). Average fluoride concentrations differ
between the eastern and western United States. The average concentrations are
340 ppm in the east and 410 ppm in the west (EPA 1980a). Fluoride
concentrations also tend to increase with soil depth. Of 30 domestic soil
samples, the mean fluoride concentration at a depth of 0-3 inches was 190 ppm,
whereas the mean concentration at a depth of 3-12 inches averaged 292 ppm (NAS
1971a).
On the other hand, soils near industrialized sources show elevated
concentrations that decrease with distance from the source and depth below the
surface. Concentrations of fluoride in the top 0.5 inches of soil located
near a phosphorus extraction facility near Silver Bow, Montana, were reported
to range from 265 to 1,840 ppm (Van Hook 1974).
5.4.4 Other Environmental Media
Several factors influence the level, of fluorides in food. These include
the locality in which the food is grown, the amount of fertilizer and
pesticides applied, the type of processing the food receives, and whether
fluoridated water is used in food preparation (McClure 1949; Myers 1978;
Waldbott 1963b). Foods characteristically high in fluoride content are
certain types of seafood (1.9-28.5 mg/kg), especially those types in which the
bones are consumed, bone products such as bone meal and gelatin, and tea,
which contains approximately 0.52 mg/cup (Cook 1969; Kumpulainen and
Koivistoinen 1977). Baby formula processed with fluoridated water can contain
1 mg/kg fluoride, yielding a dose of 0.27 mg/kg/day if the formula is
reconstituted with water containing 1.2 ppm fluoride (Forsman 1977); some
manufacturers now monitor fluoride levels in baby formula and keep them within
acceptable limits (Rao 1984).
151
5. POTENTIAL FOR HUMAN EXPOSURE
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
Fluoride intake by the general population occurs primarily through
ingestion of food and water. Since levels in ambient air are, in most cases,
below detectable limits, the levels inhaled are generally very low except for
in areas immediately surrounding industries that emit fluorides into the air.
In a study of airborne fluoride concentrations measured in community settings,
87% of all measurements at urban stations and 97% of all measurements at
nonurban stations showed concentrations below 0.05 µg/m3, the threshold of
detectability. The maximum measurements in one study were 1.89 µg/m3 at an
urban location and 0.16 ,µg/m3 at a nonurban location (Yunghans and McCullen
1970). Another study reported fluoride levels 1.5 km from an aluminum plant
(Krook and Maylin 1979). The average particulate fluoride level was 0.31 µg/m3
(5.53 µg/m3, 12-hour maximum), and the average gaseous fluoride level was
0.36 µg/m3 (6.41 µg/m3, 12-hour maximum). In an occupational setting when the
airborne concentration is frequently at the exposure limit of 2.5 mg/m3,
fluoride intake via inhalation can be 25 mg/day (OSHA 1985).
Virtually all food contains trace amounts of fluoride; estimates of the
average daily adult fluoride intake from food in the United States range from
0.8-0.9 mg (San Filippo and Battistone 1971) to 1.2-2.7 mg (Spencer et al.
1970). Total daily fluoride from diet and water in the two studies was
2.1-2.4 mg and 2.82.9-5.9 mg, respectively. Cooking food in fluoridated water
results in increased dietary fluoride levels. In England, where much more tea
is consumed, a study found daily average intake of fluoride from tea to be
1.26 mg/day in children and 2.55 mg/day in adults (Cook 1969).
In such studies, it is important to take bioavailability into account,
and not just measure the fluoride level of the consumed material. As
discussed in Sections 2.3.1.2 and 2.8, absorption is affected by factors such
as whether the material was eaten with a meal, the chemical and physical form
of the fluoride, and the current health status of the individual (Rao 1984).
For example, the bioavailability of fluoride as sodium fluoride is high. In
contrast, absorption of calcium fluoride in the solid form is rather
inefficient, but it is increased up by administration with food. Thus, the
actual absorbed dose could be smaller than that the intake levels reported in
the above studies. In addition, since determination of fluoride content in
food is preceded by ashing the sample, it is difficult to determine the amount
that is present in an ionized or ionizable form, rather than being covalently
bound in a organic molecule.
In areas where fluoride is not added to water, the total intake from
food and water does not usually exceed 1.0 mg/day (WHO 1984). Fluoride
tablets or drops are ingested in some areas where water fluoride levels are
low, providing about 0.5 mg/day. The average total dietary intake in twelve
fluoridated U.S. cities was reported to be 2.7 mg/day (Kumpulainen and
Koivistoinen 1977). In industrial settings, oral intake may also be increased
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from dust contamination of food (WHO 1984). Fluoridated dentifrices and mouth
rinses are additional sources of fluoride, particularly in small children who
do not have complete control of the swallowing reflex. Dentifrice ingestion
was inversely correlated with age; average ingested levels per brushing for
children aged 2-4, 5-7, and 11-13 was 0.30, 0.13, and 0.07 g (Barnhart et al.
1974). Average fluoride intake from these sources in children <7 years old
ranged from 0.3 to 0.4 mg/use for mouth rinses, depending on the child's age,
and were about 0.1 mg/brushing for fluoridated toothpaste use (Ericsson and
Forsman 1969).
The National Occupational Hazard Survey (NOHS), conducted by the
National Institute for Occupational Safety and Health (NIOSH) for the years
1972-1974, estimated that 68,886 workers in 6,590 U.S. plants were potentially
exposed to hydrogen fluoride in the workplace in 1970 (NIOSH 1976b). For
sodium fluoride, the NOHS estimate was 25,059 workers in 3,763 U.S. plants
(NIOSH 197613). Preliminary data from a second workplace survey, the National
Occupational Exposure Survey (NOES), conducted by NIOSH from 1980 to 1983,
indicated that 185,997 workers, including 67,073 women, in 11,254 plants were
potentially exposed to hydrogen fluoride in the workplace in 1980 (NIOSH
1984). Estimates from the same survey for sodium fluoride are 68,571 total
employees, including 21,930 women, in 2,818 plants (NIOSH 1984). Neither the
NOHS nor the NOES contain information on the frequency, concentration, or
duration of exposure of workers to any of the chemicals listed therein. These
surveys provide only estimates of the number of workers potentially exposed to
chemicals in the workplace.
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
Populations in hot climates and outdoor laborers generally have a
greater daily intake of fluorides because of a larger consumption of water.
Populations in areas such as Asia and Great Britain, where people drink
substantial amounts of tea, and in areas with high consumption of seafood,
also have greater daily intakes of fluorides (WHO 1984). People are exposed
to greater concentrations of fluoride in the groundwater in the southwestern
United States. The highest reported water fluoride concentration in each of
Nevada, southern California, Utah, New Mexico, and western Texas is at least
1.5 ppm (Fleischer 1962). People with polydipsia will also ingest larger
amounts of water, and hence will have higher fluoride exposure. Populations
downwind of phosphate fertilizer or aluminum plants can be exposed to higher
fluoride levels in the air (Ernst et al. 1986), and workers in such plants
will have occupational exposure to fluorides.
Populations living in the vicinity of hazardous waste sites may be
exposed to fluorides through contact with contaminated air, water, and soil.
Food grown near the source could also be contaminated. Data on the
concentrations of fluorides in waste site media are quite limited, and no
information was located regarding daily intake of fluorides from these
sources.
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5.7 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and programs of the
Public Health Service) to assess whether adequate information on the
health effects of fluorides is available. Where adequate information is not
available, ATSDR, in conjunction with the NTP, is required to assure the
initiation of a program of research designed to determine the health effects
(and techniques for developing methods to determine such health effects) of
fluorides.
The following categories of possible data needs have been identified by
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed.
5.7.1 Data Needs
Physical and Chemical Properties. The physical/chemical properties of
fluorides are sufficiently well characterized to enable assessment of the
environmental fate of these compounds.
Production, Import/Export, Use, and Disposal. Because fluoride is
ubiquitous in food and water, the potential for human exposure is substantial.
Human exposure to fluorine or hydrogen fluoride is unlikely outside of an
occupational setting. While fluorine, hydrogen fluoride, sodium fluoride, and
calcium fluoride all have industrial uses, the latter may also be used at
home. Information on recent production volumes of fluorine and hydrogen
fluoride was not located. In addition, although the United States relies on
imports for more than 80% of its needs, the most recent data on import and
export are for 1977 (885,000 metric tons) and 1975 (1,200 metric tons),
respectively (Grayson 1980). Information on disposal of fluorine, hydrogen
fluoride, and fluoride compounds is limited to descriptions of large-volume
industrial practices. Additional quantitative information on production,
import and export of fluorides, and common disposal practices would be useful
in assessing the release of, and potential exposure to, these compounds.
According to the Emergency Planning and Community Right-to-Know Act of
1986, 42 U.S.C. Section 11023, industries are required to submit chemical
release and off-site transfer information to EPA. The Toxics Release
Inventory (TRI), which contains this information for 1987, became available in
May of 1989. This database will be updated yearly and should provide a list
of industrial production facilities and emissions.
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Environmental Fate. Upon release to the environment, fluorides
partition to the atmosphere, soils, and sediments. The atmosphere is the main
transport medium for the compounds (NAS 1971a). Fluorides undergo
transformation in the atmosphere and in soils and surface waters. Information
on the environmental fate of fluorides is sufficient to permit a general
understanding of the widespread transport and transformation of fluorides in
the environment. More information on biotransformation by plants would be
useful in developing a more complete understanding of the environmental fate
of fluorides.
Bioavailability from Environmental Media. Fluorides are absorbed by
humans following inhalation of workplace land ambient air that has been
contaminated (Chan-Yeung et al. 1983a; Waldbott 1979), ingestion of drinking
water and foods (Carlson et al. 1960a; Spencer et al. 1970), and dermal
contact (Buckingham 1988; Browne 1974). Information is available on factors
that influence bioavailability of ingested fluoride (Rao 1984). However, this
information is rarely coupled with the available information on total ingested
fluoride to determine actual bioavailable dose. Additional information on
absorption following ingestion of contaminated soils would be useful in
determining the bioavailability of fluorides from these routes of exposure,
which may be of particular importance for populations living in the vicinity
of hazardous waste sites.
Food Chain Bioaccumulation. Fluorides have been shown to accumulate in
animals that consume fluoride-containing foliage (Hemens and Warwick 1972),
although no information has been located on whether biomagnification occurs in
tissues consumed by predators. Information on bioconcentration in terrestrial
and aquatic organisms and biomagnification in food chains would be helpful in
assessing the importance of bioaccumulation as a route of human exposure.
Exposure Levels in Environmental Media. Fluorides have been detected in ambient
air, surface water, groundwater, drinking water, and foods (Barnhart
et al. 1974; Davis 1972; EPA 1980a; Waldbott 1963b). However, hhe existing
monitoring data are not current. Estimates of intake via ingestion have been
made for members of the general population (Kumpulainen and Koivistoinen 1977;
NAS 1971a; Spencer et al. 1970; WHO 1984). Fluorides have also been detected
in a limited number of surface water, groundwater, and soil samples taken at
hazardous waste sites (Van Hook 1974). Additional information is needed on
concentrations in ambient air, surface water, groundwater, and soils,
particularly at hazardous waste sites. This information will be helpful in
estimating exposures of populations living near these sites through contact
with contaminated media.
Exposure Levels in Humans. Fluorides can be measured in urine, plasma,
saliva, tooth enamel, bone, and other tissues. Detection of fluoride in
biological tissues, particularly urine, has been used as an indicator of human
exposure to fluorides in the workplace and through consumption of fluoridated
155
5. POTENTIAL FOR HUMAN EXPOSURE
drinking water (Chan-Yeung et al. 1983a; Kaltreider et al. 1972; Spencer et
al. 1970). Additional data on fluoride levels in urine and other fluids and
tissues are needed for populations living near hazardous waste sites. This
information will be helpful in establishing exposure profiles for waste site
populations that may be exposed to higher than background levels of fluorides through
contact with contaminated media. The total human intake is of
interest, since multiple sources, all of which are generally considered safe
by themselves, could, under some circumstances, provide total intake that is
considered to be above the "safe" level.
Exposure Registries. No exposure registries for fluorides were located.
This compound is not currently one of the compounds for which a subregistry
has been established in the National Exposure Registry. The compound will be
considered in the future when chemical selection is made for subregistries to
be established. The information that is amassed in the National Exposure
Registry facilitates the epidemiological research needed to assess adverse
health outcomes that may be related to the exposure to this compound.
5.7.2 On-going Studies
Remedial investigations and feasibility studies conducted at the 177 NPL
sites known to be contaminated with fluorine, hydrogen fluoride, or fluorides
may add to the existing database on exposure levels in environmental media at
hazardous waste sites, exposure levels in humans, and exposure registries.
No other on-going studies pertaining to the environmental fate of




The purpose of this, chapter is to describe the analytical methods that
are available for detecting and/or measuring andmonitoring fluorides in
environmental media and in biological samples. The intent is not to provide
an exhaustive list of analytical methods that could be used to detect and
quantify fluorides. Rather, the intention is to identify well-established
methods that are used as the standard methods of analysis. Many of the
analytical methods used to detect fluorides in environmental samples are the
methods approved by federal agencies such as EPA and the National Institute
for Occupational Safety and Health (NIOSH). Other methods presented in this
chapter are those that are approved by groups such as the Association of
Official Analytical Chemists (AOAC) and the American Public Health Association
(APHA). Additionally, analytical methods are included that refine previously
used methods to obtain lower detection limits, and/or to improve accuracy and
precision.
6.1 BIOLOGICAL MATERIALS
Trace levels of fluoride in biological media are determined primarily by
the ion selective electrode (ISE) and gas chromatography (GC) methods.
Spectrophotometry is not used as often for analysis because it is not as
sensitive or quantitative as the other methods (Kakabadse et al. 1971;
Venkateswarlu et al. 1971). Reported recovery for most methods is greater
than 90%. Most of the methods can not distinguish among different forms of
inorganic fluoride. Table 6-1 describes the analytical methods for
determining fluorides in biological materials.
There is extensive literature on the ISE methodology because this
potentiometric analysis is the most frequently used method for fluoride
measurement in biological media. For fluoride determination in urine, NIOSH
(1987) recommends the ISE technique (Method 8308). It is simple, sensitive,
and rapid, with a detection limit in the ng/mL range. Recoveries of fluoride
are usually greater than 90%, but this is dependent on sample preparation.
The ion electrode requires the sample solution to be maintained in a specific
pH range and can only detect ionic fluoride. Interference may result from
ions that can complex with fluoride. Prior to analysis, preparation of the
biological material generally involves dilution with total ionic strength
adjustment buffer, which eliminates hydroxide interference and minimizes
cation interference (NIOSH 1987; Schamschula et al. 1985; Tusl 1970).
The ISE method was modified by Venkateswarlu (1974). Fluoride was
extracted as fluorosilane in the biological sample, followed by a back
extraction in an alkaline solution to recover the fluoride ion. This
isolation step removes most of the interfering materials. The detection of
fluoride is through a hanging drop fluoride electrode assembly. An agar
bridge between the fluoride electrode and the reference electrode allows





the sample is required, and thus greater sensitivity (0.04 ng/sample) is
obtained.
Recent studies have employed GC to measure fluoride concentrations in
human urine and plasma (Chiba et al. 1982; Ikenishi and Kitagawa 1988;
Ikenishi et al. 1988). Trimethylchlorosilane (TMCS) toluene solution was
added to samples to produce trimethylfluorosilane (TMFS). The organic layer
was injected into the GC system. The benefit of this method is its
sensitivity and wide application; it can detect bound fluorine, as well as
free fluoride ion, on the chromatogram.  This detection of bound fluorine
provides an advantage over the ISE technique, which is not suitable for bound
or organic fluoride measurements. ISE samples must be initially subjected to
isolation methods. It should also be noted that the aluminum ion may cause
interference under the operating conditions of GC, as it does with the ISE
method.
Bone fluoride levels can be measured using the ISE technique after
ashing of the sample (Boivin et al. 1988). The addition of 1,2-
cyclohexylenedinitrotetraacetic acid prevents interference by aluminum and iron. A method
was developed by Rudolph et al. (1973) in which biological samples were
subjected to irradiation followed by gamma ray identification of fluoride
concentrations. This analysis has not been fully exploited, but has been
tested in tooth samples and bone biopsies. The nuclear inelastic scattering
technique is sensitive to trace amounts of sample and requires minimal sample
preparation. Accuracy, however, is not as high as that found in the GC and
ISE techniques. The instrument used for this method is equipped with a
lithium-drifted germanium detector. Interference from bound fluoride or other
ions has not yet been shown to occur in this irradiation technique.
Most studies describe methods for monitoring fluoride in the urine,
plasma, and/or biological tissue. Little information was located regarding
fluoride levels in human enamel. Shida et al. (1986) measured fluoride
concentrations in different layers of the surface enamel of extracted
incisors. Tooth samples were decalcified and analyzed by the ISE technique.
A distribution pattern of fluoride levels on the surface layer of human enamel
was shown. However, the correlation between fluoride exposure and the
concentration in the tooth was not determined. A similar method was employed
by Schamschula et al. (1982) on enamel of children. They found that the
fluoride content of enamel did reflect fluoride exposure of the group, but
variations occurred within the individuals. A scaled-down version of this
method was employed by Retief et al. (1987). Instead of analyzing the whole
tooth, individual surfaces could be analyzed by etching the teeth with small
volumes.
The literature indicates that the ion selective electrode and gas
chromatography are the most commonly available and widely used methods.
Modifications of the sample preparation and the instruments themselves to




The ISE method is the most widely used method for determining fluoride
levels in the environmental media. Table 6-2 describes this and other methods
for determining fluoride in environmental samples, The convenience,
precision, and sensitivity of this method make it suitable for various sample
matrices. A limitation is that the electrode can identify only free fluoride
ions. Because of the inherent restriction of this technique, several
approaches have been recommended to prepare the sample for analysis. Lopez
and Navia (1988) assayed total fluoride (bound and free) in food and beverages
by initially acid hydrolyzing samples at 100°C in borosilicate vials. This
closed-system approach decreases contamination, eliminates dry ashing, and
yields high recoveries. Dabeka and McKenzie (1981) employed microdiffusion to
food samples in Petri dishes at 60°C for 24-48 hours. Difficulties arose in
controlling contamination and fluoride loss in the Petri dishes, and low
recoveries were reported. Preparation of total fluoride in dry plant material
(i.e., hay, barley, straw, corn, grass) was described by Eyde (1982); samples
were fused in nickel crucibles with sodium hydroxide at 350°-475°C. The ash
was diluted and filtered for analysis. This method is more tedious than the
others, and fluoride loss is expected from the high decomposition
temperatures. All of these preparatory techniques can liberate bound fluoride
from the sample matrices. It is important to prevent interference of other
ions and to avoid fluoride loss at high decomposition temperatures before
potentiometric analyses.
Kakabadse et al. (1971) described a pyrohydrolytic technique for tea,
coca, or tobacco samples that could be employed prior to spectrophotometric or
ISE fluoride analysis. Decomposition of the sample at 700°-1,000°C is
mediated by a current of air or pure oxygen to evolve hydrogen fluoride. An
advantage of this approach is that fluoride is collected from inorganic and
organic fluorides in one operation. Ashing, which may produce loss of organic
fluorine, is eliminated.
For the analysis of pollutants in the environment, EPA has approved the
manual electrode procedure (Method 340.2), the calorimetric procedure (SPADNS)
(Method 340.1), and the automated complexone procedure (Method No. 340.3) for
determining inorganic fluoride in air, water, and vegetation (EPA 1988).
Kojima et al. (1972) evaluated fluorine levels in laboratory organic
compounds of known compositions with a GC detection technique using an ISE.
This combined system selectively detects organic compounds and in addition
provides information on the sample composition. The sample is injected into
the gas chromatograph, which can separate the organic components and cause
hydrogenolysis. The hydrogen fluoride produced is absorbed and passed through
the fluoride ion selective electrode. A chromatogram of fluorine compound
peaks and the fluoride ion concentration are reported. This is a sensitive,






laboratory chemicals with a known fluorine composition and has not yet been
used for measuring fluorine in biological or environmental samples.
Fluoride gas or vapors in ambient air are measured primarily with the
ISE method. NIOSH (1987) recommends this method (Method 7902) for gaseous and
aerosol fluorides with the two forms undergoing collection on separate filters
before determination. However, the best method for sampling fluoride in air
depends on the form of fluoride being measured. Several modifications have
been suggested for the air sample collection. Einfeld and Horstman (1979)
found that gaseous fluoride, to some extent, may get trapped in the filter for
particulate fluoride. They suggest that postsampling heat treatment promotes
desorption of the gaseous fluoride from the particulate phase. The use of
Teflon tubing and materials in the analyzer is indicated for controlling loss
of sample ions (Candreva and Dams 1981; Danchik et al. 1980).
Young and Monat (1982) developed a dosimeter to be worn on the lapel in
the workplace for monitoring airborne fluoride vapor. A replaceable
collection element adsorbs the fluoride vapors. Samples are desorbed with
TISAR solution and analyzed on the ISE. The study authors noted its
convenience, stability, retentivity, and insensitivity to moisture at 5%-88%
humidity and competing sulfur dioxide vapors. Interference may occur from
reactive volatile fluorine compounds (i.e., uranium hexafluoride, fluorine
gas) as well as wind speed, temperature, and pressure. This dosimeter yields
a sample detection range of 0.1-387 ppm fluoride in air.
Two analytical methods for fluorine determination have been developed
based on irradiation activation of fluorine-19 (Knight et al. 1988; Shroy et
al. 1982). Instruments equipped with lithium-drifted germanium detectors
measure gamma rays for fluorine determination. This approach has a wide
application since it does not depend on a specific sample matrix or chemical
form. However, activated fluorine is unstable, and analysis may be time
consuming. Furthermore, background peaks may overlap fluorine peaks and
affect the determination.
6.3 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and programs
of the Public Health Service) to assess whether adequate information on the
health effects of fluorides is available. Where adequate information is not
available, ATSDR, in conjunction with the NTP, is required to assure the
initiation of a program of research designed to determine the health effects
(and techniques for developing methods to determine such health effects) of
fluorides.
The following categories of possible data needs have been identified by
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
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the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed.
6.3.1 Data Needs
Methods for Determining Biomarkers of Exposure and Effect. Sensitive, reproducible
analytical methods are available for detecting fluorides in biological materials
following short-term exposure (such as plasma and urine)
and long-term exposure (i.e., bone). The most prevalent technique is the ISE
method because it is reliable, simple, sensitive, and yields good recoveries
(NIOSH 1987; Venkateswarlu et al. 1971). GC is also useful for detection of
trace levels of fluoride in plasma and urine (Chiba et al. 1982; Ikenishi and
Kitagawa 1988; Ikenishi et al. 1988). Both methods can measure samples at
concentrations at which health effects may occur. Additional analytical
methods are needed for evaluating bound or organic fluorides directly from the
sample since most analytical methods require a sample preparation step to
isolate fluoride from complexes. However, the significance to fluoride
toxicology of bound or organic fluoride is unclear. Sample preparation
increases the risk of contamination and low recoveries. Thus, a need also
exists for refining initial isolation techniques.
Urinary fluoride concentration is a widely accepted biomarker of recent
fluoride exposure and has frequently been used as an indicator of fluoride
exposure in occupational studies (Chan-Yeung et al. 1983a; Kaltreider et al.
1972) and to determine exposure from drinking water (Spak et al. 1985). A
minimum fluoride level of 4 mg/L in the urine using the ISE technique has been
recommended as an indicator of recent fluoride exposure in workers (Derryberry
et al. 1963). Other possible biomarkers of fluoride exposure include fluoride
concentrations in tooth enamel (Shida et al. 1986), saliva (Peterson et
al. 1987), blood (Jackson and Hammersley 1981), and bone (Baud et al. 1978;
Bruns and Tytle 1988; Fisher 1981; Sauerbrunn et al. 1965) for which
analytical methods are available. Except for fluoride in blood, these indices
are not well established for quantitating fluoride exposure. More sensitive
methods for long-term exposure to fluorides would be useful for determining
the threshold levels that differentiate beneficial effects (caries prevention)
and detrimental effects (fluorosis). Improving methods such as ISE and GC for
other indices (plasma, tooth enamel) would be useful for more sensitive
quantitative assessment of fluoride exposure and distribution.
For biomarkers of effect following chronic exposure, investigators have
looked for skeletal fluorosis using radiographs. Bone density is a common
index used for evaluation (Kaltreider et al. 1972). Guminska and Sterkowicz
(1975) found an increase in erythrocyte enzyme activity (i.e., enolase,
pyruvate kinase, ATPase) that may reflect altered glucose metabolism during
prolonged fluoride exposure. These biochemical alterations are suggested for
possible diagnostic purposes, but they represent a response that may be
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induced in the body by a physiological change or other chemical agents.
Therefore, more specific analytical methods are needed for measuring
biomarkers of effect.
Methods for Determining Parent Compounds and Degradation Products in Environmental
Media. Human exposure to fluoride is most likely to occur from ingesting water or food
containing high levels of fluoride. Fluoride in
ambient air is another source of exposure, particularly for workers in some
occupations (smelting, electroplating, metallurgical processes). The ISE
method is the most common method for measuring fluoride in environmental
samples. It is a convenient, sensitive, and reliable method, but does not
detect bound fluorides. Several sample preparation techniques are available
for the necessary step of isolating the free fluoride ion (Dabeka and McKenzie
1981; Eyde 1982; Kakabadse et al. 1971; Lopez and Navia 1988). These methods
are usually inconvenient and yield low recoveries, along with a potential risk
of contamination. Improved collection techniques for fluoride would be useful
for increasing the accuracy and reliability of analyses.
6.3.2 On-going Studies
No on-going studies regarding techniques for measuring and determining
fluoride in biological and environmental samples were located.
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7. REGULATIONS AND ADVISORIES
Hydrogen fluoride is on the list of chemicals appearing in "Toxic
Chemicals Subject to Section 313 of the Emergency Planning and Community
Right-to-Know Act of 1986" (EPA 1987). Fluorine, sodium fluoride, and the
class of chemicals known as fluorides do not appear on that list.
No international regulations pertaining to fluorides were found. The
national and state regulations and guidelines regarding fluorine, hydrogen
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as specified
in the Toxicological Profiles.
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical adsorbed per unit
weight of organic carbon in the soil or sediment to the concentration of the chemical in
solution at equilibrium.
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or soil (i.e.,
the solid phase) divided by the amount of chemical in the solution phase, which is in
equilibrium with the solid phase, at a fixed solid/solution ratio. It is generally
expressed in micrograms of chemical sorbed per gram of soil or sediment.
Bioconcentration Factor (BCF) -- The quotient of the concentration of a chemical in
aquatic organisms at a specific time or during a discrete time period of exposure divided
by the concentration in the surrounding water at the same time or during the same period.
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group of studies,
that produces significant increases in the incidence of cancer (or tumors) between the
exposed population and its appropriate control.
Carcinogen -- A chemical capable of inducing cancer.
Ceiling Value -- A concentration of a substance that should not be exceeded, even
instantaneously.
Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified in the
Toxicological Profiles.
Developmental Toxicity -- The occurrence of adverse effects on the developing organism
that may result from exposure to a chemical prior to conception (either parent), during
prenatal development, or postnatally to the time of sexual maturation. Adverse
developmental effects may be detected at any point in the life span of the organism.
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a result of
prenatal exposure to a chemical; the distinguishing feature between the two terms is the
stage of development during which the insult occurred. The terms, as used here, include
malformations and variations, altered growth, and in utero death.
EPA Health Advisory -- An estimate of acceptable drinking water levels for a chemical
substance based on health effects information. A health advisory is not a legally




Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental concentration
of a contaminant from which one could escape within 30 min without any escape-impairing
symptoms or irreversible health effects.
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days, as
specified in the Toxicological Profiles.
Immunologic Toxicity -- The occurrence of adverse effects on the immune system that may
result from exposure to environmental agents such as chemicals.
In vitro -- Isolated from the living organism and artificially maintained, as in a test
tube.
In vivo -- Occurring within the living organism.
Lethal Concentration(LO)(LCLO) -- The lowest concentration of a
chemical in air which has been reported to have cause death m humans or animals.
Lethal Concentration(50)(LC50) -- A calculated concentration of a chemical in air to which
exposure for a specific length of time is expected to cause death in 50% of a defined
experimental animal population.
Lethal Dose(LO)(LDLO) -- The lowest dose of a chemical introduced by a route other than
inhalation that is expected to have caused death in humans or animals.
Lethal Dose(50)(LD50) -- The dose of a chemical which has been
calculated to cause death in 50% of a defined experimental animal population.
Lethal Time(50)(LT50) -- A calculated period of time within which a specific concentration
of a chemical is expected to cause death in 50% of a defined experimental animal
population.
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in a study,
or group of studies, that produces statistically or biologically significant increases in
frequency or severity of adverse effects between the exposed population and its
appropriate control.
Malformations -- Permanent structural changes that may adversely affect survival,
development, or function.
Minimal Risk Level -- An estimate of daily human exposure to a dose of a chemical that is




Mutagen -- A substance that causes mutations. A mutation is a change in
the genetic material in a body cell. Mutations can lead to birth defects, miscarriages,
or cancer.
Neurotoxicity -- The occurrence of adverse effects on the nervous system following
exposure to chemical.
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which there were no
statistically or biologically significant increases in frequency or severity of adverse
effects seen between the exposed population and its appropriate control. Effects may be
produced at this dose, but they are not considered to be adverse.
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of the concentrations
of a chemical in n-octanoland water, in dilute solution.
Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace
air averaged over an 8-hour shift.
q1* -- The upper-bound estimate of the low-dose slope of the dose-response curve as
determined by the multistage procedure. The ql* can be used to calculate an estimate of
carcinogenic potency, the incremental excess cancer risk per unit of exposure (usually
µg/L for water, mg/kg/day for food, and
µg/m3 for air).
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an order of
magnitude) of the daily exposure of the human population to a potential hazard that is
likely to be without risk of deleterious effects during a lifetime. The RfD is
operationally derived from the NOAEL (from animal
and human studies) by a consistent application of uncertainty factors that reflect
various types of data used to estimate RfDs and an additional modifying factor, which is
based on a professional judgment of the entire database on the chemical. The RfDs are not
applicable to nonthreshold effects such as
cancer.
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is considered
reportable under CERCLA. Reportable quantities are (1) 1 pound or greater or (2) for
selected substances, an amount established by regulation either under CERCLA or under
Sect. 3 11 of the Clean Water Act. Quantities are measured over a 24-hour period.
Reproductive Toxicity -- The occurrence of adverse effects on the reproductive system
that may result from exposure to a chemical. The toxicity may be directed to the
reproductive organs and/or the related endocrine system. The manifestation of such
toxicity may be noted as alterations in sexual
behavior, fertility, pregnancy outcomes, or modifications in other functions that are
dependent on the integrity of this system.
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9.  GLOSSARY
Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers can be
exposed for up to 15 min continually. No more than four excursions are allowed per day,
and there must be at least 60 min between exposure periods. The daily TLV-TWA may not be
exceeded.
Target Organ Toxicity -- This term covers a broad range of adverse effects on target
organs or physiological systems (e.g., renal, cardiovascular) extending from those
arising through a single limited exposure to those assumed over a lifetime of exposure to
a chemical.
Teratogen -- A chemical that causes structural defects that affect the development of an
organism.
Threshold Limit Value (TLV) -- A concentration of a substance to which most workers can
be exposed without adverse effect. The TLV may be expressed as a TWA, as a STEL, or as a
CL.
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged over a normal
8-hour workday or 40-hour workweek.
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route other than
inhalation, which is expected to cause a specific toxic effect in 50% of a defined
experimental animal population.
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD from
experimental data.  UFs are intended to account for (1) the variation in sensitivity
among the members of the human population, (2) the uncertainty in extrapolating animal
data to the case of human, (3) the uncertainty in extrapolating from data obtained in a
study that is of less than lifetime exposure, and (4) the uncertainty in using LOAEL data






This chapter of the profile is a health effects summary written in nontechnical language.
Its intended audience is the general public especially people living in the vicinity of a
hazardous waste site or substance release. If the Public Health Statement were removed
from the rest of the document. it would still communicate to the lay public essential
information about the substance.
The major headings in the Public Health Statement are useful to find specific topics of
concern. The topics are written in a question and answer format. The answer to each
question includes a sentence that will direct the reader to chapters in the profile that
will provide more information on the given topic.
Chapter 2
Tables and Figures for Levels of Significant Exposure (LSE)
Tables (2-1.2-2. and 2-3) and figures (2-1 and 2-2) are used to summarize health effects
by duration of exposure and endpoint and to illustrate graphically levels of exposure
associated with those effects. AU entries in these tables and figures represent studies
that provide reliable, quantitative estimates of No-Observed-Adverse-Effect Levels
(NOAELs), Lowest-Observed- Adverse-Effect Levels (LOAELs) for Less Serious and Serious
health effects, or Cancer Effect Levels (CELs). In addition, these tables and figures
illustrate differences in response by species.Minimal Risk Levels (MRLs) to humans for
noncancer end points. and EPA’s estimated range associated with an upper-bound individual
lifetime cancer risk of 1 in 10.000 to 1 in 10.000.000. The LSE tables and figures can be
used for a quick review of the health effects and to locate data for a specific exposure
scenario. The LSE tables and figures should always be used in conjunction with the text.
The legends presented below demonstrate the application of these tables and figures. A
representative example of LSE Table 2- 1 and Figure 2-l are shown. The numbers in the
left column of the legends correspond to the numbers in the example table and figure.
LEGEND
See LSE Table 2-1
(1). Route of Exposure One of the first considerations when reviewing the toxicity of a
substance using these tables and figures should be the relevant and appropriate
route of exposure. When sufficient data exist, three LSE tables and two LSE figures
are presented in the document. The three LSE tables present data on the three
principal routes of exposure, i.e., inhalation, oral, and dermal (LSE Table 2-1, 2-
2. and 2-3, respectively). LSE figures are limited to the inhalation (LSE Figure 2-
l) and oral (LSE Figure 2-2) routes.
(2). Exposure Duration Three exposure periods: acute (14 days or less): intermediate
(15 to 364 days): and chronic (365 days or more) are presented within each route of




(3). Health Effect The major categories of health effects included in LSE tables and
figures are death. systemic. Immunological, neurological, developmental,
reproductive and cancer. NOAELs and LOAELs can be reported in the tables and
figures for all effects but cancer. Systemic effects can be further defined in the
"System” column of the LSE table.
(4). Key to Figure Each key number in the LSE table links study information to one or
more data points using the same key number in the corresponding LSE figure. In this
example, the study represented by key number 18 has been used to define a NOAEL and
a Less Serious LOAEL (also see the two “18r” data points in Figure
2-l).
(5). Species the test species, whether animal or human, are identified in this column.
(6). Exposure Frequency/Duration The duration of the study and the weekly and daily
exposure regimen are provided in this column. This permits comparison of NOAELs and
LOAELs from different studies. In this case (key number 18), rats were exposed to
[substance x] via inhalation for 13 weeks, 5 days per week, for 6 hours per day.
(7). System This column further defines the systemic effects. These systems include:
respiratory, cardiovascular. gastrointestinal, hematological. musculoskeletal,
hepatic, renal, and dermal/ocular. “Other”refers to any systemic effect (e.g., a
decrease in body weight) not covered in these systems. In the example of key number
18, one systemic effect (respiratory) was investigated in this study.
(8). NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure level at
which no harmful effects were seen in the organ system studied. Key number 18
reports a NOAEL of 3 ppm for the respiratory system which was used to derive an
intermediate exposure, inhalation MRL of 0.005 ppm (see footnote “b”).
(9). LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest exposure level
used in the study LOAEL that caused a harmful health effect. LOAELs have been
classified into “Less Serious” and “Serious”effects. These distinctions help
readers identify the levels of exposure at which adverse health effects first
appear and the gradation of effects with increasing dose. A brief description of
the specific end point used to quantify the adverse effect accompanies the LOAEL.
The “Less Serious” respiratory effect reported in key number 18 (hyperplasia)
occurred at a LOAEL of 10 ppm.
(10). Reference The complete reference citation is given in Chapter 8 of the profile.
(11). CEL A Cancer Effect Level (CEL) is the lowest exposure level associated with the
onset of carcinogenesis in experimental or epidemiological studies. CELs are always
considered serious effects. The LSE tables and figures do not contain NOAELs for
cancer, but the text may report doses which did not cause a measurable increase in
cancer.
(12). Footnotes Explanations of abbreviations or reference notes for data in the LSE
tables are found in the footnotes. Footnote “b” indicates the NOAEL of 3 ppm in key




See LSE Figure 2-1
LSE figures graphically illustrate the data presented in the corresponding LSE tables.
Figures help the reader quickly compare health effects according to
exposure levels for particular exposure duration.
(13). Exposure Duration The same exposure periods appear as in the LSE table. In
this example, health effects observed within the intermediate and chronic
exposure periods are illustrated.
(14). Health Effect These are the categories of health effects for which reliable
quantitative data exist. The same health effects appear in the LSE table.
(15). Levels of Exposure Exposure levels for each health effect in the LSE tables
are graphically displayed in the LSE figures. Exposure levels are reported on
the log scale “y”axis. Inhalation exposure is reported in mg/m3 or ppm and
oral exposure is reported in mg/kg/day.
(16). NOAEL In this example, 18r NOAEL is the critical end point for which an
intermediate inhalation exposure MRL is based. As you can see from the LSE
figure key, the open-circle symbol indicates a NOAEL for the test species
(rat). The key number 18 corresponds to the entry in the LSE table. The
dashed descending arrow indicates the extrapolation from the exposure level
of 3 ppm (see entry 18 in the Table) to the MRL of 0.005 ppm (see footnote
“b” in the LSE table).
(17). CEL Key number 38r is one of three studies for which Cancer Effect Levels
(CELs) were derived. The diamond symbol refers to a CEL for the test species
(rat). The number 38 corresponds to the entry in the LSE table.
(18). Estimated Upper-Bound Human Cancer Risk Levels This is the range associated
with the upper-bound for lifetime cancer risk of 1 in 10,000 to 1 in
10.000.000. These risk levels are derived from EPA’s Human Health As.sessment
Group’s upper-bound estimates of the slope of the cancer dose response curve
at low dose levels (q1*).






Chapter 2 (Section 2.4)
Relevance to Public Health
The Relevance to Public Health section provides a health effects summary based on
evaluations of existing toxicological, epidemiological, and toxicokinetic information.
This summary is designed to present interpretive, weight-of-evidence discussions for
human health end points by addressing the following questions.
1. What effects are known to occur in humans?
2. What effects observed in animals are likely to be of concern to humans?
3. What exposure conditions are likely to be of concern to humans. especially
round hazardous waste sites?
The section discusses health effects by end point. Human data are presented first. then
animal data. Both are organized by route of exposure (inhalation, oral, and dermal) and
by duration (acute. intermediate. and chronic). In vitro data and data from parenteral
routes (intramuscular, intravenous, subcutaneous, etc.) are also considered in this
section. If data are located in the scientific literature, a table of genotoxicity
information is included.
The carcinogenic potential of the profiled substance is qualitatively evaluated, when
appropriate. using existing toxicokinetic, genotoxic, and carcinogenic data. ATSDR does
not currently assess cancer potency or perform cancer risk assessments. Marls for
noncancer end points if derived, and the end points from which they were derived are
indicated and discussed in the appropriate section(s).
Limitations to existing scientific literature that prevent a satisfactory evaluation of
the relevance to public health are identified in the identification of Data Needs
section.
Interpretation of Minimal Risk Levels
Where sufficient toxicologic information was available, MRLs were derived. MRLs are
specific for route (inhalation or oral) and duration (acute, intermediate, or chronic) of
exposure. Ideally, MRLs can be derived from all six exposure scenarios (e.g.. InhaIation
- acute, -intermediate, -chronic; oral - acute, -intermediate. - chronic). These MRLs are
not meant to support regulatory action, but to aquaint health professionals with exposure
levels at which adverse health effects are not expected to occur in humans. They should
help physicians and public health officials determine the safety of a community living
near a substance emission, given the concentration of a contaminant in air or the
estimated daily dose received via food or water. MRLs are based largely on toxicological
studies in animals and on reports of human occupational exposure.
MRL users shouid be familiar with the toxicological information on which the number is
based. Section 2.4,“Relevance to Public Health,” contains basic information known about
the substance. Other sections such as 2.6, “Interactions with Other Chemicals” and 2.7,
“Populations that are Unusually Susceptible” provide important supplemental information.
MRL users should also understand the MRL derivation methodology. MRLs are derived using a
modified version of the risk assessment methodology used by the Environmental Protection




To derive an MRL, ATSDR generally selects the end point which. in its best judgement.
represents the most sensitive human health effect for a given exposure route and
duration. ATSDR cannot make this judgement or derive an MRL unless information
(quantitative or qualitative) is available for all potential effects (e.g., systemic,
neurological and developmental). In order to compare NOAELs and LOAELs for specific end
points, all inhalation exposure levels are adjusted for 24hr exposures and all
intermittent exposures for inhalation and or,al routes of intermediate and chronic
duration are adjusted for continous exposure (i.e., 7 days/week). If the information and
reliable quantitative data on the chosen end point are available, ATSDR derives an MRL
using the most sensitive species (when information from multiple species is available)
with the highest NOAEL that does not exceed any adverse effect levels. The NOAEL is the
most suitable end point for deriving an MRL. When a NOAEL is not available, a Less
Serious LOAEL can be used to derive an MRL, and an uncertainty factor (UF) of 10 is
employed. MRLs are not derived from Serious LOAELs. Additional uncertainty factors of 10
each are used for human variability to protect sensitive subpopulations (people who are
most susceptible to the health effects caused by the substance) and for interspecies
variability (extrapolation from animals to humans). In deriving an MRL, these individual
uncentainty factors are multiplied together. The product is then divided into the
adjusted inhalation concentration or oral dosage selected from the study. Uncertainty
factors used in developing a substance-specific MLR are provided in the footnotes of the
LSE Tables.








